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ABSTRACT
Polioviruses are single stranded RNA viruses and members of the picomavirus family. 
They have an unusually long non coding region at the 5’ end which has elaborate secondary 
structure predicted to be made up of seven domains. Part of the secondary structure 
constitutes an internal ribosome entry site (1RES) which allows the virus to utilise cap- 
independent initiation of translation whilst disabling the host cell’s cap-dependent 
translation. Translation inefficiencies originally caused by disruptions of the secondary 
structure of domain V could be compensated for in monkey kidney cells in vitro by coding 
changes in the protease 2A. These coding changes were found throughout the protease 
which is otherwise quite highly conserved in polioviruses. They appear to have no effect 
on monkey neurovirulence and their activity was found to be cell specific, having little or 
no compensatory effect in a mouse cell line. Using this cell line to investigate the effects 
of mutations in functionally significant secondary structure of domain V on virus growth 
highlighted unpaired loops as being important. Shortening one loop was detrimental to the 
virus whereas the sequence of the loop was much less important. In addition, flexibility at 
another position between two stems appeared to be critical and mutations that could 
potentially alter the folding in this area rendered the virus temperature sensitive.
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This Egyptian funerary stele, dated around 1300BC, probably 
depicts the earliest record of poliomyelitis. The priest, 
Rom, shows a withered leg and dropped foot, typical signs 
of paralytic poliomyelitis. The stele currently resides in the 
Ny Carlsberg Glyptothek museum in Copenhagen.
IV
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which this thesis is a part.
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CHAPTER ONE
INTRODUCTION
1.1 GENERAL INTRODUCTION
Poliomyelitis derives its name from the Greek words ‘polios’ meaning grey and ‘muelos’ 
meaning spinal cord and polioviruses are the causative agents of the disease. It refers to 
the destruction of the neurones in the grey matter of the spinal cord, a characteristic of the 
less common but more visible major illness responsible for paralysis. An Egyptian 
funerary stele dated around 1300BC depicting the priest Rom with a withered limb is 
probably the earliest record of the disease but very few descriptions were documented until 
around the turn of this century. In 1988 the WHO announced its intention of totally 
eradicating poliomyelitis by the year 2000. Although here in Great Britain and developed 
countries such as the USA the occurrence of poliomyelitis is now extremely rare there still 
remain a number of places in the world where the disease is common (see fig 1.1) and the 
W HO’s target may need to be extended.
Key: g g  : Countries with no reported cases of indigenous poliomyelitis in 1988.
B  : Additional countries with no reported cases of indigenous poliomyelitis in 1994.
FIGURE L I  Countries with no indigenous poliovirus. The countries that had no reports 
of wild type virus infections by the year 1988 are coloured blue and the 
additional countries that have no reports of wild type virus infections 
between 1988 and 1994 are coloured red. Adapted from WHO CVI Forum, 
No 9, 1995.
Before the introduction of vaccines poliomyelitis was understandably feared, much as 
ADDS is today. The non reversible paralysis and life in an ‘iron lung’, although 
statistically rare complications of poliomyelitis, were very apparent to the general public. 
Numerous outbreaks in the first half of this century were instrumental in initiating the 
search for an effective vaccine but funding for this was intensified only in 1933 when F D 
Roosevelt, severely paralysed by poliomyelitis, became president of the United States. 
Passionate appeals from the president for sponsorship were successful and enabled first 
Jonas Salk, then Albert Sabin to formulate the vaccines that are still in use today.
1.2 THE VIRUS
1.2.1 GENERAL
Polioviruses are classified as members of the enterovirus genus of the Picornaviridae 
family. Currently there are five genera with the suggestion that some echoviruses now 
form a genus on their own called orphanovirus (fig 1.2). Picom aviruses derive their name 
from being small (pico) RNA viruses. The family of viruses is implicated in a wide range 
of diseases but all members share similar genomic and structural features.
PICORNAVIRIDAE
ENTEROVIRUSES HEPATOVIRUSES CARDIOVIRUSES RHINOVIRUSES APHTHOVIRUSES ORPHANOVIRUSES
J  I \  \  y  \  (P R E V IO U S L Y
PO L IO V IR U S E S
C O X SA C K IE V IR U S E S
E N T E R O V IR U S E S  H E PA T IT IS  A 
V IR U S
M E N G O  
VIR U S
M O U SE  C O L O M B IA  
E N C E PH A L O - V IR U S 
M Y E L IT IS  
V IR IS
M M  H U M a H b o v i n e
E C H O V IR U S E S )
/  \
E C H O V IR U S E C H O V IR U S
22 23
FIGURE 1.2 Diagram of the Picornaviridae family illustrating the five genera:
enterovimses; hepatovimses; cardioviruses; rhinoviruses; aphthoviruses 
and the suggested sixth genus, orphanoviruses. Representative vimses of 
each genus are shown.
Polioviruses are approximately 27nm in diameter, non enveloped and have a single copy of 
positive strand RNA approximately 7500 nucleotides long. They occur in three serotypes: 
type 1 ; type 2 and type 3 with type 1 responsible for most wild type paralytic infections, 
type 3 being found in a small proportion and type 2 in very few. A number of different 
strains of virus exist including the 3 attenuated Sabin strains that are used in the oral 
vaccine and many wild type viruses recovered from human cases of the disease e.g. 
Mahoney (type 1) and Leon (type 3). The first complete viral sequence to be published was 
of a type 1 Mahoney virus (Kitamura et al,  1981) and many others have followed 
(Racaniello & Baltimore 1981a; Nomoto et a l,  1982; Toyoda et a l,  1984; Stanway et al,  
1984a; Cann et a l,  1984; Hughes et al,  1986; Pollard et al,  1989; reviewed in Stanway
1990). Humans are the only natural host for the virus although some primates can be 
infected. Polioviruses can be adapted to infect mice (Armstrong 1939a; Armstrong 1939b; 
Racaniello 1984; La Monica et al,  1986) but once the human poliovirus receptor gene was 
cloned (Mendelsohn et al,  1989) various transgenic murine lines were made (Ren et al, 
1990; Jubelt et a l,  1991) and research into their use as animal models of infection is on­
going.
1.2.2. STRUCTURE OF THE VIRUS
The viral capsid is made up of 60 copies of each of the virion proteins, V P l, VP2, VP3 and 
VP4. They form an icosahedral particle (see figs 1.3 & 1.4), whose structure has been 
determined by x-ray crystallographic methods (Hogle et al,  1985), made up of sixty 
subunits called protomers. Although the capsid proteins share no sequence homology they 
share a common structural core in the shape of a triangular wedge consisting of an eight 
stranded antiparallel beta barrel or ‘jelly-rolP (Hogle et a l,  1985). Length and
conformation of the loops connecting the beta barrel strands provide the greatest 
differences between the capsid proteins.
FIGURE 1.3 Transmission electron micrograph of poliovirus at a magnification of X 
210,000. The specimen was prepared with negative staining using 4% 
aqueous sodium silicotungstate. The virus particles are icosahdral in 
shape and approximately 27nm in diameter. Electron microscopy by Dr 
D Hockley, NIBSC.
1.2.3 ASSEMBLY OF THE VIRUS PARTICLE
The viral genome is translated as a single polyprotein which is initially cleaved 
autocatalytically during translation by the protease 2A which hydrolyses the peptide bond 
at its own amino terminus to separate the capsid precursor (P I) and the non structural 
precursor (P2P3) (Toyoda et al., 1986). PI is initially cleaved to give peptides VPO, V Pl 
and VP3 which together form a protomer. Protomers then form pentamers which are able 
to form empty capsids (Palmenberg 1982). Later cleavage of VPO to give VP4 and VP2 
during RNA encapsidation (Palmenberg 1982) allows complete assembly of pentamers 
resulting in the icosahedral structure, fig 1.4 and an increase in stability. V P l, VP2 and 
VP3 are ordered together on the outer surface with VP4 internal which is myristoylated
(Chow et al., 1987; Paul et al,  1987). The myristoyl group is necessary for viral infectivity 
(Marc et a l ,  1989; Krausslich et a l,  1990). A lipid, possibly sphingosine is inserted into 
each V Pl molecule.
V Pl
VP2,
V P 3
B
PI
FIGURE 1.4 A. A geometric representation of the icosahedral structure of a poliovirus 
particle showing approximate positioning of capsid proteins V P l, VP2 
and VP3, VP4 is internal. Fivefold symmetry at the pentameric axis is 
shown.
B. Space filling models showing the positions of the surface polyproteins. 
The figure on the left is of the entire virus particle and the figure on the 
right shows a single pentamer. V Pl is coloured blue, VP2 is yellow 
and VP3 is red. VP4 is internalised and therefore not shown.
1.2.4 INTERACTION WITH THE POLIOVIRUS RECEPTOR
A deep canyon surrounding the fivefold axis of each pentamer (indicated in fig 1.4) was 
suggested to act as a receptor attachment site (Rossmann et al,  1985). This would place it 
relatively inaccessible to the host’s antibodies avoiding structural changes arising from 
antigenic escape mutations. The equivalent canyon in rhinoviruses was confirmed as a 
receptor binding site by cryoelectron microscopy (Olsen et al,  1993) but similar 
techniques have also detected a FAB (fragment antigen binding) particle of a strongly 
neutralising antibody bound into the canyon of a rhinovirus (Smith et a l,  1996). Binding 
to the receptor brings about a conformational change in the capsid that releases the RNA 
into the cytoplasm (de Sena & Mandel 1977). In contrast, a conformational change was 
found to occur in the FAB fragment on binding. Unlike the receptor, the antibody 
fragment was not found to reach the ‘floor’ of the canyon where amino acid sequence is 
highly conserved (Rossmann & Palmenberg 1988). The virus is therefore able to conserve 
the shape of the receptor binding site, required for subsequent entry of the virus into the 
cell, but still escape antibody recognition by mutating amino acids further up the wall of 
the canyon.
The human poliovirus receptor gene was cloned and its secondary structure deduced by 
examination of the amino acid sequence (Mendelsohn et al,  1989). It was found to be an 
integral membrane protein and a member of the immunoglobulin superfamily. The long 
extracellular region at the amino terminus is thought to fold into three domains which are 
highly conserved across the family. The receptor for poliovirus was the third viral receptor 
to be identified as an immunoglobulin following CD4, the major receptor for H IV l, 
(Maddon et a l,  1986) and ICAM-1, the major rhinovirus receptor (Greve et a l,  1989; 
Staunton et a l,  1989). Recently the receptor for coxsackie B viruses and adenoviruses 2
and 5 was identified as yet another transmembrane immunoglobulin (Bergelson et al., 
1997).
On binding to its receptor poliovirus undergoes a large conformational change where VP4 
is lost (de Sena & Mandel 1977) and the amino terminus of V Pl is externalised (Fricks & 
Hogle 1990). It is the exposed V Pl terminus which is responsible for liposome 
attachment, an action which is thought to facilitate the transport of viral elements across 
the cell membrane. The conformational change results in an increase in sensitivity of the 
virus to detergents and protease activity and a decrease in sedimentation rate of 160S to 
135S (de Sena & Mandel 1977). The viral RNA is also sensitive to RNaseA in the 
presence of SDS but still encapsidated (Guttman & Baltimore 1977) and this altered (A) 
particle, eluted from cells is uninfectious (Holland 1962). This particle can however infect 
Chinese hamster ovary cells or murine L cells which are normally non permissive (Currey 
et al., 1996). The RNA is then released into the cell and becomes RNaseA sensitive 
without the presence of SDS, losing all capsid protein protection (Guttman & Baltimore 
1977).
1.2.5 THE GENOME OF THE VIRUS
The poliovirus genome contains a relatively long NCR at the 5 ’ end with an elaborate 
secondary structure and a shorter NCR at the 3 ’ end followed by a poly-A tail. A single 
large open reading frame codes for the four structural proteins and the non structural 
proteins. A schematic of the genome is shown in fig 1.5. Many functional proteins that 
would appear to be precursors made up of two individual uncleaved proteins have also 
been identified as having specific activities during the life cycle of the virus.
VP4__________________________________________________________________________________3’NCR
(VPg-“ VP2 VP3 VPl 2A 2B 2C 3A 3C 3D — (A)n
3B
STRUCTURAL PROTEINS
----------------------------------- ►  NGN-STRUCTURAL PROTEINS
FIGURE 1.5 A  schematic of the polioviral genome showing the positions of the
individual protein genes, the noncoding regions and the 5’linked protein 
VPg.
W hile the polyprotein is translated, cleavage into the individual proteins is carried out by 
the proteases 2A, 3C and 3CD. 2A cleaves between tyrosine-glycine pairs and will be 
discussed later in greater detail. 3C cleaves between glutamine-glycine. The protease 3CD 
consists of sequences from both 3C and 3D and is involved in processing of the PI 
precursor (lore et al., 1988). Recently 3CD has been implicated in the binding of a 38kDa 
cellular protein to the 3 ’ end of the negative viral RNA strand during replication (Roehl et 
al., 1997). The protein 3D is itself an RNA-dependent RNA polymerase and the 3D 
component of 3CD may alter the protease recognition site. 3C was also found to be able to 
bind to RNA (Andino et al., 1993) and its role in replication is discussed later. The 
expression of 2B has also been shown to cause the disassembly of the golgi complex and 
the swelling of the endoplasmic reticulum (Sandoval & Carrasco 1997), it is the golgi 
complex that is the target for the anti-polioviral drug Ro (Ishitsuka et al., 1982a; Ishitsuka 
et a l,  1982b). This supports the hypothesis that the replication of viral RNA is carried out 
on these membranes (Guinea & Carasco 1990). 2C is involved in RNA synthesis (Li & 
Baltimore 1988) and may have helicase activity but can be provided in trans and is also 
involved in determination of the virion structure (Li & Baltimore 1990). 3B, otherwise 
known as VPg, is bound to the 5 ’ end of the viral genome but when it is present as 3AB it 
may act as a co-factor of 3D (Lama et al., 1995). The protein 2BC was shown to block the 
exocytic pathway of Saccharomyces cerevisiae (Barco & Carrasco 1995), arresting cell
growth and stimulated the formation of small membranous vesicles in the cytoplasm of 
mammalian cells. Poliovirus RNA is thought to be translated and transcribed in these 
vesicles (Caliguri & Tamm 1969; Guinea & Carrasco 1990) and infected cells are 
stimulated to synthesise phospholipids which are used in vesicle formation (Mosser et al., 
1972). The function of 3A is still unknown although 3A and 2C have affinities for cell 
membranes (Takegami et al., 1983; Bienz et al., 1987).
1.3 THE 5 ’ NONCODING REGION
1.3.1 SECONDARY STRUCTURE
The 5 ’NCR of polioviruses, approximately 740 nucleotides long, forms a very complex 
secondary structure as inferred by electron microscopy (Currey et al., 1986), comparative 
sequence analysis and mutant-revertant analysis and validated by analysis with single and 
double strand specific reagents (Rivera et al., 1988; Pilipenko et al., 1989; Skinner et al., 
1989; Le & Zuker 1990). The region is divided into 6 distinct domains and a schematic is 
shown in figure 1.6 although more structural folding probably forms. The sequence of the 
5’NCR is highly conserved within the poliovirus family and also across the enterovirus and 
rhinovirus genera. Comparison between members of the picornaviridae family largely 
reveal a structural conservation more than a sequence conservation (Jackson et al,  1994) 
but all function in the same way. Sequence is however fairly well conserved between the 
three poliovirus serotypes.
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FIGURE 1.6 A representation of the secondary structure of the 5 ’NCR of polioviruses 
showing probable positions of domains I - VI, the VPg protein linked to 
the very 5’ end, the oligopyrimidine tract and the initiating AUG codon in 
domain VI, depicted as solid rectangle (Filipenko et ai,  1989; Skinner et 
al., 1989; Le & Zuker 1990).
The 5 ’NCR of polioviruses contains both replication and translation signals and is an 
important regulatory element of the genome. Domain I forms a ‘cloverleaf ‘ that is 
required in replication for synthesis of a positive sense strand of RNA although very little 
is known about the whole process. Domains II, IV, V and VI but not III together form the 
internal ribosome entry site or 1RES which is responsible for directing ribosomes onto the 
RNA for internal initiation of translation.
1.3.2 DOMAIN V
Determinants of attenuation in all 3 Sabin strains of poliovirus are found in domain V of 
the 5 ’NCR (fig 1.7) and this domain forms part of the 1RES. Attenuating mutations in the 
5’NCR can also give rise to a cell specific temperature sensitive phenotype (Macadam et 
al., 1992). They can all be rationalised as bringing about a change in the base pairing of 
the structure and disrupt the predicted secondary structure of the domain. This is verified 
in that revertants of these viruses that have become more virulent carry either direct back
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mutations or second site mutations in the complementary strand allowing a new base 
pairing to retain overall shape. For example, in the type 1 virus, the base pair 480/525 
(483/528 in type 3 numbering of fig 1.7) changes from A/U to G/U in Sabin 1 which 
attenuates the virus. Neurovirulent revertants were found to have a G to A change at 480 
or a U to C change at 525 which would re-form the base pair as either AU or GC (Skinner 
et al., 1989; Christodoulou et al., 1990; Muzychenko et al., 1991).
C c — 5 0 0  
C A
*A c '° c  (d)
4 9 0  A A
C *G
G • C ^ ^ 510 
G - C (c)
A -U
A 480 , 0 . 0 ^ ^ 5 1 4
U ^ C C A U G G A  Q
C.  n  r; 11 n  r. n  11 U
FIGURE 1.7 A representation of the predicted secondary structure of domain V of the 
5 ’NCR of poliovirus using a type 3 Leon virus as example (Skinner et al., 
1989). Stems are labelled for descriptive purposes.
Similarly a number of viruses were constructed with mutations around the stem formed by 
bases 466 - 478 and 533 - 540 of a type 3 domain V (M acadam et al., 1992). By 
calculating the predicted free energy (AG) and the probable structures of the constructs it 
was possible to show that extent of disruption correlated with the extent of temperature 
sensitivity in BGM cells. For example simply swapping the base of 472/537 from C/G to 
G/C hardly affected the phenotype but replacement by the weaker base pair UA decreased 
stability of the structure and increased temperature sensitivity. Furthermore, different 
temperature sensitive phenotypes were found in different cell lines, implicating this 
structure in interaction with cell derived factors.
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The secondary structure of the 5 ’NCR is therefore apparently very important to the virus. 
A correctly formed secondary structure would allow specific pockets and bulges to 
assemble so that interaction with both viral and cellular factors can occur for efficient 
replication and translation.
1.3.3. TERTIARY STRUCTURE
Little is known about the tertiary structure within the 5 ’NCR, the only evidence to date 
relies on computer predictions. Analysis of highly conserved sequence in enteroviruses 
and rhinoviruses has identified a possible pseudoknot (two loops of secondary structure 
which intertwine) at the 3’ end of the 5 ’NCR (Le et al,  1992). As part of the 1RES the 
pseudoknot could be responsible for binding to cellular proteins in the initiation of 
translation and the pyrimidine rich stretch downstream from this could act in a similar way 
to the Shine-Dalgarno sequence of prokaryotic cells. A similar structure was later 
predicted for EMCV, FMDV, hepatitis A virus and Theiler’s murine encephalomyelitis 
virus (Le et al,  1993).
In addition to this another pseudoknot was also suggested to form between domains IV and 
V on observation of coupled mutations generally found in Sabin 2 (M uzychenko et ai,
1991). The changes at 398 and especially at 481 are both determinants of attenuation but 
are generally found to have reverted simultaneously in viruses excreted post immunisation. 
However no analogous coupled changes happen in the other Sabin strains giving little 
evidence to support this formation.
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1.4 REPLICATION
The cloverleaf structure of domain I contains replication signals. Interaction with the viral 
protein 3CD and a cellular protein forms a membrane associated complex that is required 
for synthesis of positive sense RNA from a negative sense template. In contrast the 
cloverleaf structure is not required in the negative strand (Andino et a l,  1990; Andino et 
al,  1993). The cloverleaf formed by the positive sense strand appears to be a requirement 
in trans for this complex to form before replication can occur and can of course be 
provided by the RNA of the infecting viral particle for the initial round of synthesis. The 
complex is not essential for negative strand synthesis.
There are a number of viral proteins involved in replication. Fundamentally 3D is a 
template and primer dependent RNA polymerase (Flanegan & Van Dyke 1979). 3CD 
binds near the 5 ’ end of viral RNA in the replication complex (Andino et al,  1990; Andino 
et a l,  1993) and 3CD/3C is also thought to be responsible for proteolytic modification of a 
cellular protein (Roehl et a l,  1997). Only the modified 38kD form of this protein appears 
to have a high affinity for binding to the 3’terminus of the viral negative RNA strand. 
From deletion mutants, residues 5-10 of this strand were found to be essential for viral 
replication (Roehl et a l,  1997). In addition the protease 3C is responsible for inhibiting 
transcription by cellular polymerase HI, converting the active form of transcription factor 
m e  to an inactive form (Clarke et al,  1991). 2C has a nucleotide binding m otif (Barton et 
al,  1995) and 2B may be required in cis as 2BC (Johnson & Sarnow 1991) but the 
requirement in replication of these proteins is unknown. The membrane associated 
precursor 3AB may act to deliver 3B (VPg) (Giachetti & Semler 1991) but it has also been 
implicated as a co-factor of the polymerase 3D (Lama et al,  1995).
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1.5 TRANSLATION
M ost cellular mRNAs have a capped extreme 5 ’ end of m^GpppNp structure which is 
utilised in cap-dependent protein synthesis. According to the scanning model (Kozak 
1978, Kozak 1989) the initiation complex binds to the RNA at the cap structure, moves 
along and synthesis begins at the first AUG codon in the correct context on the RNA. In 
contrast, poliovirus RNA terminates at the 5 ’ end with pUp (Hewlett et a l,  1976; Nomoto 
et a l,  1976). A small virally encoded protein, VPg, is attached to the 5 ’ end and is cleaved 
off before translation begins. The virus instead uses a cap-independent process for protein 
synthesis where the secondary structure of the 5’NCR acts as an internal ribosome entry 
site (1RES) and protein synthesis begins at the 9th AUG codon. This alternative translation 
initiation allows polioviruses to shut off host cell cap-dependent translation (see below), 
freeing the host cell translation machinery to synthesise viral proteins.
1.5.1 THE INTERNAL RIBOSOME ENTRY SITE
Evidence for initiation of protein synthesis by internal ribosome entry stemmed from the 
construction of bicistronic constructs with 2 reporter genes separated by the 5 ’NCR of a 
picomavirus (Pelletier & Sonenberg 1988, Jang et al, 1988). In infected cells the 
downstream cistron was found to be translated in greater amounts than the upstream cistron 
under the control of a capped RNA leader where as in the absence of the 5 ’NCR the 
downstream cistron was translated very inefficiently. This is consistent with the idea that 
few ribosomes are able to scan through the intercistronic region once translation of the first 
cistron has finished and that the secondary structure of the NCR would completely block 
scanning. Confirmation that internal initiation of translation does not require a free RNA 
5’ end was provided when a circular construct containing an EM CV 1RES was prepared
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(Chen & Samow 1995). Translation from the open reading frame placed after the 1RES 
was achieved in vitro without linearisation.
The position of the 1RES in the 5 ’ NCR lies upstream of the initiating AUG codon which is 
found at position 743 in type 3 polioviruses and has been located by the construction of 
deletion mutants (lizuka et al,  1989; Filipenko et al,  1989; Nicholson et a l,  1991; Percy 
et a l,  1992; Haller et a l,  1993). The 1RES spans a large part of the 5 ’NCR, incorporating 
domains H, IV, V and some of domain VI (fig 1.6). The conserved U-rich tract found 
between domains V and VI acts as a length specific spacer and is thought to allow the 
correct AUG codon to be brought into alignment. The ribosome therefore appears to be 
directed into place by the three dimensional structure formed by the 5 ’NCR. The unpaired 
bases found at the loop segments which are highly conserved are thought to interact either 
with the ribosome or other trans-acting proteins (Jackson et a l,  1994) or RNA in the 
tertiary structure. Defective 1RES elements contained in bicistronic constructs can 
however be complemented in trans by the coexpression of the poliovirus genome (Percy et 
al,  1992; Stone et al,  1993). The complementation required a very high level of sequence 
conservation as only intact poliovirus 1RES elements were able to successfully rescue a 
defective poliovirus 1RES elements. This suggested interactions between RNA molecules 
was possible or that transfer of the assembled ribosome initiation complex to the defective 
1RES element can occur.
There are 3 distinct 1RES and 5’NCR structures found among picomaviruses. The first is 
found in polioviruses, coxsackieviruses, rhinoviruses and enteroviruses and the second is 
found in cardioviruses and aphthoviruses. The third, found in hepatitis A virus is 
significantly different to exist in its own group (Jackson et al, 1994). The IRESes have 
slightly different functional ribosome entry sites. The first group which includes
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polioviruses direct the translational complex onto a non initiating AUG triplet which then 
moves to the authentic triplet, probably in a scanning like way (Pelletier & Sonenberg
1988). In contrast the second group of IRESes direct the complex directly to the authentic 
AUG triplet (Kaminski et a i,  1990). The hepatitis A 1RES is twenty five times less 
efficient than an EMCV virus in tissue culture and this is thought to reflect a reduction in 
affinity for cellular factors and a possible reason why the virus grows so slowly in vitro 
(Brown et a l,  1994).
The cardiovirus and aphthovirus RNAs are very efficient templates of translation in rabbit 
reticulocyte lysates whereas poliovirus, enterovirus and rhinovirus RNAs are translated 
inefficiently and incorrectly due to requirement of cellular factors from nucleated cells. In 
artificially made constructs the 1RES elements of EMCV can initiate translation from 
poliovirus RNA in cis with no detrimental effect on virus growth (Alexander et al., 1994). 
Mutant forms of the EMCV 1RES elements were also complemented in trans by 
coexpression of a positive sense intact EMCV 1RES element with no evidence of 
recombination (Roberts & Belsham 1997). In addition the cloverleaf and the 1RES seem to 
be functionally independent and non overlapping elements of the 5 ’NCR as constructs 
containing the cloverleaf of poliovirus and the 1RES of EM CV are fully functional (Rohll 
et al., 1994).
The initiation of translation of polioviral RNA requires trans-activating factors in addition 
to canonical initiation factors. This was apparent from in vitro translation studies using 
rabbit reticulocyte lysates as a translational model. Proteins synthesised were found to be 
unlike proteins produced in vivo and initiation was found to occur towards the 3 ’ terminus. 
This phenomenon was rectified with the addition of a HeLa cell or Krebs-2 cell extract
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which provided a cellular factor or factors missing or in limiting quantities in the lysates 
(Brown & Ehrenfeld 1979; Dorner et al., 1984; Phillips & Emmet 1986). Addition of this 
factor was also found to be less active for RNA from an attenuated type 2 virus than from a 
neurovirulent type 2 virus, highlighting the importance of the change at residue 481 in 
attenuation and translation (Svitkin et al., 1988).
1.5.2 INTERACTION OF CELLULAR PROTEINS W ITH THE 5’NCR 
There have been numerous accounts of proteins binding to various portions of the 5’NCR 
of polioviral RNA but the most recent work involves a 52kDa protein that bound to RNA 
at resides 559-624 and was found to be present in HeLa cells but not rabbit reticulocyte 
lysates (Meerovitch et al., 1989). This protein was then identified by protein sequencing to 
be the La autoantigen (Meerovitch et a l,  1993) which is a human antigen recognised by 
antibodies in sufferers of systemic lupus erythematosus and Sjogren’s syndrome (Tan 
1989). It functions in transcription of RNA by polymerase III in vitro (Gottlieb & Steitz
1989) and contains an RNA binding site (Kenan et al,  1991). A recombinant form of this 
protein was found to stimulate the translation of poliovirus RNA in the lysates and correct 
the aberrant initiation at the same time, although at levels far in excess of those present in 
the cell.
Investigations have found that a deletion of the C-terminal half of the La protein abolishes 
its effect on translation but still enabled binding to the 5 ’NCR of poliovirus. The protein is 
usually found in the nucleus but appears to move to the cytoplasm during poliovirus 
infection where it would be utilised. In addition, out of a number of proteins tested, only 
La, guanine nucleotide exchange factor (GEE) and eIF-2 were found to stimulate initiation 
of polioviral protein synthesis at the authentic site at the 5 ’ end (Svitkin et al,  1994). It has
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also been reported that immunodepletion of La from HeLa cell lysates represses poliovirus 
translation although this effect could not be rescued by supplementation with La (Belsham 
& Sonenberg 1996).
A 57 kDa protein (p57) was also found to bind the 5’NCR of poliovirus. It was initially 
found by mutation of the conserved oligopyrimidine tract at the position 559-565 and the 
use of UV-cross linking with extracts from HeLa cells (Pestova et al., 1991). Translation 
of poliovirus RNA was inhibited by competition with the p57 binding domain from the 
5’NCR of EMCV (Pestova et a l ,  1991) but p57 does not stimulate internal initiation of 
translation on human rhinovirus RNA by itself (Borman et at., 1993). The same protein 
was also found to interact with the 1RES of foot and mouth disease virus and was detected 
in HeLa cell extracts as well as in rabbit reticulocyte lysates (Luz & Beck 1991).
This 57kDa protein was found to be the pyrimidine tract-binding protein (PTB) (Hellen et 
al.y 1993) which is a cellular protein with at least two binding domains found to bind to 
various RNA or ssDNA sequences (Brunei et al., 1996). Purified recombinant PTB bound 
specifically to a bulged hairpin of the 1RES of EMCV more strongly than to a mutated 
version and inununodepletion of the protein from HeLa cell extracts inhibited translation of 
poliovirus RNA. PTB was also found to compete with human glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) for binding to the 1RES of hepatitis A virus (Schultz et a l,  
1996). Human GAPDH is thought to have an adverse effect on internal initiation of 
translation because it destabilises RNA secondary structure.
Although three binding sites have been identified in the 5’NCR of poliovirus, at 70-288, 
443-539 and 630-730, (Hellen et al., 1994) the function of PTB in translation is still not
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clear. The attenuating mutation of A to G at 480 does not alter the UV cross linking of 
PTB to domain V and the 630-730 region can be deleted in poliovirus RNA without effect 
in tissue culture. It is suggested that PTB is responsible for bringing a number of regions 
of the 5’NCR together to promote interaction of the 40S ribosome subunit with the RNA in 
the 5’NCR (Pestova et a l,  1991) or it could be acting as a chaperone. But as with all 
protein binding assays, evidence that a protein will interact with RNA from UV cross 
linking does not necessarily mean it is functionally significant.
Recently La, along with other RNA binding proteins hnRNP A l and PTB have been 
identified as able to prevent spurious intiations at aberrant translation sites in cap- 
dependent translation (Svitkin et al, 1996). It is proposed that these proteins bind to the 
RNA and prevent the ribosomal complex from recognising other AUG codons. This could 
explain how translation systems which lack such factors allow incorrect translation of 
poliovirus RNA and gives La a role in both types of translation initiation.
1.5.3 INTERACTION OF CELLULAR TRANSLATION INITIATION FACTORS 
From work using the EMCV 1RES, cap-independent initiation of translation was found to 
require the same canonical initiation factors as cap-dependent initiation of translation 
(Pestova et a l,  1996a). This involved primer extension to confirm accurate initiation 
complex formation with and without the addition of purified components and initiation 
factors. From this, purified cIF2, eIF3, eIF4F, Met-tRNAi^^ (the initiating tRNA molecule 
carrying methionine), ATP, GTP and 40S ribosomal subunits were found to be required for 
the 48S complex to form on the 1RES in vitro. eIF4B and PTB were not found to be 
essential but were able to enhance complex formation. This meant that neither mechanism
2 0
of initiating translation required other specific factors and implied that the 1RES structure 
itself, not IRES-specific factors is able to direct internal entry of ribosomes.
In cap-dependent initiation eIF2F promotes binding of the initiating Met-tRNAi^®  ^to 40S 
subunits and this is stabilised by eIF3, forming a 43S complex. eIF3, along with other 
factors, is then responsible for promoting binding of the 43S complex to the RNA. The 
cap-binding complex eIF4F then assists the 43S complex to bind near the RNA 5’ cap by 
interacting with eIF3. In cap-independent initiation the complex binds internally to the 
1RES.
eIF4F itself is made up of three subunits: eIF4A, a helicase; eIF4E, the cap-binding protein 
and eIF4G (formerly called p220, eIF-4y, eIF-4Fy). Cap-independent initiation on an 
EMCV 1RES was found to require only the eIF4A and eIF4G subunits (Pestova et a l,  
1996a). Infection with picomaviruses results in the inhibition of cap-dependent translation 
which correlates, for rhinoviruses, aphthoviruses and enteroviruses, with the cleavage of 
eIF4G by a viral protease to allow viral cap-independent translation to take precedence in 
the cell (Etchison et a l,  1982; Etchison & Font 1985; Kraussllich et a l ,  1987; Devaney et 
al,  1988).
The functional domains of eIF4G were mapped by using purified cloned deletion mutants 
in vitro. Cap-independent initiation was found to require only the central third of the 
protein which was found to Specifically bind to an EMCV 1RES up-stream of the initiation 
codon (Pestova et a l,  1996b). eIF4E interacts toward the amino-terminus of eIF4G while 
eIE3 and eIF4A interact towards the carboxy-terminus. eIF4A however is able to bind to 
the 1RES without the carboxy-terminus of eIF4G. It is eIF4A that unwinds RNA, probably 
downstream of where it binds, to allow entry of a single stranded region into the binding
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site of the 40S ribosome subunit (Pause et al., 1994a). This requires ATP (Ray et al., 
1985; Pestova et a l,  1996a).
1.5.4 CLEAVAGE OF eIF4G
The enteroviruses and rhinoviruses cleave eIF4G with the protease 2A whereas the 
aphthoviruses (FMDV) cleave with the unrelated L protease (Medina et a l,  1993). The 
cleavage sites are only 7 residues apart and have the same effect (Kirchweger et a l,  1994). 
Cleavage of eIF4G by 2A and L separates eIF4E, which is bound to eIF4G, from the rest of 
the cap binding complex, removing the ability of the complex to bind to the cap structure 
and cap-dependent translation is inhibited (Lamphear et a l,  1995) (see fig 1.8). In the 
picomaviridae family, only the enteroviruses, the rhinoviruses and the aphthovirus induce 
shut off of host cell translation by eIF4G cleavage. Hepatitis A virus and some echoviruses 
(orphanoviruses) do not stimulate an inhibition of host cell translation in infected cells 
(Coller et a l,  1990) and no eIF4G cleavage is detected (Coller et a l,  1991). The 
cardioviruses are thought to inhibit cell translation by simple competition of viral and 
cellular RNA but may also induce a change in ion concentration to assist this (Svitkin et 
al,  1978; Mosenkis e ta l ,  1985; Duke e ta l ,  1992).
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FIGURE 1.8 A simplified diagram to show the cleavage effect of 2A  and L proteases on 
eIF4G of the initiation complex. eIF4G is lost from the complex which 
results in loss of cap-binding ability. Adapted from Belsham &
Sonenberg (1996).
Initial evidence indicated that poliovirus protease 2A altered an unknown cellular protease 
which then cleaved eIF4G because the ‘p220ase’ cleavage activity seemed to be scpâiate 
from 2 A. Anti-2 A serum failed to block eIF4G cleavage (Lloyd et a l,  1986) and eIF3 
appeared to be required (Wyckoff et a l,  1990; Wyckoff et a l,  1992). This was overturned 
when coxsackievirus and rhinovirus recombinant 2A was found to be able to directly 
cleave the factor without the presence of eIF3 (Lamphear et a l,  1993). It is conceivable 
that poliovirus 2A acts in a different way but unlikely because of the high homology 
between the proteins and the difference could be due to poor purification of proteins in the 
initial experiments. eIF4G also has a binding site for eIF3 which could give confusing co­
purification results.
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Complete removal of the RNA coding for the leader protein in FMDV produces a viable 
virus but one which has a slower replication cycle, a delayed initiation of viral protein 
synthesis and is less efficient in host cell protein synthesis shut off (Piccone et a l,  1995). 
A virus of this construction has been found to be a possible attenuated vaccine candidate 
with promising results in tests with Hereford steers (Mason et a l ,  1997). The FMDV 
leader protein, unlike the poliovirus 2A protein is found only to cleave eIF4G and has no 
role in polyprotein processing. Therefore shut off of host cell protein synthesis is not 
absolutely essential for viral proliferation. In contrast the removal of 2A and the insertion 
of an EMCV 1RES in its place renders a virus non viable (Molla et a l,  1993b). This means 
that 2A has a role other than in autocatalytic cleavage.
1.5.5 ALTERNATIVE MECHANISMS FOR INHIBITION OF CELLULAR 
TRANSLATION
Cleavage of eIF4G alone only inhibits 70% of host cell protein synthesis whereas infection 
with poliovirus results in complete inhibition (Bonneau & Sonenberg 1987a; Pérez & 
Carasco 1992). Other possible mechanisms may therefore occur. Recently two small 
proteins have been found that bind to the cap binding protein, eIF4E, once one of them has 
been dephosphorylated (see fig 1.9). This results in disassociation of elF4E from the cap 
binding complex and inhibition of cap-dependent translation (Pause et a l,  1994a). 
Dephosphorylation of this protein, 4E-BP1, has been found in poliovirus infected cells and 
interaction of it with eIF4E does not seem to affect cap-independent translation of 
poliovirus (Pause et a l,  1994b). This process was also found to occur in cells infected 
with EMCV (Gingras et a l,  1996). EMCV causes host cell translation to be shut off but it 
occurs later in the infection cycle than that found in poliovirus infection and no virus 
induced cleavage of eIF4G occurs (Mosenkis et a l,  1985).
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FIGURE 1.9 Diagram to show an alternative method of inactivation of the cap-binding 
ability of the cap-binding complex. Dephosphorylation of 4E-BP1 allows it 
to bind to the cap-binding protein eIF4E which dissociates from the 
complex. Adapted from Belsham & Sonenberg (1996).
An alternative mechanism of inhibition of cellular translation may be phosphorylation of 
the initiation factor eIF2a, a subunit of eIF2, which has been shown to occur in poliovirus 
infected cells (Black et al., 1989; O’Neill & Racaniello 1989). Phosphorylation of this 
factor prevents its recycling and has an inhibitory effect on cap-dependent translation but 
may also affect cap-independent translation. eIF2 acts as a substrate for double-stranded- 
RNA-activated protein kinase (p68). It is thought that double stranded RNA synthesis 
during poliovirus infection induces high levels of p68 autophosphorylation although levels 
of p68 decrease. Subsequent phosphorylation of eIF2a results in a reduction in protein 
synthesis which then causes levels of p68 to be reduced. This elaborate system is thought
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to exist because unlike viruses such as influenza, adenoviruses and vaccinia virus, 
poliovirus causes no direct inhibition of p68 (Black et al., 1989).
1.5.6 INTERNAL INITIATION OF TRANSLATION
Picomaviruses are not the only RNA frameworks that can utilise intemal initiation of 
translation. Other vimses and some cellular RNAs also have this ability. The human 
hepatitis C vims, a flavivims, has a relatively long 5’NCR with elaborate predicted 
secondary stmcture (Brown et a l,  1992) which can direct intemal initiation of protein 
synthesis in dicistronic constmcts (Tsukiyama-Kohara et a l,  1992; Wang et a l,  1993; 
Fukushi et a l,  1994; Rijnbrand et a l,  1995; Reynolds et a l,  1995; Honda et a l,  1996). 
There is currently conflicting evidence as to minimura requirements of RNA needed for 
accurate initiation, possibly due to some interference from the RNA of reporter sequences 
in the dicistronic constmcts. Unlike picomavimses part of the coding region seems to be 
necessary (Reynolds et a l,  1995; Honda et a l,  1996) and intemal initiation occurs at the 
initiating AUG codon like the cardiovims and aphthovimses and undergoes no scanning at 
all (Reynolds et a l,  1996). Indeed vimses classified as pestivimses, a genus of the 
flavivims family, all appear to have an 1RES and utilise intemal entry of ribosomes in 
translation initiation (Poole et al,  1995).
Infectious bronchitis vims, a coronavims, has a genome which is tricistronic with three 
open reading frames. Protein synthesis from the third is mediated by an intemal initiation 
cap-independent mechanism (Liu & Inglis 1992). Also late mRNAs from adenovimscs 
have a common 200 base 5’NCR which can enhance translation of most mRNAs when it is 
added to their 5’ ends. Adenovims induced inhibition of host cell cap-dependent 
translation does not involve cleavage of eIF4G but inactivation by dephosphorylation of 
the cap-binding protein eIF4E (Huang & Schneider 1991). Recently the human leukeamia
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virus was also found to contain an IRES-like sequence with evidence of a polypyrimidine 
region (Attal et a l,  1996). Retroviruses also contain other, shorter regions of RNA 
secondary structure to which viral proteins bind in a translation regulatory manner e.g. Rev 
protein of HIV-1 binds to the Rev response element (RRE) and is essential for expression 
of gag and pol proteins (reviewed in Cullen 1992).
The first mammalian RNA found to utilise intemal initiation of translation was identified 
by Macejak & Samow (1991). Synthesis of the immunoglobulin heavy-chain binding 
protein (BiP) was detected during polioviral infection after cap-dependent translation had 
been inhibited and the 5’ leader of the mRNA was found to be able to direct intemal 
ribosome entry. Following this discovery, the homeotic gene antennapedia (Antp) mRNA 
of Drosophila melanogaster (Oh et al., 1992), mRNAs in cell extracts from 
Saccharomyces cerevisiae (lizuka et al., 1994), human fibroblast growth factor 2 (FGF-2) 
mRNA (Vagner et al., 1995) and eIF4G mRNA (Gan & Rhoads 1996) have all been 
discovered to initiate intemal entry of ribosomes by RNA stmctures. In fact BiP, Antp and 
FGF-2 were all found to have a common RNA structural motif from computer folding 
analysis (Le & Maizel Jr. 1997).
The rationale of the ability of eIF4G mRNA being able to utilise cap-independent 
translation was proposed by Gan & Rhoads (1996). As the protein itself is involved in 
cap-dependent translation, any reduction in its concentration would reduce efficiency of 
this type of translation. eIF4G could then be synthesised using the altemative method in an 
autoregulatory mechanism. In addition, BiP shows some sequence homology with heat 
shock proteins and also increases in cells during stress as heat shock proteins do. It is
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conceivable therefore that eIF4G concentration may also increase as a result of stress so 
that synthesis of specific proteins is not a limiting factor at such times.
Polioviruses would therefore appear to utilise a translation mechanism that eukaryotic cells 
are already able to employ when required. It is known that during mitosis the rate of 
protein synthesis is reduced to 25% of the rate during interphase and that the interaction of 
the cap-binding complex is reduced in mitotic cell extracts (Bonneau & Sonenberg 1987b). 
This mitotic block has no effect on poliovirus translation and phosphorylation of the cap- 
binding protein is implicated as a switch of this process. Furthermore phosphorylation of 
the cap-binding protein decreases when cells are heat shocked and addition of the protein 
during this state stimulates synthesis of non heat shock proteins.
1.6 THE VACCINES
In response to public feeling that the problem of poliomyelitis should be addressed, two 
different vaccines were formulated. Generally administered as trivalent preparations to 
confer immunity to all three serotypes, their success has been immense. The Salk 
inactivated poliovirus vaccine (IPV), administered intramuscularly, was first introduced in 
1954 and the Sabin oral poliovirus vaccine (OPV) in 1960. These are still in use today.
Jonas Salk prepared the IPV from virus grown in monkey kidney cell cultures and 
inactivated with formalin. Field trails in Canada, Finland and the USA showed it to be safe 
and effective but problems arose immediately after its release. Inadequately inactivated 
vaccine was linked to the development of paralytic poliomyelitis and subsequent death of 
vaccinees in the ‘Cutter incident’ (Nathanson & Langmuir 1963). The first case of vaccine 
related poliomyelitis was admitted to hospital literally days after the vaccine was released
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and the outbreak was traced to faults in production which were rectified. Since this 
incident there have never been any other IPV related cases and the vaccine is still regularly 
used.
Albert Sabin in contrast developed a vaccine that contained live virus and was 
administered orally, the route of natural infection. He prepared his vaccine by passaging 
virulent precursors of type 1 and type 3 viruses and a naturally attenuated type 2 virus 
isolated from wild type infections through a series of tissue cultures (Sabin & Boulger 
1973). The virus therefore became adapted to conditions enforced through the tissue 
cultures which were different to those found in natural human infection. Sabin vaccine 
virus strains were thus developed that were selected for their low monkey neurovirulence 
and their ability to replicate in the human gut but retained antigenic determinants that could 
bring about an immune response.
It is necessary to batch test the Sabin vaccine to ensure that the virus has not altered in 
neurovirulence during production and a standard monkey neurpvirulence test was 
introduced for this (WHO 1983). No other test or assay has been found that accurately 
provides a measure of the virulence. A number of vaccine related cases of poliomyelitis 
have however occurred. It is estimated that the incidence of occurrence is calculated at 1 
per 5.3 X 10^  for first time vaccinees and 1 per 2 X 10^  overall (Nkowane et al., 1987).
Inactivated and live vaccines each have their own advantages that influence their usage in 
different countries. The OPV avoids the use of needles which need to be sterile and can be 
traumatic for many adults and children and induces higher levels of secretory 
immunoglobulin A in the gut which is a similar response to wild type infection. The
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mucosal immunity is however short lived and in contrast the IPV acts primarily to induce 
circulatory antibodies in the blood stream. The OPV brings about problems in its 
transportation as a cold chain has to be maintained from manufacture to immunisation. 
The use of deuterium oxide and magnesium chloride were tested to prevent heat 
inactivation but as many other vaccines are now included in the cold chain this is no longer 
a problem.
In addition there remains a residual pool of virus in the environment as long as the live 
vaccine is administered as oral vaccinees can excrete virus up to 73 days post 
immunisation (Minor et a l,  1986). Excreted type 3 virus was found to have reverted to a 
relatively high level of neurovirulence within 48 hours (Evans et a l,  1985). In contrast, 
where IPV is administered of course no excretion occurs. There is some evidence however 
that vaccination with IPV followed by OPV results in a greater frequency of faecal 
shedding than vaccination with OPV followed by OPV (Abraham et a l,  1993). This may 
prove a problem when the decision to stop vaccination world-wide is taken, the use of the 
OPV may be prohibited and only IPV will be used.
The understanding of the attenuation of polioviruses could only begin to be divulged 
when the appropriate molecular biology methods were developed. It may therefore be 
surprising that the Sabin vaccines have been in use for nearly four decades and 
attenuation is still not completely understood. Sequence comparison shows that there are 
many base changes produced during derivation of vaccine strains but the number of 
major attenuating determinants was found to be quite small, as summarised in fig 1.10 
below. This fine balance reinforces the need for continued rigorous batch testing,
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1.6.1 ATTENUATION
An enormous amount of research has been carried out to determine the important 
attenuating mutations. Much of the work has exploited the infectivity of cDNA clones 
(Racaniello & Baltimore 1981b) and RNA transcripts derived from them using a T7 
promotor within the plasmid clone (Van der Werf et al., 1986). ‘Cut and paste’ techniques 
between virulent precursors, virulent revertants for type 2, and attenuated viruses initially 
identified where attenuating regions of the genome were. Cloning techniques and site 
directed mutagenesis have given information of individual mutations and the detection of 
revertants has given further insight into the way in which the mutations affect the virus and 
an understanding of the stability of the vaccine.
The type 1 component of the vaccine is very rarely implicated in vaccine related 
poliomyelitis and this is probably due to the fact that it has 56 nucleotide differences when 
compared to the neurovirulent Mahoney strain. A relatively large number of mutations 
may be required for a revertant virus to arise and the vaccine strain is therefore relatively 
stable (Omata et al., 1986). As a result of this type 1 attenuation is not completely 
resolved.
Originally three determinants of attenuation in Sabin 1 were identified: a change at 480 in 
the 5’NCR; a change in the 3D polymerase gene and the loss of a base at the start of the 
poly-A tail (Christodoulou et a l,  1990). This work used temperature sensitivity as a 
measure of neurovirulence but using a monkey neurovirulence test the change at 480 was 
identified as making an important contribution to attenuation with only a minor effect on 
temperature sensitivity (Kawamura et a l,  1989). This change of an A to G is thought to 
weaken the base pair of AU at 480/525 and destabilise the domain V structure. Using a
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non transgenic mouse model and a mouse adapted version of Mahoney the change in 3D 
was also found to contribute albeit to a lesser extent than the 480 change (Tardy-Panit et 
al., 1993). A further study using transgenic mice highlighted a number of changes in VPl, 
VP3 and VP4 that were thought to interfere with receptor binding and other associated 
events. This study also claimed that the changes in 3D and the 3’NCR were determinants 
of temperature sensitivity and not neurovirulence (Bouchard et al., 1995). This was further 
substantiated in McGoldrick et a l,  (1995) in which the mutations at 480 and in 3D were 
investigated in monkey neurovirulence tests and found not to be strong attenuating 
determinants.
The issue is somewhat complicated by the different ways of detecting neurovirulence 
although the monkey neurovirulence test must be decreed the most reliable as a measure of 
human neurovirulence. There have been no vaccine related epidemics since using this test. 
Temperature sensitivity merely measures an in vitro observation linked in some cases to 
neurovirulence. Attenuation of type 1 therefore appears to be due to a number of 
contributory changes with no single very strong determinant.
Attenuation for the remaining virus types is better understood. Type 2 polioviruses have 
two major determinants of attenuation. A change of G to A at position 481 in the 5’NCR 
which is thought to disrupt RNA secondary structure in domain V and an amino acid 
change at position 143 in VPl caused by a change in residue 2908 which possibly 
interferes with receptor mediated events (Ren et a l,  1991; Macadam et a l,  1993). The 
change to A at 481 is thought to make a base pair with the U at 511. This is usually 
unpaired and would put extra strain on the domain V structure.
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For thè type 3 virus à change of C tô U at position 472 in the 5’NCR is a determinant of 
attenuation (Westrop et al., 1989) and is responsible for a translation deficiency (Svitkin et 
al., 1990). A weakening of the base pair from CG to UG in one of the domain V stems is 
thought to destabilise the structure. Another mutation at residue 2034 which changes 
amino acid 91 in VP3 from serine to phenylalanine was also found to attenuate the virus 
(Westrop et al., 1989). This mutation is thought to inhibit the assembly of protomers into 
pentamers (Macadam et al., 1991a). A third mutation at position 2493 changes amino acid 
6 in VPl from an isoleucine to a threonine in the vaccine strain (Weeks-Levy et a l,  1991) 
which probably affects either the assembly of the capsid or uncoating of the RNA.
Type 1
480
62U3
3D-73
(A)n
Type 2
Type 3
2908
VPl-143
472
2034 2493
VP3-3 V Pl-6
FIGURE 1.10 A schematic diagram of the 3 poliovirus serotypes indicating positions of 
some of the base changes associated with attenuation.
Evolution of the vaccine strains in the human gut involves more than point mutations. As 
the vaccine is administered as a trivalent preparation a single cell could be infected with 
more than one virus at any one time. This can give rise to intertypic recombihæits whose 
functions are unknown but have been suggested as an ev^ion of the immune system 
(Minor 1993). Recombination was detected between type 2 and type 3 Sabin strains with 
cross-over occurring in the genome coding for non-structural proteins (Minor et al., 1986).
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On following the excretion of type 3 virus from a primary vaccinee a typical profile was 
obtained: type 3/type 1 and type 3/type 2 recombinants were detected at days 10-11 with a 
cross-over in the gene for 2C and type 3/type 2/type 3 recombinants were then detected at 
day 28 with a further cross-over in the gene for 3D (Cammack et al., 1988).
1.7 THE VIRAL PROTEIN 2A
Polioviruses code for 2 proteases, 2A and 3C which process the polypeptide into individual 
proteins during the viral replication cycle. 2A is a small serine like protease, with a 
cysteine in place of the serine in the active site, of just 149 amino acids in length, cleaving 
at tyrosine-glycine peptide bonds. Only two of the ten possible tyrosine-glycine bonds are 
cleaved which indicates interaction with unknown factors, possibly structural cues. 
Mutational analysis has highlighted the threonine residue two bases away from the 
cleavage site as being important for cleavage (Lee & Wimmer 1988).
A putative model (fig 1.11) of the a-carbon chain was deduced from comparison with 
small bacterial serine proteases (Bazan & Fletterick 1988) with the putative catalytic triad 
being residues 20, 38 and 109. Residues 88, 89 and 124 are possibly involved in substrate 
binding (Hellen et al., 1991; Yu & Lloyd 1991). A zinc binding site was detected on the 
2A of human rhinoviruses and zinc depletion was shown to inactivate the virus 
(Sommergruber et al., 1994). Zinc binding sites are found on other serine proteinases. 
Similarly the proteolytic activity of poliovirus and rhinovirus 2A was inhibited by elastase- 
specific inhibitors elastinal and methoxysuccinyl-Ala-Ala-Pro-Val-chloromethylketone 
(Molla et al., 1993a). The substrate binding pocket of 2A is presumably comparable to the 
elastase binding pocket. The amino acid sequence of the protease is fairly well conserved 
with nearly 90% identity within polioviruses.
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FIGURE L U  Predicted structure of the 2A poliovirus protease based on structure of 
small bacterial serine proteases (Bazan & Fletterick 1988; Yu & Lloyd 
1991). Residues 20,38 and 109 represent the putative catalytic triad and 
residues 39, 88, 89 and 124 represent highly conserved amino acids.
2A cleaves itself autocatalytically from the polyprotein at the interface of VPl and its own 
amino terminus. This occurs before complete synthesis of the polyprotein, separating the 
capsid precursor and the non capsid precursor and is the initial proteolytic event. 2A is 
also responsible for an altemative cleavage in the polyprotein during processing in some 
viruses. The protease 3C routinely cleaves to give 3C and 3D but in this case 2A cleaves 
further into the 3D part of the protein to give 3C  and 3D’ (Lee & Wimmer 1988). In 
addition, acting again as a protease, 2A is responsible for shut off of host cell translation as 
discussed above where it directly cleaves the eukaryotic initiation complex subunit eIF4G.
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1.7.1 2A AND THE 5 'N CR
For the majority of viruses reversion of the ts phenotype that results from disruption to 
domain V in the 5’NCR involves re-forming the structure as previously described. This 
can be visualised by analysis of protein synthesis where a base pair disruption brings about 
a reduction in efficiency of synthesis in BGM cell culture at elevated temperatures. When 
the base pair is re-formed efficiency of synthesis is restored. This is demonstrated in fig 
1.12 where base pair strength at 472/537 correlates with efficiency of protein synthesis at 
38.5°C (personal communication, A. J. Macadam).
472/537
CG GC UA
2 3 4 5  2 3 4 5  2 3 4 5
ir.iïïiiiïïira
w - •
FIGURE 1.12 Protein synthesis at 38.5°C in BGM cells infected with viruses that differ 
only at the base pair 472/537 as indicated. Infected cells were pulsed with 
Methionine for 30 min at 2, 3, 4 and 5 hours post infection. Cell lysates 
are then run on acrylamide gels.
However non ts viruses were selected which retained their domain V disruption but were 
no longer ts (Macadam et a i,  1994). Parental viruses were either Sabin 2 or a type 3/type 2 
Leon/Lansing construct that had a range of individual domain V mutations created by site- 
directed mutagenesis. The revenant viruses were found to have compensating mutations 
in the coding region for 2A that resulted in amino acid substitutions. The compensating 
mutations were found to be able to restore protein synthesis in BGM cell culture
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comparable to that resulting from reversion in domain V at a time when host cell 
translation was already inhibited (see fig 1.13). It appeared that the protein 2A was 
responsible for enhancing protein synthesis in some way.
P2/SABM
2 2.5 3 3.5 4 5
F S/t175‘
2 2.5 3 3.5 4 5
S2/39A
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FIGURE L I 3 Protein synthesis at 38.5°C in BGM cells. Infected cells were pulsed
with labelled methionine for 30 min at 2, 2.5, 3, 3.5, 4 and 5 hr post 
infection. Viruses were Sabin 2 and derivatives. PS /1175’ differed only in 
the 5 ’ end and S2/39A differed only in 2A. Positions of viral polypeptides 
are indicated. Taken from Macadam et ai,  (1994).
The levels of viral RNA in infected cells were comparable for all three viruses indicating 
that neither the disruption to domain V or the enhancing effect of 2A affected replication 
rates. The affect of 2A is therefore suggested to be on translation.
Earlier, Hambidge & Samow (1992) had suggested that 2A  acted as a translational 
transactivator of poliovirus translation. Using bicistronic constructs of two reporter genes 
separated by the poliovirus 1RES they detected enhanced translation of the second cistron 
in poliovirus infected cells even before cap-dependent translation had been inhibited 
indicating that cap-independent translation does not fundamentally require the cleavage of
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eIF4G. Following this, translation from 1RES driven RNAs was examined with expression 
of various parts of the poliovirus genome. Enhancement of translation of these RNAs was 
found to occur in cells in which 2A was expressed. As 1RES elements can direct cap- 
independent translation of a reporter gene in rabbit reticulocyte lysates without the 
presence of polioviral proteins it therefore appears that 2A acts as an enhancer of cap- 
independent translation rather than an indispensable requirement.
For 2A to affect translation it would appear to have to interact with either the RNA of the 
5’NCR to help form the tertiary structure or with the cellular proteins involved with 
translation. No evidence for 2A binding to the 5 ’NCR has yet been found. 2A was also 
shown to have a role in replication (Molla et aL, 1993b).
1.8 D4TRODUCTION TO PROJECT
As discussed above, the Sabin vaccine strains have major attenuating mutations in domain 
V of the 5 ’NCR and are known to revert here during their passage through the gut of a 
vaccinee. This poses a problem of possible vaccine related poliomyelitis in primary 
vaccinees or their contacts. A more stable vaccine that does not revert would therefore be 
favourable. However weakening the 5 ’NCR of the vaccine strain in a more genetically 
stable way may not prevent reversion to virulence as mutations in the 2A protein were 
found to be able to compensate in vitro for the domain V mutations (Macadam et aL, 
1994).
This thesis will describe an investigation into these compensating 2A changes initially 
discovered whilst studying domain V reversion. It will show that there are many positions 
and substitutions that can be found and that they all compensate a ts phenotype to different
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extents. The cell specificity of 2A changes will be discussed along with the use of this in 
selection of domain V revertants. Important areas of domain V will be outlined from this 
selection and analysed using mutagenesis experiments. Results from these experiments 
will give information about functionally important areas of the 5 ’NCR domain V.
39
CHAPTER TWO
MATERIALS AND METHODS
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2.1 SOLUTIONS AND MEDIA
2.1.2 PURIFICATION OF DNA
PHENOL MIX
PHENOL/CHLOROFORM MIX 
TE BUFFER 
SOLUTION 1
SOLUTION 2 
SOLUTION 3
p r e p -a -g e n e  b i n d i n g  b u f f e r
P R E P -A-GENE W ASH BUFFER
2.1.3 PURIFICATION OF RNA
15% SUCROSE SOLUTION
45% SUCROSE SOLUTION
SDS/SODIUM ACETATE
50g phenol shaken with 
50ml lOmM tris-HCl pH 8.6 
0.1 g dihyroxyquinoline
50ml phenol mix with tris buffer 
50ml chloroform
lOmM tris-HCl pH 7.5 
ImM  EDTA
50mM glucose 
25mM tris-HCl pH8 
lOmM EDTA
0.2M sodium hydroxide 
1% SDS
3M potassium acetate pH 4.8
6M sodium perchlorate 
50mM tris-HCl 
ImM  EDTA 
pH 7.4
20mM tris 
2mM EDTA 
0.4M sodium chloride 
50% ethanol 
pH 7.5
15% RNase free sucrose 
33% normal saline 
lOmM tris-HCl pH 7.4
45% RNase free sucrose 
33% normal saline 
lOmM tris-HCl pH 7.4
0.1% SDS
0.15M sodium acetate pH 6.0
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2.1.4 SEQUENCING AND ELECTROPHORESIS OF DNA AND RNA
SEQUENCING GEL
W ACKER’S SOLUTION
6% acrylamide 
42% urea
0.3% methylenebisacrylamide 
0.12% ammonium persulphate 
1 X T B E
to set: Ipl TEMED ml'* gel mix
0.003% methacryloxy- 
propyltrimethoxysilane 
(Sigma)
0.003% glacial acetic acid 
in ethanol
ANNEALING BUFFER 280mM tris-HCl pH7.8 
1 OOmM magnesium chloride 
350mM sodium chloride
LABELLING MIX FOR DNA SEQUENCING
LABELLING MIX FOR RNA SEQUENCING
2pM  dGTP 
2pM  dCTP 
2pM  dTTP
2pM  dlTP 
2pM  dCTP 
2pM  dTTP
TERMINATION MIXES FOR 
RNA SEQUENCING
0.5mM dATP 
ImM  dITP 
0.5mM dCTP 
0.5mM dTTP
FOR ‘A ’ MIX: 0.25mM ddATP 
FOR T  MIX: 0.5mM ddlTP 
FOR ‘C ’ MIX: 0.25mM ddCTP 
FOR T ’MIX: 0.25mM ddTTP
TERMINATION MIXES FOR 
T7 DNA SEQUENCING
127pM dATP 
127pM dGTP 
127pM dCTP 
127pM dTTP
8.5mM magnesium chloride 
38mM tris-HCl pH 7.5 
42mM sodium chloride 
FOR ‘A ’ MIX: 15pM ddATP 
FOR ‘G ’ MIX: 15pM ddGTP 
FOR ‘C ’ MIX: 15pM ddCTP 
FOR T ’ MIX: 15pM ddTTP
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TERMINATION MIXES FOR 
DNA CYCLE SEQUENCING
15pM dATP 
15|liM  dGTP 
15pM dCTP 
15|liM  dTTP
FOR ‘A ’ MIX: 600pM  ddATP 
FOR ‘G ’ MIX: 30|iM  ddGTP 
FOR ‘C ’ MIX: 450|iM  ddCTP 
FOR T ’ MIX: 1200|iM ddTTP
FORM AMIDE DYE MIX 20ml formamide (saturated with 
amberlite)
0.8ml 0.5M EDTA 
6pg xylene cyanol 
6pg bromophenol blue
10 X TRIS BORATE EDTA (TBE) 900mM tris 
9(X)mM boric acid 
25mM EDTA 
pH 8.3
GLYCEROL LOADING BUFFER 50% glycerol 
lOmM EDTA 
20mM tris-HCl pH 7.5 
bromophenol blue 
xylene cyanol
2.1.5 E-COLI PROPAGATION
LURIA BROTH 1% Bacto Tryptone 
0.5% Bacto yeast extract 
0.5% sodium chloride
LURIA-AGAR 1.5% Nobles agar in Luria-broth
LURIA-BERTAINI BROTH 1% Bacto Tryptone 
0.5% Bacto yeast extract 
1 % sodium chloride
LURIA-BERTAINI AGAR 1.5% Nobles agar in Luria-Bertaini 
broth
TY BROTH
TY AGAR 
H-TOP AGAR
1% Tryptone 
1 % Bacto yeast extract 
0.5% sodium chloride 
pH 7.4
1.5% Nobles agar in TY broth
1% Tryptone 
0.8% sodium chloride 
0.8% Nobles agar
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M9 AGAR 40mM sodium phosphate 
20mM potassium chloride 
8mM sodium chloride 
20mM ammonium chloride 
1.5% agarose
20mM magnesium sulphate 
O.lmM calcium chloride 
0.2% glucose 
1 mM thiamine-HCl
TRITURATION BUFFER
SOC
2.1.6 TISSUE CULTURE
MEM
D-MEM
lOOmM calcium chloride 
70mM magnesium chloride 
40mM sodium acetate 
pH 5.5
2% Bactotryptone 
0.5% yeast extract 
lOmM sodium chloride 
2.5mM potassium chloride 
20mM magnesium chloride 
20mM magnesium sulphate 
20mM glucose
Modified Eagle’s Medium
Dulbecco’s Modified Eagle Medium 
0.00 IM  sodium pyruvate 
0.04M sodium bicarbonate
SALINE A
NORMAL SALINE
TRYPSIN
PBS
PBS’A ’
PENICILLIN/STREPTOMYCIN
140mM sodium chloride 
5mM potassium chloride 
5mM glucose
72mM sodium chloride
6% trypsin in saline A
0.13M sodium chloride 
2mM potassium chloride 
0.9mM calcium chloride 
0.5mM magnesium chloride 
1 ImM sodium phosphate
0.9mM potassium phosphate
170mM sodium chloride 
3mM potassium chloride 
lOmM sodium phosphate dibasic 
2mM potassium phosphate dibasic
20,000 units per ml of each
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FUNGIZONE 0,02% fungizone
BICARBONATE
NAPHTHALENE BLACK
lO X H B SS
100 X GLUCOSE
10 X DEAE-DEXTRAN
0.52M sodium bicarbonate 
0.001% phenol red
0.1% Naphthalene Black 
1.36% sodium acetate 
6% acetic acid
5% HEPES 
8% sodium chloride 
0.37% potassium chloride 
0.125% sodium phosphate
10% glucose
0.5% DEAE-dextran
2.2 TISSUE CULTURE CELLS
HEp-2C Human Caucasian larynx carcinoma epitheliod cells
(Toolan, 1954; Moore, et aL, 1955)
Growth medium 
1 X M EM  
4% Bicarbonate 
5% ECS 
1%P/S 
l% F u
Plaque assay overlay
1 X M E M
5% Bicarbonate
2% ECS
1% P/S
l% F u
1 % Nobles agar
BGM African Green Monkey kidney cells.
(Barron, et aL, 1970; Dahling, et aL, 1974))
Growth medium
1 X M EM
2.5% Bicarbonate
5% ECS
1%P/S
l% F u
1.5% HEPES
Plaque assay overlay
1 X M E M
5% Bicarbonate
4% ECS
1%P/S
l% F u
1 % Nobles agar
L20B Mouse connective tissue derived cells transformed with a cDNA clone 
of human poliovirus receptor. A kind gift from V Racaniello.
(Pipkin etaL, 1993)
Growth medium 
1 X D-MEM 
10% ECS 
1 % Glutamine 
1%P/S 
l% F u
Plaque assay overlay
1 X MEM
3% ECS
5% Bicarbonate
1% P/S
l% F u
1 % Nobles agar
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2.3 E-COL/CELLS
TGI
XLl-BLUE
D H 5a
The TGI strain was used to transform and grow M l3 phage. Its 
genome included a deletion in the lacZ gene so that blue/white 
selection could be used with vectors carrying the complement gene. It 
also included a supE gene required by phage and the F factor that 
allowed infection by M13 phage. These cells were grown in TY broth.
This E-Coli strain was also used to transform and grow M13 phage in 
place of the TGI strain when it lost the ability for M l 3 infection. The 
XL 1-blue genome included the F factor for M l3 infection, a deletion 
in the lacZ gene for blue/white selection, the recA gene that prevents 
homologous recombination and the supE gene that is required by 
phage. These cells were grown in TY broth.
The D H 5a E-Coli strain was used to transform and grow BR223 
plasmid DNA. Its genome included the recA gene that prevent 
homologous recombination, the hsdR17 gene that abolishes DNA 
restriction but not protective méthylation and also carried the supE 
gene. These cells were grown in Luria-Bertaini broth or Luria broth 
when preparing electro-competent cells.
2.4 PRIMERS
13/n antisense, for types 1,2 and 3 poliovirus, at position 629-645 
ACC GGA TGG CCA ATC C
PC R F sense, for types 1, 2 and 3 poliovirus, at position 23-51 
CCA GAG GCC CAC GTG GCG GCT AG
PC R 9 antisense, for type 3 poliovirus, at position 774-799 
GAG CGC CTA CTT TTT GGG ATG ATA C
OLL390 sense, for type 2 poliovirus, at position 390-404 
GCC ACG GGA CGC TAG
LL390 antisense, for type 3 poliovirus, at position 390-404 
CTA GCG TCC CGT GGC
AM20 sense, for type 2 poliovirus, at position 3204-3225 
GAG TGG TGA ATG ACC ACA ACC C
AM21 antisense, for type 2 poliovirus, at position 4566-4588 
AGT GAG TAT GTG GAG GTG TTC TC
AM24 antisense, for type 2 poliovirus, at position 3559-3582 
CTC CTG GAT TCA GAG TAG TAG AC
AM27 antisense, for type 2 poliovirus, at position 3857-3876 
AAT CCA CTC CCA AAT GCA GC
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AM31 sense, for type 2 poliovirus, at position 3521-3543 
GGC AUA GAC UCA AUU GCU AGA UG
AM37 sense, for type 2 poliovirus, at position 3605-3631 
CTT TCA TTG GGC CCN NC/GT TCC AAT ACA
AM38 sense, for type 2 poliovirus, at position 3605-3631 
CTT TCA TTG GGC CCA CCN TCC AAT ACA
AM39 antisense, for type 3 poliovirus, at position 459-488 
CCT GCT CCA TGG NNN GGA TTA GCC GCA TTC
AM40 antisense, for type 3 poliovirus, at position 459-488 
CCT GCT CCA TGG TAG GAT TAG CCG CAT TC
AM41 antisense, for type 3 poliovirus, at position 459-488 
CCT GCT CCA TGG AGG ATT AGC CGC ATT C
WTPmlI3266 sense, for coxackie virus, at position 3266-3288 
AAA CAC GTG AGA GTG/C TGG TGC/T CC
WTBstE3939 antisense, for coxackie virus, at position 3916-3939 
TCT GTA ATG GTG CTG GTN ACC AT
M13 1211 antisense, for M l3, at position 6290-6306 
GTA AAA CGA CGG CCA GT
All 13 antisense, for types 1, 2 and 3 poliovirus, at position 4153-4163 
AGU UGG UUG AA
All 141/2 antisense, for types 1, 2 and 3 poliovirus, at position 3809-3821 
GAG ACA UUA GAG A
ARWTI sense, for type 1 poliovirus, at position 3337-3356 
GTG/A GAT/C TAT/C AAA/G GAC/T GGN AC
3’W TAR antisense, for types 1, 2 and 3 poliovirus, at position 3810-3829 
ATN CCC/T T G C /r TCC ATN GCC/T TC
ARW Tm antisense, for type 3 poliovirus, at position 3705-3715 
AGT ATG CCA CC
WT#3 antisense, for types 1, 2 and 3 poliovirus, at position 3731-3747 
CCA TGT TGA CAC/T CTG AG
WT#4 antisense, for types 1, 2 and 3 poliovirus, at position 3797-3815 
CAT TCA AAT CCC TGA TGT C
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2.5 METHODS
2.5.1 DNA EXTRACTION
DNA extraction was carried out as described in Sambrook et aL, (1989) on three different 
scales. This was performed on overnight cultures prepared by inoculating medium with a 
single colony from an agar plate and incubating in an orbital shaker at 37°C. A ‘mini’ prep 
used 1ml to produce enough DNA for quick diagnostic purpose where as ‘midi’ and 
‘midi/maxi’ preps, on 20ml and 200ml of culture respectively, were carried out to produce 
large amounts of DNA for RNA transfection and cloning.
Initially cells were pelleted and all traces of growth medium removed. The pelleted cells 
were then resuspended in solution 1, transferred to ice and solutions 2 and 3 were added in 
ratios of 0.05:0.1:0.075 with respect to the original volume of culture used. With the addition 
of RNase A, this was incubated at room temperature for 15 min before precipitated proteins 
were pelleted and supernatant removed. For a ‘mini’ prep, phenol/chloroform extraction was 
carried out before the DNA was precipitated at -20°C in either 1 volume of isopropanol or 2 
volumes of ethanol and 0.1 volume of 3M sodium acetate. DNA could then be used in a 
sequencing reaction. For larger scale preps the DNA was precipitated prior to 
phenol/chloroform and chloroform extraction. A selective re-precipitation followed this. 
Concentration of DNA was estimated by visualisation on an ethidium bromide agarose gel.
2.5.2 RESTRICTION DIGESTS
Restriction digests were carried out as suggested by the enzyme manufacturer’s protocol.
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2.5.3 PCR REACTIONS
A standard lOOpl PCR reaction (Saiki et aL, 1985) contained 200ng of each primer, 0.2mM 
dNTP, 1 X manufacturer’s buffer, 1 unit of Tag DNA polymerase enzyme (Saiki et aL, 1988) 
and were overlayed with mineral oil to prevent evaporation inside the tube. SuperTaq 
(Stratech) was used when preparing DNA for sequencing reactions where as AmpliTaq 
(Perkin Elmer) was selected when preparing DNA for cloning experiments due to its higher 
fidelity. A Hybaid OmniGene TR3 SM2 thermocyler with an accuracy of ±0.5°C was used. 
Cycle lengths and temperatures were selected to provide optimum conditions for each set of 
primers.
2.5.4 VISUALISATION OF DNA
Electrophoresis of DNA was carried on 1% SeaKem agarose gels (Flowgen) in 1 X TBE 
buffer as electrolyte with bromophenol blue and xylene cyanol as running markers. Gels 
were freshly made in 1 X TBE with ethidium bromide (Bio-Rad) at Ing/ml and DNA 
visualised using UV light (Sambrook et aL, 1989).
2.5.5 PURIFICATION OF DNA AND PCR PRODUCTS USING PREP-A-GENE MATRIX 
Purification of PCR amplified DNA fragments from PCR reaction mixtures was achieved 
using Prep-A-Gene silica based matrix (Bio-Rad). The matrix selectively binds DNA 
fragments of 100 base pairs and above at an efficiency of at least 0.2pg per pi of suspended 
matrix.
PCR samples were decanted without taking any mineral oil into clean tubes and the DNA 
allowed to bind to the matrix for 10 min at room temperature in 3.5 volumes of binding 
buffer. For DNA in agarose slices 6 volumes of binding buffer were used. Matrix was 
pelleted by centrifuging for 30s, the binding buffer removed by aspiration and washed with
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500pl of wash buffer 3 times. The DNA from the dry pellet was eluted in 25pl of 
GDW  at 56°C for 10 min and the matrix separated by centrifugation for 30s.
2.5.6 M13 SINGLE STRANDED PHAGE DNA EXTRACTIO N
An exponential culture of E. coli cells was grown by inoculating TY broth with a 1:100 
ratio of an overnight culture and incubating at 37°C for 2 hours in an orbital shaker. 
Plaques were then picked into 1.2ml of this culture and grown at 37°C for 4.5 hours. 
Bacterial cells from  1ml of this were then pelleted and discarded. The phage in the 
supernatant were precipitated at room tem perature with 200pl o f a 20% PEG 6000 
solution in 2.5M  sodium chloride. Pelleted phage were resuspended in lOOpl of TE 
buffer and extracted once with phenol mix before precipitating at -20°C in 3 volum es 
of ethanol and 0.1 volum e of 3M sodium acetate. Single stranded DNA was then 
pelleted, washed in 70% ethanol and dried before eluting in TE buffer.
2.5.7 RNA PUR IFICA TIO N  FROM  TISSUE CU LTU RE FLUID AFTER 
PREPARATION OF VIRUS ON SUCROSE GRADIENTS
Continuous 30ml sucrose gradients were prepared in centrifuge tubes from  15ml of the 
15% solution and 15ml of the 45% solution. Virus in tissue culture fluid was m ixed 
with 1 drop of N onidet P40 (BDH) and added carefully to the top of the gradient and 
centrifuged at 80000XG for 4 hours at 4°C. The gradients were then harvested by 
bottom  puncture and 2ml fractions were collected. From  many years of experience the 
peak fractions 3, 4, 5 and 6 are found to contain poliovirus particles. These were 
pooled and the virus pelleted by centrifuging at 60000X G overnight. Pelleted virus 
was resuspended in 500pl SDS/sodium  acetate, extracted tw ice with phenol/ 
chloroform  mix, once with chloroform  and precipitated in 2 volum es of ethanol and
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50mM sodium chloride at -20°C for 1 hour. The clean RNA was then pelleted, dried and 
resuspended in GDW.
2.5.8 RNA EXTRACTION FROM TISSUE CULTURE FLUID
Aliquots of 900pl of tissue culture fluid were treated with Ipg  Proteinase K (Boehringer 
Mannheim) in 1% SDS by incubation at 37°C for 15 min. This was followed by extraction 
with phenol/chloroform twice and chloroform once. RNA was then precipitated in 0.1 
volume of 3M sodium acetate and 2 volumes of ethanol at -20°C for 1 hour. Pelleted RNA 
was washed with 70% ethanol and freeze dried before eluting in GDW. Storage in 70% 
ethanol at -20°C decreased the rate of RNA degradation. This method was described in 
Macadam et aL, (1989).
2.5.9 RNA TRANSFECTION FROM PLASMID DNA
Infectious RNA was generated from a linearised plasmid which contained a T7 promoter 
upstream of full length cDNA copies of the poliovirus genome (van der W erf et aL, 1986).
Plasmids were linearised with S a d  (New England Biolabs) according to manufacturer’s 
protocol and the DNA was cleaned using the Prep-a-Gene method. At least 500ng of DNA 
was used in a 50pl reaction containing 1 X manufacturer’s buffer, 5mM DTT, 0.5mM 
rNTP’s, 15units RNAguard (Pharmacia) and 15units T7 RNA polymerase (Stratech). This 
was incubated at 37°C for 30 min and a sample run on a 1% agarose gel to check for 
synthesis of RNA. A mixture of ice cold 1 X HBSS/glucose/DEAE-dextran was added, 
200pl for a 25cm^ flask and 1ml for a plaque assay, and the reaction left on ice for 30 min. 
Serial log dilutions were made in the 1 X mix for an assay. This was then used to inoculate 
cells sheets which had been washed 3 times in PBS’A ’. Inoculum was removed by 
aspiration, and cells incubated at room temperature for 20 min. Inoculum was removed by
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aspiration, growth medium added and cells incubated at 37°C until CPE was achieved whilst 
the cell control survived. Cell sheets were then frozen and virus collected as for general vims 
growth.
2.5.10 cDNA SYNTHESIS
Synthesis of cDNA from tissue culture extracted RNA was carried out using AMV reverse 
transcriptase (Life Sciences Inc). Reactions were carried out in 0.4mM dNTP, 1 X 
manufacturer’s buffer, 5ng random hexamers (Boehringer Mannheim), 7 units of enzyme and 
incubated for 1 hour at 42°C.
2.5.11 PRIMER PURIFICATION AFTER SYNTHESIS
Primers were made ‘in house’ on an Applied Biosystems 392 RNA/DNA synthesiser. The 
primers were eluted from columns using 1.5ml of a 35% ammonium solution pushed through 
at 0.5ml every 30 min. Deprotection was carried out by incubating at 56°C overnight and the 
oligonucleotide precipitated in 0.1 volume 3M sodium acetate and 3 volumes of ethanol at 
-20°C for 1 hour. The pelleted primer was washed in 70% ethanol, freeze dried and eluted in 
GDW. Concentration of the primer was measured by optical density (OD) at 260nm on a 
Philips PU 8720 UV/VIS scanning spectrophotometer using the following equation:
OD X 33 = concentration in pg/ml.
2.5.12 T7 DNA SEQUENCING
Chain-terminating sequencing (Sanger et aL, 1977) was performed on a number of different 
DNA starting materials: 1) ds plasmid DNA; 2) ds PCR product and 3) ss M13 DNA with a 
minimum of lOOng DNA.
1. Ds plasmid DNA was denatured in 0.2M sodium hydroxide at 37°C for 15 min and then 
precipitated in 0.3 volume of potassium acetate (pH 4.8) and 7.5 volumes of ethanol at
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-20°C for 1 hour. DNA was then pelleted and dried before eluting in a total volume of 
14pl with lOOng of primer and 2pl of annealing buffer. Annealing took place at 37°C for 
20 min.
2. Ds PCR products that had been prepared using the Prep-a-Gene method were denatured 
with lOOng primer and 0.2M sodium hydroxide at 37°C for 10 min. This was then 
neutralised with 0.2M hydrochloric acid and 2pl annealing buffer in a total volume of 14pl 
and incubated at 37°C for 10 min.
3. Ss M13 DNA was simply annealed with lOOng primer and 2pl annealing buffer in a 14pl 
reaction at 60°C for 10 min.
The denatured/annealed DNA mixes were then labelled with a reaction containing 2pl 
labelling mix, 1(j 1 adA TP (ICN), l|al O.IM DTT, 2pl GDW and 3 units T7 DNA 
polymerase at room temperature for 5 min. This mix was then equally divided into 2.5pl of 
each termination mix and incubated at 37°C for 5 min before the reaction was stopped by the 
addition of formamide dye. Samples were boiled before electrophoresis on a 6% acrylamide 
gel.
2.5.13 CYCLE SEQUENCING
Each sequencing reaction required 2pmol of primer to be labelled with 2pmol (6pCi) P^  ^
ydATP using lunit of polynucleotide kinase (Pharmacia) and IX  manufacturer’s buffer. This 
reaction was incubated at 37°C for 20 min and label incorporation was measured. This was 
achieved by dotting 0.5pl on adsorbent paper and comparing the counts per s recorded before 
and after the primer was precipitated with 10% trichloroacetic acid and washed with ethanol. 
The primer was used in sequencing only when percentage incorporation exceeded 20%. The 
primer was then heated to 90°C for 2 min to denature the enzyme.
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Approximately 200ng of PCR product, cleaned using the Prep-a-Gene method, was needed 
for each reaction. Initially a 16pl reaction mix was made for each DNA containing 2pmol 
labelled primer, 1 X manufacturer’s buffer and 1 unit of SuperTaq (Stratech). This was then 
equally divided between the 4 termination mixes to make a total of 8pl and overlayed with 
mineral oil. Using the Hybaid OmniGene thermocyler 10 cycles were performed with a 40s 
denaturing step, a 30 s annealing step and a 2 min elongation step. The reaction was then 
stopped with formamide dye and samples boiled for 2 min before electrophoresis.
2.5.14 RNA SEQUENCING
Sequencing was carried out using a method similar to that described in Evans et aL, (1985) 
using RTase in place of the Klenow fragment of E Coli DNA polymerase I. RNA purified by 
sucrose gradient was incubated at room temperature for 5 min with 15pmol of primer, 1 X 
manufacturer’s buffer, IpCi P^^adATP, 0.15% labelling mix and 5units RTase (Boerhinger 
Mannheim). This was then equally divided between 2pl each of the four termination mixes 
and incubated at 42°C for 10 min. The reaction was stopped by adding formamide dye to 
each mix and samples were boiled for 2 min before loading on a 6% acrylamide gel for 
electrophoresis.
2.5.15 POLYACRYLAMIDE GEL ELECTROPHORESIS OF SEQUENCING 
REACTIONS
Sequencing reactions were run on 6% acrylamide denaturing gels at 15mA per gel, using 
bromophenol blue and xylene cyanol as approximately 10 and 100 base pair markers 
respectively. Cambridge gel apparatus was used with eared plates siliconised with 
dimethyldichlorosilane to repel the gel and non-eared plates treated with 2.5ml wacker 
solution to make the gel adhere. Plates were taped using x-ray film thick spacers and TBE 
buffer as running buffer. Once run as required the plates were separated, the gel fixed for
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15min in 10% glacial acetic acid, washed for 15 min and dried in an oven for 30 min before 
exposing to x-ray film.
2.5.16 PLATING M13 BACTERIOPHAGE
Competent TGI cells were thawed on ice and lOOpl used per ligation reaction along with 
1.5pl DMSO and 5pl of ligation mix and incubated on ice for 30 min. This mix was then heat 
shocked at 42°C for 90s before adding to 3ml molten H-top agar containing 200pl of an 
overnight culture of TGI cells. The agar was then poured onto TY-agar plates which were 
inverted and incubated at 37°C overnight. When blue/white selection was used 480pg IPTG 
and 600pg X-gal was added to the molten agar.
2.5.17 PREPARATION OF ELECTRO-COMPETENT D H 5a CELLS
This method was described in the electroporator manual (1991). An overnight culture of cells 
was prepared by inoculating 500 ml Luria-broth with a single colony from a stock plate, kept 
at 4°C and re-plated every 2 months. This was then used to inoculate Luria-broth at a ratio of 
1:100 and cells were grown at 37°C in an orbital incubator to an optical density of 0.4 at 
600nm. After incubating on ice for 1 hour cells were pelleted at 4000XG at 4°C for 15 min 
and resuspended in 1 volume of ice cold GDW. This was repeated with continually smaller 
volumes of 0.5, 0.5, 0.02 of GDW and finally a 0.003 volume of filter sterile cold 10% 
glycerol. Aliquots of 200pl were stored at -70°C.
2.5.18 ELECTROPORATION
For each reaction, Ipl of a 1:5 dilution of ligation mix was added to 40pl of cells and allowed 
to stand on ice for 1 min. Electroporation was carried out as described in the operating 
manual (1991) in disposable 2mm gap cuvettes using a BTX ECM 600 Electroporation 
System at 2.45kV and 1290 for 5-6 ms. 1ml of SOC was immediately added and cells
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incubated at 37°C for 1 hour prior to plating out on selective agar. Conditions were advised 
in the electroporator manual (1991).
2.5.19 PREPARATION OF CHEMICALLY-COMPETENT TG I CELLS
An overnight culture of cells was prepared by inoculating TY-broth with a single colony from 
a stock M9 plate, kept at 4°C and re-plated every 2 months. This was then used to inoculate 
TY-broth at a ratio of 1:100 and cells were grown at 37°C in an orbital shaker to an optical 
density of 0.5 at 600nm. After incubating on ice for 2 hours the cells were pelleted at 
2500XG at 4°C for 15 min and resuspended in 1 volume (of original culture volume) 
trituration buffer. After incubation on ice for 45 min this was repeated with resuspension in 
0.1 volume. Glycerol was added to a final concentration of 15% and aliquots stored at -70°C.
2.5.20 TEMPERATURE SENSITIVE PLAQUE ASSAYS
Temperature sensitive plaque assays were performed as described in Macadam et a l, (1991b). 
Cell monolayers were prepared in 6 well plates, duplicates were prepared for each virus at 
each temperature used. After removal of growth medium wells were inoculated with serial 
log dilutions of virus diluted in 1 X MEM and allowed to adsorb to the cells for 20 min. Cells 
were then overlayed with a 1% solution of Nobles Agar (Difco) in a 1 X MEM growth 
medium and sealed with pressure film when set. Inverted plates were then incubated in CO2 
incubators or thermostatically controlled water baths, accurate to within 0.01 °C (Grant SP). 
Temperatures were determined using a Digitron 3204-pt platinum probe digital thermometer. 
After 3 days, agar was removed and cell sheets stained with Naphthalene Black. The 
temperature, T°C at which a virus is defined as ts is the temperature at which logio(titre at 
35°C /titreatT°C )=l.
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2.5.21 VISUALISATION OF PLAQUES
Virus was grown on cell monolayers in 6 well plates as for the ts plaque assays and overlayed 
with 1% Nobles Agar and 1 X MEM medium. After 3 days incubation a further 1.5ml 
overlay was added containing 1% Nobles Agar, 0.017% filter sterile neutral red (Sigma) 1 X 
MEM growth medium and plates were incubated the right way up at 35°C for 4 hours. After 
incubation, the agar above the visible plaques was taken out using a glass pasteur pipette and 
incubated in 1ml 1 X growth medium at 4°C overnight so that any virus could diffuse into the 
medium. Virus bulk could then be grown using this as inoculum. As Neutral Red is very 
light sensitive plates were shielded as much as possible.
Plaques were selected according to what the experiment involved. If non ts revertants were 
required, larger plaques at a relatively high temperature were picked. If virus was simply 
being plaque purified, plaques were picked at 35°C. All plaques selected were individual and 
spaced out as much as possible. The highest dilution that plaques were visible was usually the 
one where plaques were selected.
2.5.22 PROPAGATION OF VIRUS
Viruses were grown on HEp-2C monolayers until CPE was established as described in Minor 
(1980). Cell sheets were then frozen to -20 °C, thawed to release virus and cell debris 
removed by centrifugation. Long term storage was carried out at -70°C.
2.5.23 MONKEY NEUROVIRULENT TEST
Monkey neurovirulence was tested in a W HO approved procedure (WHO 1983).
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CHAPTER THREE
ABILITY OF CODING CHANGES IN THE 
PROTEASE 2A TO COMPENSATE FOR PROTEIN 
TRANSLATION INEFFICIENCIES RESULTING 
FROM 5’NCR MUTATIONS
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3.1 INTRODUCTION
At the start of this project ten non ts revertant polioviruses had been characterised that had 
retained mutations in domain V that destabilised secondary structure but had alternative 
mutations in the coding region of 2A. These 2A mutations were able to rescue the ts 
phenotype resulting from translation inefficiencies that were initially due to the domain V 
mutations. Destabilising domain mutations are usually compensated for in vivo by further 
domain V mutations that re-form the secondary structure necessary for internal initiation of 
translation of the viral RNA. 2A is a small viral protease responsible for shut off of host 
cell translation and polyprotein processing but these rescuing mutations appeared to reveal 
yet another function. The work carried out prior to that described in this thesis was 
published in Macadam et at., (1994).
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FIGURE 3.1 A representation of the predicted secondary structure of domain V of the 
5 ’NCR. Numbering and sequence used is of a type 3 Leon poliovirus. 
Stems are labelled for descriptive purposes.
The viruses in this study were derived from two types of ts parental strains. The first was 
Sabin 2 (S2) which is ts due to the 481 (484 in type 3 numbering, see fig 3.1) G to A 
mutation, or a virus whose first 491 bases were from a Sabin 2 virus, the rest from a non ts 
revertant Sabin 2 virus (P117/S5’). The second type were site directed mutants of
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Leon/Lansing constructs (LL) where the first 789 bases were derived from a Leon type 3 
virus, the rest from a Lansing type 2 virus (Skinner et al., 1989). They were constructed to 
introduce base pairing or deletions in domain V which are not naturally occurring e.g. 
LL472/537 UC had a UC mismatch and LLA483 had a single base deletion at 483 (see fig 
3.1) (Skinner et a l,  1989; Macadam et al., 1992). The mutants were ts in their growth in 
BGM cells and this was measured as the ratio of the pfu/ml at 35°C to that at 39°C (see 
table 3.1).
PARENT Logio(pfu at 35°C/ REVERTANT Log 10 (pfu at 35°C/
(PRECURSOR) pfu at 39°C) VIRUS pfu at 39°C)
(P2/117) 0.2 - -
(P2/1175’) 0.3 - -
P2/Sabin 2.2 S2/39A 0.6
P117/S5’ 2.3 S5’39A 0.4
S5’39B 0.1
S5’39C 0.1
S5’39D 0.2
Leon/Lansing (LL) 0.1 - -
LL472/537UG 2.0 UG/39A 0.3
LLA472 4.0 A472/39A 0.5
LL479/532UC 2.8 UC/39A 0.2
LLA483 4.0 A483/39A 0.9
LL514A 3.0 514/39A 0.4
TABLE 3.1 Comparison of ts phenotypes of parent and revertant viruses in BGM cells. 
Taken from Macadam et al., (1994).
All parent viruses were ts to different degrees in BGM cells (see table 3.1) as the changes 
to domain V disrupt to different extents. For comparison, the equivalent non ts viruses 
were constructs of Sabin 2 with a 481 G (P2/117 and P2/1175’) (Macadam et al., 1991b) 
and the original Leon/Lansing virus containing no 5’NCR mutations. Revertant viruses 
were picked following plaque formation at 39°C on BGM cells and were found to be
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relatively non ts but again to slightly different degrees from each other (table 3.1). On 
sequencing, the 5 ’NCRs of these revertants were identical to the mutant viruses from 
which they were derived. Further sequencing revealed that all revertants had mutations in 
the gene for the protease 2A resulting in coding changes (see table 3.2).
ISOLATE AMINO ACID DIFFERENCE
S2/39A 96 His-Tyr
S5’39A 19 Tyr-His
S5’39B 8 Ala-Val
S5’/39C 79 Thr-Ala
S5’/39D 122 Ile-Val
UG/39A 25 Glu-Gly
A472/39A 80 Phe-Leu
514/39 A 10 Tyr-Cys
UC/39A 82 Tyr-His
A483/39A 23 Thr-Ile
TABLE 3.2 Amino acid differences in the 2A coding regions of non ts revertants at the 
start of the project. Taken from Macadam et al., (1994).
Protein labelling experiments in BGM cells confirmed that the non ts revertants carrying 
2A changes had restored protein synthesis efficiencies comparable to the restoration 
obtained by direct back mutation in the domain V. In addition there was no apparent 
difference in shut off of host cellular translation in cells infected with these and other 
viruses and no differences in levels of extracted viral RNA.
Reconstruction of three of these revertants: 8 Ala-Val; 19 Tyr-His and 96 His-Tyr, by 
insertion of a PCR amplified 2A coding region into a Sabin 2 clone confirmed the effect of 
these mutations. All three were able to rescue the ts phenotype brought about by the 
5’NCR disruption leading to the conclusion that the changes in 2A were responsible for 
rescuing this phenotype.
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The objective of the work described in this chapter was to identify further 2A changes in 
non ts isolates so as to detect any clustering, link specific mutations to specific 5’NCR 
disruptions, to determine any importance of RNA sequence and to gain some idea of the 
functional basis of the suppressor effects.
RESULTS
3.2 DETECTION OF MUTATIONS IN 2A
A number of non ts revertant viruses that had been plaque picked in BGM cells grown at 
39°C or 39.3°C were available for sequencing throughout their 2A genes and virus stocks 
were grown in 25cm^ flasks of HEp-2C monolayers at 35°C. This exerts little selection 
pressure on the virus because in these cells the ts phenotype is observed at much higher 
temperatures (Macadam et a l, 1992), making them more permissive to the phenomenon. 
Sequencing was achieved by phenol/chloroform extraction of RNA from tissue culture 
fluid, cDNA synthesis and PCR amplification of the 2A region using primers AM20 and 
AM21. PCR products were purified using the Prep-a-Gene silica matrix method and the 
entire gene was sequenced by cycle sequencing using ^^^-dA T P  labelled primers AM27 
and AM20. Examples of results from sequencing gels can be seen in fig 3.2. Most had 
already been sequenced through domain V of the 5 ’NCR to verify they retained parental 
disruptions but where this information was not available the area was amplified from 
cDNA by PCR using primers PCR F and 13/11 (see chapter two). Sequencing was carried 
out as for the 2A region using labelled 13/11 as primer.
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FIGURE 3.2 Photographs of examples of sequencing autoradiographs showing some of 
the coding changes in 2A. Changes were found in non ts revertant viruses 
selected in BGM  cells. Viruses still contained a mutation in domain V of 
the 5’NCR as indicated.
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3.3 POSITIONS OF 2A CHANGES
Eighteen more BGM selected non ts viruses were sequenced throughout the 2A gene and 
these data along with previous results published in M acadam et al., (1994) are presented in 
table 3.3. The titres at the higher temperature of 39°C were chosen as representative so as 
to display a clear difference between non ts Leon/Lansing and most other ts viruses. It 
shows that a very broad range of 2A changes were found and no apparent link can be 
immediately seen. For example, a single 5 ’NCR disruption was found to give rise to many 
different mutations in 2A e.g. five separate 2A changes were found in Sabin 2 revertants 
and five different 2A changes were found in revertants of LL472/537 UG. All grew to 
slightly different degrees at the higher temperature, indicating that the mutations do not 
affect the protein to exactly the same degree. All revertants displayed similar plaque 
morphology, generally larger than parental ts viruses but comparable to equivalent non ts 
viruses. In addition table 3.3 does not convey that some non ts revertant viruses containing 
the same coding change in 2A were plaque picked on two separate occasions.
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5 ’NCR DISRUPTION 2A CODING CHANGE Logio(pfu at 35°C/pfu at 
39°C)
Sabin 2 - 484 A None 2.2
or 8 Ala - Val 0.1
P117/S5’ 19 Tyr - His 0.4
79 Thr - Ala 0.1
96 His - Tyr 0.6
122 He - Val 0.2
LL 471/538 AA None 1.7
65 Glu - Lys 0.5
LL 471/538 GA None 1.8
122 I le -V a l 0.7
LL472/537 UG None 2.0
25 Glu - Gly 0.3
33 He - Val 0.2
93 Tyr - His 0.9
106 Pro - Ser 0.5
134 S e r-T h r 0.5
LL472/537 UA None 1.0
30 Ala - Pro 0
LLA472 None 4.0
80 Phe - Leu 0.5
17 Cys - Tyr 0.7
LL473/ 536 UG None 2 .0 t
45 Lys - Glu 0 .5 t
79 Thr - Ala 0 .4 t
LL479/532 UC None 2.8
82 Tyr - His 0.2
LL482/529 AC None 2.8
25 Glu - Gly 0.3
70 Tyr - Cys 0
LLA483 None 4.0
23 Thr - He 0.9
LLA483/528 None 2.5
48 Gly- Asp 0.2
LL514A None 4.0
10 Tyr - Cys 0.4
19 Tyr- Cys 1.5
LL514C None 1.5
65 Glu - Val 0.2
TABLE 3.3 Final list of non ts revertants of viruses with eleven different 5 ’NCR
disruptions with corresponding amino acid differences in the 2A coding 
region and comparison of titre at 35°C to that at 39°C in BGM cells, 
t  Figures are quoted from an assay where the higher temperature was 
39.3°C to better show the phenotype of the parent virus.
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The changes were found along the entire length of the 149 amino acid 2A polypeptide and 
substitutions were found to be acidic, basic or hydrophobic with no conservation of size or 
electrodensity (see table 3.4). A single 2A mutation was found in all viruses sequenced, 
suggesting that all revertants were using the same method to rescue translation 
inefficiencies. Changes did not derive from PCR errors as different PCR reactions from 
the same virus were found to have the same change. In addition a single 2A amino acid 
change was found in two different viruses e.g. a change of threonine to alanine at residue 
79 of the 2A polypeptide was found in non ts revertants of Sabin 2 and LL473/536 UG. In 
all of these cases both viruses were found to have the same base change in the codon 
despite being selected from different parental viruses None of the RNA sequence changes 
in 2A were found to be silent and two different substitutions were found at residues 19 and 
65 albeit in different parental viruses.
Interestingly five of the mutations changed a tyrosine residue to either a histidine or 
cysteine residue. Similarly four of the changes resulted in valine residues. The 
significance of this is unclear but in most of these cases the base changes involved a 
transition rather than a transversion. Evidence exists to suggest that transitions, changes of 
A to G or G to A, are more frequently found in polioviruses than transversion, changes of 
C to U or U to C (Kuge et a l, 1989).
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2A CODING CHANGE 5 ’NCR DISRUPTION
8 Ala - Val Sabin 2
10 Tyr - Cys LL514A
17 Cys - Tyr LLA472
19 T y r - H i s Sabin 2
19 Tyr - Cys LL514A
23 Thr - He LLA483
25 Glu - Gly LL472/537 UG 
LL482/529 AC
30 Ala - Pro LL472/537 UA
33 He - Val LL472/537 UG
45 Lys - Glu LL473/536 UG
48 Gly - Asp LLA453/528
65 Glu - Lys L L 471/538 AA
65 Glu - Val LL514C
70 Tyr - Cys LL482/529 AC
79 Thr - Ala Sabin 2 
LL473/536 UG
80 Phe - Leu LLA472
82 Tyr - His LL479/532 UC
93 Tyr - His LL472/537 UG
96 His - Tyr Sabin 2
106 Pro - Ser LL472/537 UG
122 He - Val Sabin 2 
L L 471/538 GA
134 Ser - Thr LL472/537 UG
TABLE 3.4 List of differences found in the 2A coding regions of non ts revertants with 
corresponding 5 ’NCR disruptions in domain V.
3.4 POSITIONS OF AMINO ACID CHANGES ON PROTEIN M ODEL 
The alignment depicted in figure 3.3 below shows a comparison of six different poliovirus 
amino acid sequences obtained from the GenBank database and is reproduced from 
Macadam et al., (1994). From this, the amino acid sequence of poliovirus 2A was 
estimated to be approximately 93% conserved. In figure 3.3 the residues where
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compensating mutations were found are shown in red. Only four out of twenty are found 
in variable positions (25, 33, 45 and 134), the rest are at highly conserved positions within 
polioviruses. It is interesting to note that the change at residue 33 of valine to isoleucine 
found in a virus with a UG mismatch at 472/537 is also found in Lansing, Leon and Sabin 
3 and that the change found at residue 134 in LL472/537 UG is also found in Sabin 1. This 
would suggest that these 2A changes have no effect on neurovirulence. However changes 
at 25 and 70 were associated with, but not proved to be, determinants of mouse 
neurovirulence in a mouse adapted strain LS-a (Lu et al., 1994). Figure 3.3 also shows that 
the majority of changes are found in the first 100 residues of the protein, with most of these 
appearing in the first 50. In addition the clustering of changes between residues 8 - 2 5  and 
79 - 96 originally described in M acadam et al., (1994) is not completely consolidated with 
the additional changes reported here.
68
1 50
P l / S a b i n ----------------------   - n ----------------- - t - - r -------------
P l / M a h o n e y     d ------------ n ---------s -------- - t - - r -------------
P 2 / S a b i n  --------------------- ------------------------  --------------------- ------------------------ - a - - r - l ---------
P 2 / L a n s i n g -----------------   - n i - - i ---------- v ---------------- i -
P 3 / L e o n ------------------------   k -----------1 - - i --------------- - v --------------------
P 3 / S a b i n ---------------------    k --------------- - - i --------------- - v --------------------
P 3 / F i n l a n d  --------------------- ------------------------ ------------------------ ------------------------ - t ---------------- i -
C o n s e n s u s  GFGHQNKAVY TAGYKICNYH LATQEDLQNA VSVMWNRDLL V-ESKAQGTD
5 1  1 0 0
P l / S a b i n      n ------ ------------------------
P l / M a h o n e y      n ------ ------------------------
P 2 / S a b i n   s - - t - --------------------------- i ------------------------ e ------ ------------------------
P 2 / L a n s i n g   h t - --------------------------- 1 -----------  e ------ ------------------------
P 3 / L e o n  --------------------- ------------------------ ------------------------ ------------------------ ------------------------
P 3 / S a b i n  --------------------- ------------------------ ------------------------ ------------------------ ------------------------
P 3 / F i n l a n d  ------------- s t - --------------- s r - ----------------------- ------------------------ ------------------------
C o n s e n s u s  SIARCNCNAG VYYCESRRKY YPVSFVGPTF QYMEANDYYP ARYQSHMLIG
1 0 1  1 4 9
P l / S a b i n  --------------------- ------------- h  ------------------------  1 ------------- ----------------------
P l / M a h o n e y  --------------------- ------------- h  ---------------------------------------------- ----------------------
P 2 / S a b i n  --------------------- ------------------------ ------------------------ ------------------------ ----------------------
P 2 / L a n s i n g  --------------------- ------------------------ ------------------------ ------------------------ ----------------------
P 3 / L e o n    - - V --------------- ------------------------ ----------------------
P 3 / S a b i n    - - v --------------- ------------------------ ----------------------
P 3 / F i n l a n d  --------------------- ------------------------ ------------------------ ------------------------ ----------------------
C o n s e n s u s  HGFASPGDCG GILRCQHGVI GIITAGGEGL VAFSDIRDLY AYEEEAMEQ
FIGURE 3.3 Amino acid sequences of poliovirus 2A. Sequences were from the GenBank 
database and amino acid sequence obtained using the ‘translate’, ‘pileup’ 
and ‘pretty’ programs on GCG. Conserved residues are shown as dashes (-) 
and differences to the consensus are shown as lower case letters. Positions 
where compensating amino acid changes were found are shown in red. 
Adapted from Macadam et al., (1994).
As discussed in the introduction a putative a-carbon chain model of the protease 2A was 
constructed based on the structure of bacterial serine proteases (Bazan & Fletterick 1988; 
Yu & Lloyd 1991). This model does not necessarily represent the definitive folding of 2A 
but highlighting the positions of the compensating mutations found here in this model 
points to some evidence of clustering at the top and bottom-left (see fig 3.4) although the 
effect is not exclusive.
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FIGURE 3.4 Possible a-carbon chain model of 2A. The putative catalytic triad is made 
up of residues 20,38 and 109 and highly conserved residues are at 39, 88, 89 
and 124. Probable positions of suppressor mutations are indicated as black 
circles with residue number.
All the mutations seem to lie on the outside of the protein which could implicate a surface 
or binding function but this may be simply because 2A is very small. None were found at 
positions of high conservation in small serine proteases but three mutations, at positions
17,19 and 122 seem to be close to the proposed active site. A proper evaluation of the 
positions and implications to folding of these changes will require a crystal structure of 2A.
3.5 DIFFERENT EFFECTS OF 2A MUTATIONS WITH A SINGLE DOMAIN V 
MUTATION
From table 3.4 many different changes in 2A appear to be able to rescue the ts phenotype 
resulting from a domain V mutation. The amino acid changes show no consistency and can
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be found in different positions in 2A. For example a non ts revertant of LL472/537 UG 
selected in one plaque was found to have sequence heterogeneity and this virus was further 
plaque purified in HEp-2C cells to separate any sub-populations. A total of four individual 
plaques were picked, grown and sequenced through domain V to ensure they still had the 
mismatch and through 2A as described above. Each was found to have a different 2A 
coding change and on assaying in BGM cells all were less ts than the parent virus.
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35°C 39°C
FIGURE 3.5 Plates from a ts plaque assay in BGM cells. The viruses assayed were all
Leon/Lansing constructs and had a UG mismatch at 472/537. Three viruses 
also had amino acid substitutions in 2A: 1 = LL472/537 UG; 2 = LL472/537 
UG E25G; 3 = LL472/537 UG S134T; 4 = LL472/537 UG P106S. Plates 
incubated at 35°C in the first column were inoculated with 10 fold dilutions 
from 10'^ to 10 ^ Plates incubated at 39°C in the second column were 
inoculated with dilution from 10'^ to 10'^.
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Figure 3.5 depicts some of the plates from the ts assay in BGM cells for these viruses. It 
clearly shows the dramatic drop in virus growth of the parent virus at the higher 
temperature of 39°C and the effect of the 2A coding changes on virus growth. Comparison 
of plaque morphology shows a reduction in size at the higher temperature which is a 
general trend in all cases but that all viruses were comparable at 35°C. Although the 
revertants all grew at the elevated temperature they were non ts to slightly different degrees 
as can be seen from fig 3.5 and table 3.5 further indicating that not all the 2A changes are 
exactly equivalent.
Virus 2A Coding Change Log 10 (pfu at 35°C/pfu at T°C) for 
BGM cells
38°C 38.5°C 39°C 39.5°C
Leon/Lansing - 0 0 .2 0 .4 0 .7 5
472/537 UG - 0 .5 1.7 2 .7 3
472/537 UG/2A.1 25 Glu - Gly 0 0 .2 0 .4 1
472/537 UG/2A.2 134 S e r-T h r 0 0 .3 0 .5 0 .6
472/537 UG/2A.3 93 Tyr - His 0 0 .2 0 .4 1
472/537 UG/2A.4 106 Pro - Ser 0 0 .3 0 .9 0 .6
TABLE 3.5 Comparison of ts phenotype in BGM cells of a non ts revertant and
subsequent plaque purified viruses containing 2A coding changes with 
precursor viruses.
The graph in fig 3.6 also shows that all the non ts revertants of LL472/537 UG with 2A 
mutations have similar profiles to the Leon/Lansing (472/537 CG) virus and reductions in 
titres are very small with increasing temperature. In contrast, the LL472/537 UG virus has 
a large reduction in titre with temperature.
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FIGURE 3.6 Graph o f log reduction in titre with increasing temperature for
Leon/Lansing, LL472/537 UG and non ts revertants of it carrying 2A 
mutations.
3.6 REVERSION OF TS IN BGM CELLS
There were a very large number of non ts revertant viruses that had previously been 
selected in BGM cells and found to retain 5 ’NCR mutations and consequently not all of 
them were sequenced during this project to confirm they had a change in 2A. In addition, 
for many domain V mutations, e.g. deletion mutants, there is no direct back mutation 
possible. It is very difficult therefore to calculate the proportion of revertants that are 
likely to have mutations in 2A rather than direct back mutations in domain V. However 
there are seven viruses in table 3.3 able to potentially revert in the 5’NCR but this 
reversion was never observed in BGM cells. Seventeen non ts revertants of these viruses 
were found to have 2A changes. For these viruses it would appear that the probability of 
reversion via changes in 2A was at least seventeen times greater than the probability of 
reversion in domain V.
The fact that there were so many revertant viruses that had 2A mutations could be an 
indication that there are more places in 2A that the virus can use for reversion. Clearly if
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the virus were limited only to reversion in domain V there are two positions where 
spontaneous mutations can arise and result in a viable non ts virus i.e. direct back mutation 
or a mutation in the opposite strand. If the virus also has the whole of 2A for this, there are 
more positions where a change could arise during replication. From the data presented 
above there are at least 22 residues, possibly more, that can potentially mutate. In addition 
different changes at each position could also occur.
Non ts revertant viruses with domain V reversions can be selected in BGM cells. In 
particular some viruses with 514 C or A were found to revert back to 514 U (personal 
communication, A. J. Macadam) and viruses with mismatches in the base pair 472/537 
were found to revert only by re-forming the pair (Macadam et al., 1992). However 
mismatches at 472/537 resulted in the most severe ts phenotype of all viable mutants 
constructed (Macadam et al., 1992). It is conceivable that the mechanism by which 2A 
changes are able to compensate for domain V mutations has limits and therefore no 2A 
changes would ever be found in viruses of this type. This idea will be addressed below.
3.7 FFFFCT OF A CHANGE OF PHENYLALANINE TO LEUCINE AT POSITION 80 
IN A LL472/537AC VIRUS
The virus LL472/537 AC was made by site directed mutagenesis of a Leon/Lansing clone 
(Macadam et al., 1992) and has a mismatch of AC at 472/537. This mismatch was found 
to affect the growth of the virus quite significantly leading to a ts phenotype at the lowest 
temperature of 36.5°C along with LL472/537 AG and LL472/537 CC, of the viruses 
discussed in M acadam et al., (1992). The domain V structure of this virus did not appear 
to support efficient translation.
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There were no viruses with compensatory 2A changes from any of the very ts viruses 
mentioned above. All non ts revertants obtained were found to have re-formed base 
pairing in domain V relatively quickly as the growth of the virus was so impaired. It was 
therefore of interest to determine if a change in 2A was capable of rescuing such a 
phenotype. Using a clone of LL472/537 AC, an amino acid change at residue 80 in 2A was 
introduced. A change of phenylalanine to leucine at this position was found in a non ts 
revertant of a virus with a deletion at 472, LLA472 (see table 3.3). A deletion at 472 
results in a highly ts virus although not as ts as LL472/537 AC. The temperature of 
expression of the ts phenotype was reported as 37.5°C for LLA472 and 36.5°C for 
LL472/537 AC in Macadam et a i, (1992). This could be due to the fact that a deletion at 
472 still allows a two base pair stem to form whereas a mismatch here would completely 
disrupt it. The reconstruction of such a ts virus with a mutation at residue 80 would 
investigate how well a change in 2A  was able to suppress the effects of these 5 ’NCR 
changes. In a non ts revertant of LLA472 an alternative change of cysteine to tyrosine at 
residue 17 of 2A was also found.
3.7.1 CONSTRUCTION OF THE LL472/537 AC/F80L VIRUS
A portion of the 2A gene from the virus with the change at residue 80 was amplified in a 
PCR reaction using primers AM20 and AM27 (see chapter two). Amplified DNA of 672 
bases spanned the codon for residue 80 as well as unique restriction sites Xhol at 3297 and 
B gin at 3790. PCR was carried out using a large amount of DNA, a highly processive and 
accurate polymerase, AmpliTaq (Perkin Elmer), and as few cycles as possible so as to 
minimise the likelihood of mistakes being randomly introduced. The DNA was purified 
using the Prep-a-Gene method prior to cleavage with Xhol (New England Biolabs) and 
B gin (New England Biolabs) to give a 493 base pair fragment. Plasmid DNA purified
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from a liquid culture of the clone containing a cDNA copy of the Leon/Lansing virus with 
an AC mismatch at 472/537 was also cleaved with these enzymes.
The 493 base pair fragment of 2A with the change at residue 80 and the large fragment of 
the LL472/537 AC clone were purified from agarose gel slices following electrophoresis of 
digested DNA by the Prep-a-Gene method. After ligation of the corresponding fragments, 
DNA was electroporated into D H 5a electrocompetent cells. Colonies growing on 
selective agar were picked and grown in liquid culture. DNA extracted from these was 
used in a T7 sequencing reaction with primers AM20 and AM27. The entire insert was 
sequenced to check both the sequence at the codon for residue 80 and to check no other 
mutations had been introduced by PCR error.
Plasmid DNA from correct clones was purified from liquid culture and linearised using 
Sail (New England Biolabs). RNA made using T7 RNA polymerase and diluted in a IX 
HBSS/glucose/DEAE-dextran mix was used to transfect monolayers of HEp-2C cells in 
25cm^ flasks. Flasks were incubated at 35°C and checked daily for CPE. RNA is very 
unstable and prone to degradation. Transfection of poor quality RNA will not result in 
growth of any virus and can lead to viruses being falsely deemed non viable. In order to 
discount this, the transfection of the clone was carried out in duplicate with positive and 
negative controls included. As expected, all cells displayed CPE after only 36 hours 
except those mock infected. This meant that the LL472/537 AC/F80L virus was viable. 
Negative control cells were still healthy after six days.
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FIGURE 3.7 Photograph of a sequencing autoradiograph of the LL472/537
AC/F80L clone showing the T to C change at 3617. This changes the codon 
for residue 80 from CUU (phenylalanine) to CCU (leucine). T7 sequencing 
was carried out on a PCR product made from primers AM20 and AM 27 
using AM27 as primer. Lanes are marked AGCT.
Supernatant from flasks of transfected cells, frozen when CPE was observed, formed viral 
stocks. Once again, sequence of 2A was checked. This was performed on a PCR product 
using cDNA made from extracted RNA. PCR primers were AM20 and AM27 and AM27 
was used in a T7 sequencing reaction (see fig 3.7). The virus was also assayed in BGM 
cells with Leon/Lansing and LL472/537 AC as controls. Results show that the change of 
phenylalanine to leucine at residue 80 had no effect on the ts of the virus (see table 3.6). 
Although the domain V sequence was not obtained there was no evidence or either a 
change to GC or AU at this base pair as both would be reflected in a smaller drop in titre 
with temperature. Viruses with both the 472/537 AC mismatch and the change at residue 
80 of 2A were as ts as the parent virus LL472/537 AC. It must be noted that if the values 
for titre reduction at 39°C in table 3.3 are compared the virus LL472/537 AC does not
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appear to be very ts. The values at 38°C display ts a little more. This highlights the inter­
assay variation that can occur and the need for control viruses in each assay.
VIRUS Logio(pfu at 35°C/pfu 
at38°C )
LogioCpfu at 35°C/pfu 
at 39°C)
Leon/Lansing 0.4 1.7
LL472/537 AC 1.8 2.6
LL472/537 AC/F80L 2.1 2.5
TABLE 3.6 Table to show the log drop in titre at 38°C and 39°C with comparison to 
that at 35°C of the viruses Leon/Lansing, LL472/537 AC and LL472/537 
AC/F80L in BGM cells. Results shown for LL472/537 AC/F80L are an 
average of the two viruses reconstructed separately from the same original 
clone.
These results suggest that not all ts phenotypes resulting from changes in domain V of the 
5’NCR can be compensated for by coding changes in the protease 2A. A change of 
phenylalanine to leucine at residue 80 was able to compensate for the strong ts determinant 
of a deletion at 472 but was unable to compensate for an even stronger ts determinant of an 
AC mismatch at 472/537. Although only one change was reconstructed here it would 
appear that there is a limit to the compensatory role of 2A with a single amino acid change. 
Coupled with this is the fact that no non ts revertants of this virus were found with changes 
in 2A. Obviously to test this, other 2A mutations should be introduced into this clone as 
not all of the substitutions associated with a single domain V mutation are equivalent. It is 
possible therefore that other changes may have a stronger effect.
3.8 INTRODUCTION OF CHANGES IN AMINO ACID AT POSITIONS 79 AND 80 OF 
THE PROTEIN 2A
Further evidence that all the changes in 2A listed in table 3.3 were responsible for rescuing 
the ts phenotype can be provided by cloning reconstruction. However three different 2A 
mutations had already been shown by this method to suppress a ts phenotype resulting from
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a domain V mutation in previous work (Macadam et al., 1994) and all non ts revertants 
studied here proved to bear a change in 2A as described above. Furthermore no silent 
changes were discovered so it would appear that the actual change in amino acid was more 
important than the change in RNA. Despite these arguments it is conceivable that the 
changes in RNA of the 2A gene either enhanced or inhibited secondary or tertiary structure 
which could be responsible for the enhancement of translation efficiency.
This question was addressed using site directed mutagenesis to introduce a range of 
mutations in a single residue of 2A. Codons for residues at positions 79 and 80 of the 
protease 2A were altered so as to bring about different amino acids and non synonymous 
codons for the same amino acid at these positions. A change of threonine to alanine at 
position 79 was found in non ts revertants of both Sabin 2 and LL473/536 UG and a 
change of phenylalanine to leucine at position 80 had been found in a non ts revertant of 
LLA472 (see table 3.3). Reconstruction described here was carried out using a cDNA 
clone of Sabin 2. For ease of manipulation, the Apal restriction enzyme site at position 
3522 was previously removed by cloning a silent change into the RNA at this point that is 
not detrimental to the virus (personal communication, A. J. Macadam). Absence of this 
site naturally occurs in Sabin 1 and its removal leaves a single Apal site that can be used 
for cloning purposes. In this experiment unique restriction sites for Apal and SnaBI 
restriction enzymes were utilised at positions 3617 and 4455 respectively.
Degenerate primers AM37 and AM38 (see chapter two)were designed for this mutagenesis 
both spanning the Apal site. For AM37, the bases corresponding to the 79th codon of 2A 
were degenerate f  e. NNC/G. This meant that a combination of bases could be introduced 
into the amplified DNA so that any amino acid could result from the full length clone. In 
the case of AM38, only the first base of the 80th codon was degenerate. For all three to be
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degenerate the primer would have been longer to incorporate the Apal site and the 
necessary overlap for binding to the template. Consequently only isoleucine, valine, 
leucine or phenylalanine could be introduced at position 80 from codons ATC, GTC, CTC 
or TTC.
Part of the 2A gene was amplified so as to incorporate the Apal and SnaBI sites using 2pg 
of DNA of the clone with either primers AM37 and AM21 or AM38 and AM21. Ten 
cycles of a PCR reaction generated DNA containing a mixture of sequence at the codons 
for amino acids 79 (from AM37) or 80 (from AM38). Amplification was carried out using 
lu  of AmpliTaq (Perkin Elmer), a highly processive polymerase and mixed with O.lu Vent 
DNA polymerase (New England Biolabs), a proof reading enzyme, so as to obtain a high 
quantity of DNA with as few mistakes as possible (Barnes 1994). This mixed DNA was 
ligated into the original Sabin 2 clone using restriction enzymes Apal and SnaBI.
After transfection into E Coli cells separate colonies were selected and grown in liquid 
culture. DNA from these was then sequenced using primer All MVi in a T7 sequencing 
reaction. From this, for position 79, ten clones were selected with ten different codons 
coding for eight different amino acids, six of which were not previously found at this 
position. This meant that there were two clones with alanine and two clones with serine 
arising from different codons. For position 80, four clones were selected with four 
different codons for amino acids although one of them with a phenylalanine at position 80 
was identical to Sabin 2. This is summarised in table 3.7. After transfection with RNA 
transcribed from these clones, resulting viruses were assayed in BGM cells to determine 
whether the changes introduced acted in the same way as the changes previously identified 
in the non ts revertants.
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CLONE CODON SEQUENCE AMINO ACID
SABIN 2 ACC/TTC 79-Thr/80-Phe
S2/2A/79E GAG/TTC 79-Glu/80Phe
S2/2A/79R AGG/TTC 79-Arg/80Phe
S2/2A/79W TGG/TTC 79-Trp/80Phe
S2/2A/79L CTG/TTC 79-Leu/80Phe
S2/2A/79Ta ACG/TTC 79-Thr/80Phe
S2/2A/79H CAC/TTC 79-His/80Phe
S2/2A/79Aa GCG/TTC 79-Ala/80Phe
S2/2A/79Ab GCC/TTC 79-Ala/80Phe
S2/2A/79Sa TCG/TTC 79-Ser/80Phe
S2/2A/79Sb AGC/TTC 79-Ser/80Phe
S2/2A/80F ACC/TTC 79-Thr/80-Phe
S2/2A/80V ACC/GTC 79-Thr/80-Val
S2/2A/80L ACC/CTC 79-Thr/80-Leu
S2/2A/80I ACC/ATC 79-Thr/80-Ile
TABLE 3.7 List of mutant viruses made by site directed mutagenesis of a Sabin 2 clone. 
Changes introduced into the RNA sequence are listed along with the 
resulting amino acid change at either position 79 or 80 in 2A.
3.8.1 EFFECTS OF AMINO ACID AT RESIDUE 79 OF 2A
Ten viruses with differences in the 79th codon of 2A were assayed in BGM cells along 
with the original non ts revertant of Sabin 2 with a threonine to alanine substitution at this 
residue. The results are displayed in table 3.8. From these, the original non ts revertant of 
Sabin 2 (Sabin 2/T79A) is shown to be more ts than the Sabin 2 virus with a G at 481. 
This further illustrates that a change in 2A is not necessarily equivalent to re-forming 
domain V secondary structure in terms of effect on a ts phenotype.
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VIRUS LogioCpfu at 35°C/pfu at 
37.5°C)
LogioCpfu at 35°C/pfu at 
38.5°C)
Sabin 2 -4 8 1  G 0.3 0.6
Sabin 2/T79A 0.3 1.0
Sabin 2 0.1 >2
S2/2A/79E 0.1 1.5
S2/2A/79R 0.8 2.9
S2/2A/79W 0 0.8
S2/2A/79L 0.2 2.7
S2/2A/79Ta 1.2 3.2
S2/2A/79H 0 0.7
S 2/2 A/79 Aa gcg 0.2 1.4
S2/2A/79Ab gee 1.1 1.8
S2/2A/79Sa teg 0.3 1.3
S2/2A/79Sb age 0.1 2.7
TABLE 3.8 Table of results from a ts assay in BGM cells of Sabin 2 viruses with
different amino acids at residue 79. The log drop in titre was calculated at 
37.5°C and 38.5°C from that at 35°C. A non ts Sabin 2 virus with a G at 
481 was used as comparison along with the original revertant with a change 
at residue 79.
It is also clear that not every amino acid substitution at this position has the same effect. 
Some of the ts viruses, S2/2A/79E, S2/2A/79L, S2/2A/79Aa and S2/2A/79Sb, are more 
like the non ts viruses at lower temperatures but very ts at the higher temperature. This 
would imply that these amino acids are able to exert only a limited effect. Other viruses, 
S2/2A/79R, S2/2A/79Ta and S2/2A/79Ab already display a relatively ts phenotype at 
37.5°C. The non ts viruses are S2/2A/79W, S2/2A/79H and to some extent S2/2A/79Sa. 
None of the substituted amino acids in these three groups of viruses show any similarity in 
size, shape or electrodensity e.g. basic arginine, polar threonine and non polar alanine at 
residue 79 result in ts viruses.
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Viruses with different codons for the same amino acid were also represented in this 
experiment. These synonymous amino acids were alanine, threonine and serine with an 
alanine present in Sabin 2 and threonine present in the original non ts revertant selected in 
BGM cells. Table 3.9 below compares these viruses and indicates the drop in titre with 
temperature detected in BGM cells.
VIRUS AND CODON LogioCpfu at 35°C/pfu at 
37.5°C)
LogioCpfu at 35°C/pfu at 
38.5°C)
Sabin 2/T79A GCC 0.3 1
S2/2A/79Aa GCG 0.2 1.4
S2/2A/79Ab GCC 1.1 1.8
Sabin 2 ACC 0.1 >2
S2/2A/79Ta ACG 1.2 3.2
S2/2A/79Sa UCG 
S2/2A/79Sb AGC
0.3
0.1
1.3
2.7
TABLE 3.9 Table of log drop in titre at 37.5°C and 38.5°C compared to that at 35°C for 
viruses with different codons but the same amino acids for residue 79. 
Synonymous amino acids were alanine, threonine and serine.
There would appear to be some effect of RNA sequence in addition to the amino acid 
effect observed as not all the viruses with the same amino acid have comparable values for 
drop in titre with temperature. Polioviruses were reported to have no codon preference, 
unlike other picomaviruses (Stanway et a l, 1990). Any differences in ts of viruses with 
synonymous codons would therefore be unlikely to be due to codon usage unless BGM 
cells have an unexpected preference. Changing RNA could affect any secondary structure 
formed. Coding RNA is unlikely to have a highly ordered structure as it would limit 
evolutionary sequence drift, although from phylogenetic studies 2A has a different 
evolutionary path from the other picomaviral proteins. It is possible therefore that the 
RNA for 2A could have a dual purpose of coding for a polyprotein and some regulatory 
RNA function like part of the hepatitis C 1RES. It is conceivable that the viruses have 
other changes and further sequencing should be carried out to ensure that the 5 ’NCR has
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not reverted in some viruses. In addition problems were encountered with the assay 
method and limited time did not allow for any repeats to confirm the results presented here.
3.8.2 EFFECTS OF AMINO ACID AT RESIDUE 80 OF 2A
Four viruses with different amino acid changes introduced at residue 80 of 2A were 
assayed in BGM cells along with a non ts Sabin 2 virus with a G at 481 which was used as 
a control. As can be seen from table 3.10 the virus with the Sabin 2 codon for 
phenylalanine at residue 80 was ts. Perhaps not surprisingly the virus with at leucine a 
residue 80, S2/2A/80L, was relatively non ts since a change of phenylalanine to leucine at 
this position was found in a non ts revertant of LLA472. The LLA472 virus is much more 
ts than Sabin 2, and the 2A change that is able to compensate for a deletion at 472 is also 
able to compensate for a change of G to A at 481 in Sabin 2. In addition, results shown in 
table 3.4 above confirm that a single change in 2A is able to compensate for more than one 
domain V mutation and that there are no direct links between nucleotide changes in domain 
V and 2A. The S2/2A/80V virus with a valine at residue 80 was also found to be as non ts 
as S2/2A/80L whereas S2/2A/801 was as ts as a Sabin 2 virus.
VIRUS LogioCpfu at 35°C/pfu at 
38°C)
LogioCpfu at 35°C/pfu at 
39°C)
Sabin 2 -4 8 1  G 0.3 0.6
Sabin 2/T79A 0.4 1.0
Sabin 2 0.1 2.0
S2/2A/80V 0.3 0.5
S2/2A/80L 0.2 0.3
S2/2A/80I 0.2 2.2
S2/2A/80F 0.5 2.3
TABLE 3.10 Table of results from a ts assay in BGM cells of Sabin 2 viruses with
different amino acids at residue 80. The log drop in titre was calculated at 
37.5°C and 38.5°C from that at 35°C. A non ts Sabin 2 virus with a G at 
481 was used as comparison along with the original revertant with a change 
at residue 79.
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The results from these experiments indicate that not all amino acid substitutions at this 
position are able to compensate equally for ts phenotypes resulting from domain V 
mutations. There does not however appear to be any simple rule about the effect of size or 
electrodensity of amino acid substitution as indicated above in fig 3.4. In addition there 
also appears to be some effect of code used for codon 79 but further investigations should 
be carried out to study this.
3.9 EFFECT OF 2A CHANGES ON MONKEY NEUROVIRULENCE 
All the evidence for the translational enhancing effect of the 2A mutations described above 
was carried out in vitro using ts as a measure. Although ts and attenuation have been 
shown in some cases to be manifestations of the same genotype it was not necessarily true 
of this phenomenon. A monkey neurovirulence test was carried out to W HO guidelines 
(WHO 1983), except that fewer animals were used, comparing an attenuated Sabin 2 virus 
(481 A), a virulent Sabin 2 virus with a G at 481 and Sabin 2 viruses carrying either the 
H96Y or the Y19H 2A mutations.
The results, illustrated in table 3.11 show that the Sabin 2 variants with 2A mutations 
H96Y and Y19H had attenuated phenotypes comparable to the attenuated phenotype of 
Sabin 2. Both the clinical score and the mean lesion score recorded for these viruses were 
similar, contrasting with the results for Sabin 2 with a G at 481. Ts phenotypes of the 2A 
mutations were however similar to Sabin 2/481G rather than Sabin 2 (Macadam et a l, 
1994). This would therefore suggest that although 2A appears to have some role in 
translation, in addition to being responsible for shut off of host cell translation, the effect of 
this does not change the virulence of the virus for monkeys by intraspinal inoculation. This 
suggests that the ability of the protease 2A to affect translation is either cell specific or
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species specific and any changes in 2A arising during vaccine manufacture or passage in 
the human gut may have no implications on increasing neurovirulence.
VIRUS CLINICAL
SCORE
MLS (RANGE) VIRUS PHENOTYPE
SABIN 2 0/4 0.21 (0.14-0.27) ATTENUATEDATS
SABIN 2/481G 3/4 1.25 (0.93-1.83) VIRULENT/NON TS
SABIN 2/H96Y 0/4 0.22 (0.12-0.37) ATTENUATED/NON TS
SABIN 2/Y19H 0/4 0.34 (0.23-0.51) ATTENUATED/NON TS
TABLE 3.11 Results of the monkey neurovirulence test with Sabin 2, a Sabin 2 with a G 
at 481 and two Sabin 2 viruses with compensating 2A changes selected in 
BGM cells. The clinical score refers to the number of animals showing 
signs of paralysis in one or more limb. MLS refers to the mean lesion score 
determined by histological analysis of stained spinal cord slices.
The 2A changes discussed here were all selected after passage of virus in BGM tissue 
culture. Although viruses grow quite well in BGM cells, different selection pressures may 
be exerted on passage in the human gut. This might suggest that 2A is exerting its effect 
from interaction with cellular factors whose expression may be cell specific. These results 
further define the domain V secondary structure as a location of determinants of 
neurovirulence. Both the attenuated Sabin 2 virus and the non ts revertants with 2A 
changes had a disruption to domain V secondary structure and were unable to cause 
paralysis. In contrast the Sabin 2 with a G at 481 and the non-disrupted domain V 
secondary structure was neurovirulent. W hat is not apparent from this is how well the non 
ts revertants with 2A changes would grow in the gut. It is feasible that the enhanced 
growth of these viruses observed at higher temperatures in BGM tissue culture would also 
be observed on passage in the gut. Changes in 2A could enable a virus to grow better in 
the gut and thus able to bring about an improved immune response but with no selection 
pressure to revert in the 5’NCR. This would make such viruses ideal vaccine candidates.
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3.10 DISCUSSION
The work described in this chapter consolidated the observation that amino acid changes in 
the protease 2A could compensate for disruptions in domain V and render a virus non ts 
(Macadam et a l, 1994). A total of twenty eight Sabin 2 and Leon/Lansing viruses that 
were non ts on assaying in BGM cells were sequenced through domain V and all were 
found to have retained the domain V mutations originally responsible for their ts 
phenotypes. On sequencing through the gene for the protease 2A, viruses were instead 
found to have one coding change.
Although only three of the 2A coding changes were previously reconstructed into a Sabin 2 
virus and confirmed to be able to compensate the ts phenotype (M acadam et al., 1994), the 
result can presumably be extrapolated to the rest of the changes found. All viruses were 
found to carry one base mutation and all of them were found to alter amino acids. If the 
changes were simply the result of evolutionary drift and errors made during RNA 
replication, silent base changes would have also been found. Indeed some viruses would 
have been found to have no changes at all in this region. Clearly there appears to be some 
selection pressure exerted by BGM cells to produce a 2A coding change. Furthermore, 
viruses with 2A changes were still attenuated when monkeys were intraspinally inoculated 
in a W HO neurovirulence test. This indicated that the phenomenon was cell specific or 
simply an in vitro observation and that changes in 2A would not alter the neurovirulence of 
vaccines. Therefore a disruption to domain V was a determinant of attenaution and ts 
whereas a change in 2A was a determinant of ts only.
Overall, changes were found at twenty two different residues along the length of the 2A 
polyprotein although most were in the first 100 of the 150 amino acids. A virus with a 
single domain V mutation could be rendered non ts by more than one 2A change, at least
five, and the same 2A change could be selected in viruses with different domain V 
mutations. In addition the same 2A mutations could be selected from the same virus on 
separate occasions. Although there was no trend of type of substitution that occurred, 
except perhaps the preference of transition over transversion, not all of the changes were 
equivalent. This was illustrated both by site-directed mutagenesis at positions 79 and 80 
and by comparison of the phenotypes arising from the five different 2A changes found in 
LL472/537 UG derived viruses. Different amino acids at either residues 79 or 80 produced 
viruses with different ts phenotypes with no link between size, shape or electrodensity. 
The effect of the changes in 2A also had limitations. Despite the fact that a change at 
residue 80 was found to compensate a ts phenotype resulting from deletion of nucleotide 
472, when the change was introduced into a virus with an even more severe phenotype due 
to disruption of the entire stem, no effect was observed. In addition, changes introduced 
into the codon for residue 79 suggested some role for RNA sequence.
The viral protease 2A is known to cleave the initiation factor eIF4G which causes the shut 
off of host protein synthesis. The protein translation machinery in the cells can then be 
employed to synthesise only viral proteins in a cap-independent manner. The results 
presented here show that 2A has another, possibly cell specific, role during protein 
synthesis. Exactly how the mutations in 2A exert their effect is not known. To have found 
so many different mutations is perhaps surprising and may suggest that the effect is an 
artefact. If all the changes had been found to cluster around a very small area then it would 
be easy to assume that the function is localised on the protein at that area and the amino 
acid changes are able to improve the function. Alternatively if the changes had been found 
near the catalytic triad or putative catalytic site the protease activity might be altered. This 
is not the case and no effect on shut off was observed in M acadam et al., (1994).
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However the number of mutations may not be so surprising if the ability of 2A to bind to a 
cellular factor is considered. The mutations could conceivably disrupt a protein-protein 
binding function. Therefore by reducing the ability of 2A to bind to a cellular factor, that 
factor is released to play a part in protein synthesis. Many cellular factors have been found 
to bind to the 1RES and some act to enhance the efficiency of protein synthesis rather than 
play a essential role. A cell specific factor would have to act in a similar way, perhaps as 
an RNA ‘chaperone’ (Svitkin et a l, 1996). This would also explain why many viruses 
were selected with 2A changes rather than domain V reversions. There would be many 
ways in which a binding function could be destroyed but usually only one or two ways 
domain V could revert. Therefore a virus is more likely to mutate in 2A and remain viable 
than in domain V.
An RNA binding function of 2A cannot be completely ruled out but it is unlikely. No 
known RNA binding motifs can be identified and no evidence for it has been obtained. 
Despite this, all the changes in 2A were detected in viruses with disruptions to the 
secondary structure of RNA and there would appear to be some kind of possible link. 2A 
could somehow be binding to the disrupted domain V region and allowing it to re-form the 
secondary structure. However, as described above, the large number of mutations 
throughout the protein suggest that a binding function is disturbed. In addition the possible 
cell specificity of the enhancing function of 2A suggests interaction with a cell specific 
protein factor.
If the cell factor binding hypothesis is correct then the cellular factor would be present in 
BGM cells but not in monkey neuronal cells. This could therefore be tested by looking for 
differences in cDNA libraries made from the two types of cell. Purified 2A protein could 
also be used with an expression library to test for binding. Production of recombinant 2A
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is unfortunately technically difficult as expression in eukaryotic cells is lethal, causing the 
shut off of cap-dependent translation (Davies et a i, 1991). Placing the 2A gene under HIV 
tat activation allowed a permanent inducible cell line to be made (Sun & Baltimore 1989). 
Expression in bacteria does not guarantee correct folding but appears to be sufficient for 
some activity (Sommergruber et a i, 1989; Sommergruber et a l,  1992; Liebig et a l, 1993).
Recombinant protein production in large quantities would also enable the crystal structure 
of 2A to be determined. Currently only putative predictions exist from information already 
obtained about serine proteases. Consequently the positions of the changes found here 
cannot be accurately plotted although as 2A is a very small protein the positions of changes 
described here would probably be found on the surface. Effects of changing amino acids 
could also be calculated using computer programs.
The results presented in this chapter lead on to further investigations. As mentioned above, 
the cellular factor which is interacting with 2A could be identified. More non ts revertants 
could be characterised to perhaps identify all the possible 2A changes. It could take a very 
long time but may give further insight into how the changes affect the protein once the 
crystal structure is determined. Reversion in other cell lines could identify more cell 
specificity and present more scope to the identification of the interacting cellular factor.
Further study should be carried out as to how a Sabin strain virus with a change in 2A 
behaves as a vaccine. It is possible that the attenuating change at 481 (type 2 numbering) 
would be genetically stable in culture and in vivo when in combination with a change in 2A 
and make a safer vaccine. A study of the evolution of virus in the monkey CNS or in a 
chimpanzee feeding experiment would indicate just how stable the virus is. At this point in 
time the W HO is particularly concerned with complete eradication of poliomyelitis in the
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very near future and perhaps a change in vaccine at this late stage is unlikely. The 
attenuated vaccine is under much debate in this initiative as it poses a problem of excretion 
of live virus in vaccinees. However any information gained could be useful in the future 
development of other enterovirus vaccines.
More work should be carried out on the viruses with changes introduced at residue 79. It is 
unclear why the viruses with different codons but the same amino acids should have such 
different ts phenotypes. A new regulatory role for the coding RNA is possible and cannot 
be completely outruled. Codon usage may also be more important than previously 
calculated in either polioviruses or the eukaryotic cells in which the virus polyprotein is 
translated. Alternatively other changes could have been introduced in the clones during 
their construction and sequencing of the 5 ’NCR should be carried out first. This 
experiment could also be carried out using an alternative residue to confirm whether 
changes in RNA are significant. Residues could also be altered in positions where changes 
have not yet been found to determine how much the protein can be changed. In addition 
the natural variation of 2A in polioviruses or enteroviruses as a whole could be determined.
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CHAPTER FOUR
COMPARISONS OF WILD TYPE SEQUENCES
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4.1 INTRODUCTION
The previous chapter described the discovery of twenty two coding changes in the 
poliovirus protein 2A that are able to rescue a ts phenotype resulting from disruption to the 
secondary structure of the 5 ’NCR. Heterogeneity of 2A at the amino acid level was 
measured at less than 7% from the consensus as a result of comparison of only seven 
naturally occurring viruses, including the three Sabin strains, in M acadam et al., (1994) and 
reproduced here in fig 4.1. If this is a true representation of variation then the selection of 
such a large range of changes described in the previous chapter is perhaps surprising.
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FIGURE 4.1 Amino acid sequences of poliovirus 2A . Sequences were from the
GenBank/EMBL database and amino acid sequence obtained and analysed 
using the ‘translate’, ‘pileup’ and ‘pretty’ programs on GCG. The threshold 
was set at 1.5 when using ‘pretty’ so that all amino acid differences were 
displayed. Conserved residues are shown as dashes (-) and differences to 
the consensus are shown as lower case letters. From M acadam et al., 
(1994).
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The first complete RNA sequence of an entire poliovirus was published in 1981. Since that 
time many other complete sequences have been published and can be found on the 
GenBank/EMBL Database. Although this contains both complete and partial sequence 
data of wild type and Sabin virus strains the number of wild type sequences that have been 
elucidated remains small. The database holds several partial sequences of 2A but these 
contain information of only the first 60 bases (Rico-Hesse et a l,  1987). The story is much 
the same for the 5 ’NCR of the virus although many more partial sequences of only the 
5’NCR exist in the database.
The objective of the work described here was to obtain more sequence data of wild type 
viruses for comparison and to determine how much the protein 2A has varied over time. 
Evidence from genetic and phylogenetic comparisons of viruses from the enterovirus genus 
suggests that the capsid and the 3 ’NCR regions seem to have evolved together, indicating a 
link between the two (Poyry et al., 1996). The 5 ’NCR has undergone little evolution, 
probably due to importance of conservation of secondary structure and 2A has evolved by 
itself, possibly because it acts alone (Poyry et a l, 1996). More sequence data on domain V 
of the 5 ’NCR was also desirable in light of the results of the previous chapter.
RESULTS
4.2 W ILD TYPE VIRUSES
The National Institute for Biological Standards and Control, where this project was based, 
holds many samples of serotyped poliovirus extracted from clinical samples. These have 
been collected from patients with various forms of the disease poliomyelitis for the last five 
decades and from all over the world. Viruses are grown in tissue culture either at the 
Institute or country of origin and stored at -70°C in tissue culture fluid. Nine such viruses
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were selected from this stock for sequencing, three of each serotype, dating from 1952 to 
1991 and isolated from six different countries (see table 4.1).
SEROTYPE NAME IN 
TEXT
ISOLATE YEAR OF 
ISOLATION
PLACE OF 
ISOLATION
TYPE 1 P l . l Lennette 77675 1955 Hawaii
P1.2 Morocco 5/78 1978 Morocco
PI 3 Gam 92 1986 Gambia
TYPE 2 P2.1 Lennette 77728 1953 California, USA
P2.2 Morocco 92/78 1978 Morocco
P2.3 Pakistan 2/90II 1990 Pakistan
TYPE 3 P3.1 Lennette 77730 1952 California, USA
P3.2 Morocco 109/76 1976 Morocco
P3.3 India 40/91 1991 India
TABLE 4.1 List of wild type viruses selected for sequencing. All nine were taken from 
stocks held at the National Institute for Biological Standards and Control.
4.2.1 SEQUENCING THE 2A GENE
Viruses were initially grown in HEp-2C monolayers in 25cm^ flasks and RNA was 
extracted from tissue culture fluid using phenol/chloroform. This was then used to 
synthesise cDNA for template in a PCR reaction. Primers used previously on the non ts 
revertants in chapter three, AM 20 and AM21 (see chapter two) were initially tested with an 
annealing temperature of 37°C so as to allow hybridisation despite the expected 
mismatches. This however caused problems with contamination and non specific binding. 
Raising the annealing temperature in later cycles of a PCR reaction to encourage specific 
binding produced no improvement and using the higher temperature for all cycles resulted 
in no product at all. Consequently new primers were designed with degenerate bases from 
sequence information already available on the database. These primers, 3 ’W TAR and 
ARWTI (see chapter two) were again tried together and with the corresponding pair from 
AM20 and AM21 but again the lower annealing temperature produced contamination 
problems and the higher temperatures produced no product. Specifically making cDNA
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with the antisense primer A RW Tin instead of the random hex amers routinely used had no 
effect, again probably because of the large number of mismatches.
It was then decided that direct RNA sequencing may produce better results as shorter 
primers are used in these reactions. These would have less chance of encountering 
problems with primer hybridisation. Viruses were again grown in 25cm^ flasks of HEp-2C 
monolayers and purified on a 15-30% sucrose gradient. Pelleted RNA was then used in 
RNA sequencing reactions with primers All 13, All 141/2 (see chapter two) and ARW Tin. 
The first two were designed to be complementary to Sabin strains of virus and had 
previously been successfully used on wild type viruses (personal communication, G. 
Dunn). Unfortunately no readable sequence could be obtained using this method which 
was probably due either to the inefficiency of primer hybridisation or to poor quality of 
RNA.
In an attempt to again make a PCR product from these viruses which could then be 
sequenced more primers were designed with fewer degenerate bases from comparison with 
coxsackieviruses and polioviruses from the GenBank/EMBL database. Coxsackieviruses 
show the highest homology to polioviruses when comparing nucleotide sequence similarity 
of the PI region (Palmenberg 1989), the 5 ’NCR and to a smaller extent the P2 region 
(Poyry et a l, 1996). These primers, W TPmlI3266 and W TBstE3939 (see chapter two) 
incorporate the restriction sites Pm ll and BstE respectively for possible future cloning of 
PCR products. A PCR reaction of 30 cycles was carried out where the first 5 had an 
annealing temperature of 37°C and this was raised to 50°C for the next 25. This meant that 
in the early rounds of amplification the primers could bind with a little less specificity than 
the later rounds when the majority of the templates would be identical to the primer. From
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this, PCR products were obtained without contamination which were cleaned using the 
Prep-a-Gene silica matrix method.
Purified DNA was then used as template in a T7 sequencing reaction. Unfortunately only 
the W TBstE3939 primer was able to produce any sequence but from information this 
provided, two other primers were designed, WT#3 and W T#4 (see chapter two), from 
which more of the 2A gene sequence was obtained. Unfortunately not all of the 2A coding 
sequence was acquired and the sequencing is incomplete. The sequences of the wild type 
viruses obtained were compared and the result of the ‘pileup’ and ‘pretty’ programs in the 
Genetics Computer Group are displayed in appendix 1. Sequences were then translated 
using the ‘translate’ program and the comparison is displayed in fig 4.2.
The nucleotide sequence comparison displays a high third base variation that would indeed 
present primer hybridisation problems. The comparison of the amino acid sequences 
however shows that the variation is much less and that most of the nucleotide variation 
produces silent changes. Both the PCR and sequencing primers would appear to be more 
specific to type 2 viruses as the majority of the 2A sequence was actually obtained for these 
viruses. Despite this, not all the changes appear to be specific to a serotype although 
complete variance does occur at many positions. In addition there is no evidence of 
evolution over time in any of the serotypes from either the amino acid or nucleotide 
sequences. All the viruses would appear to be the result of individual outbreaks as none of 
these viruses seem to be direct descendants from the earlier sample.
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FIGURE 4.2 A comparison of the 2A amino acid sequences from the nine wild type
viruses sequenced. Leon is also included so as to orientate the incomplete 
sequence data. The amino acid sequence was calculated from the nucleotide 
sequence using the GCG ‘translate’ program and the alignment was made 
using ‘pileup’ and ‘pretty’ programs with the threshold set at 1.5.
Conserved residues are shown as dashes (-) and differences to the consensus 
are in lower case. Blanks are shown as full stops (.) where no sequence was 
obtained and the x denotes cross bands and the places where sequence could 
not be read.
4.3 COMPLETE VIRUS SEQUENCES FROM DATABASE
All complete poliovirus sequences that are available on the GenBank/EMBL database were 
selected for comparison with sequence data obtained here and details of them are listed in
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table 4.2. However it must also be noted that the correct Sabin 2 sequence was later 
published by Pollard et al., (1989) but as there are no differences in the regions under study 
here the Toyoda et al., (1984) sequence can be directly taken. M ahoney, Leon/37, Leon 
119 and Finland viruses were all isolated from cases of poliomyelitis whereas Lansing and 
the W2 virus were mouse adapted viruses, Lansing being virulent, W 2 being attenuated. 
Although Leon 119 virus was isolated as a virulent revertant of Sabin 3 the 2A and domain 
V sequences of these were found to be identical and therefore Leon 119 is omitted from 
amino acid comparisons. Virus W2 is the only addition to the fig 4.1 amino acid 
comparison from M acadam et al., (1994).
STRAIN SEROTYPE ACCESSION
NUMBER
REFERENCE
Sabin 1 I V01150 Nomoto et al., 1982
Sabin 2 II :X00595 Toyoda et a l, 1984/ 
Pollard et al., 1989
Sabin 3/Leon a lb III X00596 Toyoda et al., 1984/ 
Stanway et a l, 1983
Mahoney I J02281 Kitamura gr a/., 1981/ 
Racaniello & Baltimore 
1981a
Lansing II M12197 LaM onica er a/., 1986
W2 II D00625 ŸQVQM et al., 1990
Leon 119 III X01076 Cann et al., 1984
Leon/37 III KO1392 Stanway et al., 1984a
Finland III X04468 Hughes et al., 1986
TABLE 4.2 List of viruses whose complete sequences are available on the
GenBank/EM BL database and used in comparison of wild type viruses 
sequenced here in the 2A gene and domain V of the 5 ’NCR. Accession 
numbers and original references are listed.
A comparison of nucleotide sequence can be found in appendix 2. Leon 119 is included to
show that the sequence is the same as for Leon. As for the figure in appendix 1 for the
wild type viruses sequenced here the extent of third base variance throughout the entire
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region can easily be seen. A similar comparison of 2A amino acid sequences to that 
displayed in fig 4.1 but including W 2 is displayed in fig 4.3. The same GCG computer 
programs (GCG Programme Manual 1994) were used for its construction. The addition of 
W2 changes the consensus slightly at amino acids 33 and 42 and W 2 has two coding 
changes at places not previously listed and the consensus at position 33. Otherwise the 
figure given for amino acid variation in Macadam et al., (1994) is not altered.
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FIGURE 4.3 2A amino acid sequences of all published complete poliovirus. Sequences 
were from the GenBank/EMBL database. Amino acid sequences were 
obtained and analysed using the ‘translate’, ‘pileup’ and ‘pretty’ programs 
on Genetics Computer Group. The threshold was set at 1.5 when ‘pretty’ 
was used so as to display all amino acid differences. Conserved residues are 
shown as dashes (-) and differences to the consensus are shown as lower 
case letters.
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The first third amino acids show the most variation from the consensus with eleven out of 
fifty positions varying and the last third show highest homology with only four out of forty 
nine positions varying. This is in contrast to the nucleotide sequence which shows the 
same variation throughout the region. Therefore more of the third base changes in the last 
third must be silent than in the first third. This suggests that the last third of the amino 
acids make up an area of the 2A protein that has a more fundamental role in the functioning 
of the protease, perhaps near the active site. Until the crystal structure of the protein has 
been deciphered it is impossible to decide where all the residues actually lie.
A complete comparison of all the wild type viruses taken from the database and all the 
information obtained from the nine wild type viruses sequenced here is shown in figure
4.4. The relatively high conservation of amino acid sequence can be seen with some 
evidence that changes are serotype specific. Some variation of the viruses sequenced here 
was found at positions where changes were found in the sequences from the database e.g. 
14, 23, 27, 28, etc., and some variation was found at new positions e.g. 33, 47, 56, 59 etc. 
Although not all the sequences are complete the first fifty amino acids of the protease 
would be predicted to have the highest variation.
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FIGURE 4A  Full comparison of 2A sequences including data from the eight viruses from
the database and the nine wild type viruses sequenced here. The figure was 
complied using ‘pileup’ and ‘pretty’ GCG programs with the threshold set at
1.5. Conserved bases are shown as dashes (-) and differences to the 
consensus in lower case. Missing sequence is shown as full stops (.) and 
positions where the sequence was not determined denoted as (x). Positions 
o f compensating 2A changes are indicated in red in the consensus.
4.4 CONSERVATION OF 2A IN THE ENTEROVIRUS GENUS
Sequence comparison of poliovirus 2A above highlighted areas of conservation and areas 
of variation. To further analyse the evolution of this protease, sequences from other
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picomaviruses were also compared. Viruses were selected from only complete sequences, 
on the GenBank/EMBL database and accessed using GCG.
As depicted in chapter one (fig 1.2) polioviruses are members of the enterovirus genus 
along with coxsackieviruses and enteroviruses. Other close phylogenetic relatives, 
determined by sequence analysis, are rhinoviruses and to a lesser extent, apthoviruses 
(Palmenberg 1989). The 2A protease of apthoviruses is much shorter and the leader 
protein is instead responsible for cleavage of eIF4G resulting in shut off o f host cell 
synthesis. It was therefore decided to include only sequences from coxsackieviruses, 
enteroviruses and rhinoviruses. Echoviruses were previously all classified as enteroviruses 
and because of the close sequence similarity to coxsackieviruses one echovirus sequence 
was also included along with a sequence of a swine vesicular virus. All the viruses listed 
below in table 4.3 also have similar 1RES and 5’NCR regions.
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NAME ACCESSION
NUMBER
REFERENCE
HUMAN RHINO VIRUS IB D00239 Hughes et al., 1988
HUMAN RHINOVIRUS 2 :X02316 Skem et a i, 1985
HUMAN RHINOVIRUS 14 K02121 Stanway et al., 1984b 
Callahan et al., 1985
HUMAN RHINOVIRUS 16 L24917 Lee et al., 1995
HUMAN RHINOVIRUS 89 M l 6248 Duechler et al., 1987
COXSACKIEVIRUS A9 D00627 Chang et al., 1989
COXSACKIEVIRUS A16 U05876 Poyry et al., 1994
COXSACKIEVIRUS A21 D00538 Hughes et al., 1989
COXSACKIEVIRUS A24 D90457 Supanaranond et al., 1992
COXSACKIEVIRUS B1 M l 6560 lizuka et al., 1987
COXSACKIEVIRUS B3 M33854 Lindberg et al., 1987 
Klump et al., 1990
COXSACKIEVIRUS B4 ;X05690 Jenkins et al., 1987
COXSACKIEVIRUS B5 X67706 Zhang et al., 1993
ECHOVIRUS 11 :K80059 Auvinen & Hyypia 1990
ECHOVIRUS 12 X79047 Kraus et al., 1995
SWINE VESICULAR 
DISEASE VIRUS H/3 ‘76
X54521 Inoue et al., 1989
ENTEROVIRUS 70 D00820 Ryan et al., 1990
BOVINE ENTEROVIRUS 
VG-5-27
D00214 Earle et al., 1988
TABLE 4.3 Table of all viruses included in a comparison of 2A sequences from viruses 
in the enterovirus genus. Viruses are listed along with their accession 
number on the GenBank/EM BL database with the journal reference.
The 2A sequences obtained from these viruses were translated into the amino acid 
sequence using the ‘translate’ GCG program. A comparison of all the sequences, 
including those obtained for polioviruses was calculated using ‘pileup’ and ‘pretty’ GCG 
programs. The results obtained are reproduced in fig 4.5. As only complete sequences are 
used the sequences for the viruses listed in table 4.1 and sequenced here were not included.
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FIGURE 4.5 A comparison of 2A amino acid sequences from rhinoviruses,
polioviruses, coxsackieviruses (Cox) and enteroviruses (Entero). 
Sequences were obtained from the GenBank/EMBL database. Amino 
acid sequence was obtained using the ‘translate’ program on GCG. The 
comparison was compiled using ‘pileup’ and ‘pretty’ GCG programs. 
The threshold was set at 1.5 when using ‘pretty’. Differences to the 
consensus are shown in lower case letters and positions of compensating 
2A changes found in non ts revertant polioviruses and discussed in 
chapter three are indicated in red. Other abbreviations are echoviruses 
(Echo) and swine vesicular disease virus (SVD).
An immediate observation from the comparison above is that although there are small areas 
of high conservation across all of the viruses listed, there are three clear groups: the 
rhinoviruses; the polioviruses (including coxsackievirus A21 and coxsackievirus A24) and 
the coxsackieviruses which also includes enteroviruses, echoviruses and the swine 
vesicular disease virus. The coxsackieviruses and the polioviruses also show more 
sequence homology to each other than to the rhinoviruses. These results are of course
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completely expected from past phylogenetic studies. Numbering of residues is slightly 
different as the proteins are of slightly different lengths with some residues either missing 
or inserted within the different groups.
The putative catalytic triad residues of 2A, numbered here as 21, 39 and 111 are completely 
conserved. The residues found to be highly conserved in small serine proteases, numbered 
here as 40, 90, 91 and 126 are mostly conserved except for one change at residue 40 in 
enterovirus 70 and two changes at 126, in rhinovirus 2 and in coxsackievirus A 16. This is 
also an expected result as all 2A sequences are able to act as a protease. In addition, the 
highest variation is found in the first two thirds of the amino acid sequence with more 
conservation found in the last third. This was also found when comparing only 
polioviruses and reflected in the 2A compensating mutations also being found mainly in 
the first two thirds. High conservation of the region made up of the forty nine residues 
implies it is important to the function of the whole protein, possibly forming part of the 
active site or playing a role during folding. Indeed the largest run of conserved amino acids 
throughout all the viruses is the five residues at 109-113 which are GDCGG. This must be 
a very important region to the protease and appears to be found very close to the active site 
on the three dimensional model predicted by Bazan & Fletterick (1988) and Yu & Lloyd 
(1991) and displayed in chapter one (fig 1.11).
Positions of compensating 2A changes found in non ts revertants of polioviruses discussed 
in chapter three are shown in red in the consensus sequence in figure 4.5. W ithin the 
polioviruses, positions of the changes are generally highly conserved but when other 
viruses are included the picture is a little more complicated. Only two of the changes, at 
residues 50 and 108, are in positions of total conservation (106 in poliovirus numbering). 
Most of the changes are at positions that are conserved within the three groups but differ
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between groups. In addition some of the changes are in positions where polioviruses share 
conservation with rhinoviruses and some where polioviruses share conservation with 
coxsackieviruses.
These results give some insight about the compensating changes. Only two changes were 
found at a position of complete conservation which suggests that the fundamental protease 
activity that all the proteins share is not affected. M ost changes were found to be at 
positions that were conserved only within a group. This would perhaps suggest that the 
changes are altering a poliovirus specific function of 2A. Therefore no effect would be 
expected from the introduction of equivalent changes into viruses outside of the poliovirus 
group.
4.5 DOMAIN V OF THE 5’NCR
Results from the previous chapter presented some link between the 5 ’NCR disruptions of 
domain V and the gene 2A. Therefore it was decided that comparison of domain V 
sequence data from the nine wild type viruses selected from NEBSC stocks and listed in 
table 4.1 may show the same genetic drift as the 2A sequence data. A sequence 
comparison of the wild type viruses obtained from the GenBank/EM BL database is 
displayed in fig 4.6 and was constructed in the same way as for the 2A sequences.
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FIGURE 4.6 Domain V sequences of all published polioviruses. Sequences were from 
the GenBank/EMBL database and analysed using the ‘pileup’ and ‘pretty’ 
programs on Genetics Computer Group. Conserved residues are shown 
as dashes (-) and differences to the consensus are shown as lower case 
letters.
Sequences were then folded into secondary structure using ‘foldRN A ’ and ‘squiggles’ 
programs on GCG which also calculate the predicted free energy of the structures. These 
can be seen in fig 4.7. The structure is most stable in terms of thermodynamics at the 
lowest free energy value. Therefore when more than one structure can form from one 
sequence, it is the one with the lowest free energy value that is more likely to form. Other 
alternatives may also be present in the population at relatively low proportions, particularly 
when the energy differences are very small and they may exert some effect on the 
phenotype of the virus.
For all domain V structures base 484 and the large loop formed by bases 514-527 were 
forced to be unpaired following the structure of Skinner et a l, (1989) and Filipenko et al., 
(1989) published from thermodynamic folding and double and single stranded specific 
reagents rather than the structure of Le & Zuker (1990). For all published sequences
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shown here free energy was increased by approximately 3 kcal/mol when this loop was 
unpaired. Evidence from the Sabin 2 attenuating mutation at 481 suggests that this base is 
not paired with the U at 511. A change of G to A found in Sabin 2 would make the base 
pair stronger and it is this mutation which has been shown to attenuate the virus (Ren et a i, 
1991; Macadam et al., 1991b; Macadam et a i, 1993). Sabin 2 is always found to revert 
back at this position to remove the AU base pair. The loop formed by bases 514 to 527 is 
highly conserved across both the poliovirus family and the enterovirus genus but there is 
little evidence to suggest any base pairing from strand specific reagents. An unpaired loop 
could interact within the 5 ’NCR or with cellular or viral proteins. In addition, the domain 
V structures of the viruses from the database do not show the unnamed three base stem 
made up of bases 464-476 and 580-582 (type 3 numbering) although this was used for free 
energy calculations.
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FIGURE 4.7 Domain V structures of the viruses whose entire sequences are published 
on GenBank/EMBL database. Structures and free energy values were 
determined using ‘foldRN A’ and ‘squiggles’ programs.
Free energy calculated from predictions of secondary structure can be correlated with the 
temperature at which a virus displays a ts phenotype for viruses that only differ in domain 
V (Macadam et al., 1992). Values presented in fig 4.7 show that there is no strict 
correlation with free energy and virulence. Mahoney has a relatively high free energy in 
comparison to the values for Sabin 1 and Sabin 2. In contrast Sabin 3 has a relatively low 
free energy value, lower than the values for Lansing and W2. Clearly free energy values 
are a valuable tool to determine which of the alternative structures are more likely to form 
when the sequence could allow variations. However these values are a guide and do not 
necessarily reflect the complex interactions, both within the rest of the RNA structure and 
with protein factors, that are fundamental to the lifecycle of the virus.
4.6 SEQUENCING DOMAIN V OF THE 5 ’NCR
Domain V proved easier than 2A to sequence as the primers PCR F and PCR 9 used 
previously with the non ts revertants worked well on the wild type viruses. PCR products 
were purified using the Prep-a-Gene matrix method and sequenced with primers 13/n and 
aLL390 (see chapter two). However sequence was obtained from only eight of the viruses
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as no PCR product could be made for the P3.3 virus. Fig 4.8 displays the domain V 
sequence comparison between these viruses calculated from ‘pileup’ and ‘pretty’ GCG 
programs.
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FIGURE 4.8 Comparisons of the 5 ’NCR domain V sequences of eight of the nine 
previously un-sequenced wild type viruses. Sequences were compiled 
using ‘pileup’ and ‘pretty’ GCG programs. A consensus sequence is 
displayed and differences to this are shown as (-).
The sequences of domain V were folded and analysed using ‘foldRN A’ and ‘squiggles’ 
GCG programs and can be seen displayed in fig 4.9. The calculated free energy values are 
also displayed. Many of the viruses have the potential to make an extra GU base pair 
between bases 490 and either 507 or 508. If this is allowed to occur, the predicted free 
energy is decreased, making it a more energetically stable structure. However the overall 
structure of domain V would be altered, increasing either stem (c) or (d) by one base pair 
and making the ‘hinge’ at this position more constrained. In the P3.2 virus, this extra base 
pair is AU and much more likely to form than a GU pair. Other structures and shapes are
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successfully conserved and only the bases around the loop between stems (b) and (c) are 
forced to pair or unpair in the ‘foldRNA’ GCG program as discussed above.
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FIGURE 4.9 Predicted domain V secondary structures and calculated free energy values 
of the eight wild type viruses sequenced here. Structures were determined 
using ‘foldRNA’ and ‘squiggles GCG programs.
From observation of these structures the virus P2.3 would appear to be vaccine related as it 
has the Sabin 2 change of G to A at 481. Other changes in the genome must have also 
occurred to change the neurovirulence. The virus P3.1 appears to have undergone quite a 
rearrangement at stem (a). The loop between stems (a) and (b) is however conserved as 
three bases whilst stem (b) is reduced to six base pairs. P l . l  also has different base pairs in 
stem (d) which appear to reduce the free energy of the structure quite considerably as other 
stems and loops seem comparable to those found in PI . 2 and P I .3.
4.7 SEQUENCE CONSERVATION IN DOMAIN V
When the eight sequences taken from the database are added to the second eight that were 
sequenced, a clear pattern of sequence conservation is found. Figure 4.10 shows this 
comparison obtained using ‘pileup’ and ‘pretty’ GCG programs. The individual stems and 
loops of domain V formed by the sequence are also indicated to give a better picture of 
areas of conservation.
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FIGURE 4.10 A comparison of all the domain V sequences sequenced here and 
obtained from the GenBank/EMBL database. The figure was compiled 
using ‘pileup’ and ‘pretty’ GCG programs. Conserved bases are shown 
as dashes (-) and differences as lower case letters. Individual stems and 
loops that the sequence forms are indicated.
Using figure 4.10 a distinct pattern of conserved bases and non conserved bases can be 
observed. The areas that show a high level of variation are stem (d) and the short loops 
either side of it although secondary structure is maintained by covariance. In contrast stem
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(a), the adjacent loops and the stem just before it are highly conserved. The loop at the 
‘top’ of domain V, adjacent to stem (d) shows more conservation in the second half (bases 
499-501) than the first half. These results compare favourably with comparisons of 
poliovirus 1RES structures in Poyry et al., (1992) and Jackson et al., (1994) except for 
P3.1.
Stem sequences could conceivably be regarded as more resistant to genetic drift as both 
sides of the stem need to mutate together to avoid any disruptions to the secondary 
structure. It may be interesting to note therefore that loops can be as conserved as stems. 
This suggests that loops do not merely exist as spacers between stems and their sequence is 
just as important as for stems. This also suggests an interaction either with other loops of 
the 5 ’NCR secondary structure with protein factors involved in replication or translation. 
In the case of the ‘top’ loop adjacent to stem (d) the second, more conserved half may play 
a part in interactions rather than the first half. Alternatively the sequence of a loop may 
play a part in the stacking of secondary structure e.g. the fourteen base loop between stems
(b) and (c) is extremely conserved.
4.8 DISCUSSION
The high conservation of 2A at the amino acid level calculated from seven sequences in 
Macadam et a l, (1994) was further corroborated by the addition of sequences from W 2 and 
Leon/119 although a few more residues were found to vary. The comparison of coding 
RNA sequence for 2A displays the high third base variance that occurs within the different 
strains and caused problems with accurate primer hybridising. Changes are however not 
generally specific to each serotype. The sequencing carried out for this project is 
incomplete but the information obtained further supports the fact that variation of amino 
acid sequence in 2A is minimal. This observation gives credence to the fact that 2A
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changes discussed in chapter three are functional and did not just occur from evolutionary 
variation.
Comparisons with other picornaviral sequences revealed that for 2A, polioviruses are very 
similar to coxsackieviruses, particularly coxsackievirus A21 and coxsackievirus A24. This 
is in complete agreement with previous phylogenetic studies. Conservation was generally 
quite high within the individual poliovirus, coxsackievirus, rhinovirus and enterovirus 
groups but considerably less within the whole group. Analysis of the positions of the 
compensatory changes showed that the protease activity was almost certainly not affected 
as only two were found at positions of complete conservation and that the effect is 
probably restricted to polioviruses. In addition a five base GDCGG m otif at residues 109- 
123 which is probably part of the enzymatic active site was also found to be highly 
completely conserved. The last third amino acids in the sequence in fact displayed the 
highest conservation, indicating an important fundamental role for this part of the protein.
Conservation of domain V sequence is somewhat dominated by the conservation of 
functional secondary structure. Comparison of all the sequences, both those taken from the 
GenBank/EM BL database and those obtained for this project shows that stems (c) and (d) 
and the end loop made up of bases 498-502 display the highest variation whilst 
maintaining the secondary structure. In addition the sequences of unpaired loops were 
found to be as conserved as stems. Loops do not therefore simply exist to act as spacers 
between stems. Some loops will almost certainly interact with either protein factors or 
other areas of the 5 ’NCR.
Calculations of the free energy values of domain V sequences indicated the
thermodynamic stability of the domain V secondary structure in isolation is not necessarily
linked to the neurovirulence of the virus. Changes that alter the secondary structure of
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domain V are clearly determinants of neurovirulence but a certain amount of instability can 
be accommodated before the virus is non viable. Conservation of the functional structure 
would appear to be the major factor. Free energy values are however useful tools in the 
distinction between alternative structures.
Sequencing data could be further consolidated with the completion of the sequencing of 
both 2A and domain V. New primers can be designed from information obtained here. 
Perhaps individual primers for each serotype should be made to avoid the use of too many 
degenerate bases. The first fifty amino acid residues would be predicted to have the 
highest variation. In addition only data from complete sequences on the GenBank/EMBL 
database were used here whereas partial sequences of 2A could also have been added.
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CHAPTER FIVE
CELL SPECIFIC ACTIVITY OF THE 
COMPENSATORY ROLE OF 2A
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5.1 INTRODUCTION
The non ts revertants of Sabin 2 and Leon/Lansing mutants discussed in chapter three were 
all selected in BGM cells which derive from monkey kidney cells. Monkeys can be 
experimentally infected with poliovirus which results in a disease similar to the human 
form (Couderc et a l, 1989; Hashimoto et a l, 1984). An African green monkey kidney cell 
line was found to encode two slightly different poliovirus receptors, a l  and a2 , in two 
separate loci of the genome (Koike et a l, 1992). Both are homologous to the human 
poliovirus receptor in terms of genomic sequence and function. Expression of the receptor 
may be tissue specific but the BGM cell line appears to express the a l  form (personal 
communication, A. J. Macadam).
After the successful cloning and characterisation of the human poliovirus receptor gene 
(Mendelsohn et a l, 1989), transgenic mice were made that expressed the human poliovirus 
receptor gene (Ren et a l, 1990). Independently, mouse cell lines were transformed with 
the cDNA for the human poliovirus receptor. Cells became susceptible to all three strains 
of poliovirus infection on expression of the receptor (Mendelsohn et a l, 1986). The cell 
line used in this institute is the L20B cell line, originally derived from mouse connective 
tissue. L20B cells can be infected by all types of poliovirus and normal CPE occurs 
although they are slightly less sensitive to infection than HEp-2C cells (Pipkin et a l, 1993). 
Viruses also grow as expected e.g. Sabin strains are temperature sensitive and wild type 
viruses are not. In particular the ts phenotype associated with mutations in domain V of the 
5’NCR that is expressed in BGM cells is also seen, albeit at lower temperatures (Macadam 
et a l, 1992). Polioviruses do not infect non transformed mouse cell lines.
It was decided to determine how the non ts revertants carrying 2A mutations would behave 
in the L20B cell line. All the viruses had been selected using only the BGM (monkey) cell
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line and their phenotypes in these cells was examined in chapter three. Evidence from 
monkey neurovirulence tests showed that these non ts viruses were attenuated and this 
could indicate that the enhancing effect of 2A is cell specific and involves interactions with 
cellular factors. It was therefore of interest to determine how the non ts revertants behaved 
in a different cell line and the transformed mouse line was chosen because of the species 
difference and the similar effects of 5’NCR mutations in BGM and L20B cells.
RESU LTS
5.2 TEMPERATURE SENSITIVITY ASSAYS IN L20B MONOLAYERS 
Temperature sensitivity plaque assays were carried out in L20B cells to mirror the previous 
assays in BGM cells. Many of the non ts revertants of Leon/Lansing derived and Sabin 2 
viruses that had compensating 2A changes were assayed along with appropriate controls.
5.2.1 LL472/537 UG
Initially four of the non ts revertants of LL472/537 UG were assayed in L20B cells. For 
controls, the original ts LL472/537 UG and non ts Leon/Lansing (with a CG at 472/537) 
viruses were used. The drop in titre with temperature for the LL472/537 UG revertants for 
both BGM and L20B cells are displayed in table 5.1 and fig 5.1.
VIRUS Logio (pfu at 35°C/pfu at T°C) for 
BGM cells
Logio(pfu at 35°C/pfu at T°C) for 
L20B cells
38°C 38.5°C 39°C 39.5°C 37.5°C 38.2°C 38.5°C 39°C
LL472/537 UG 0.5 1.7 2.7 3 0.1 2.3 3.0 3.0
UG/2A E25G 0 0.2 0.4 1 0.7 2 2.6 3.7
UG/2A Y93H 0 0.2 0.4 1 0.3 1.1 2.6 3.9
UG/2A PI065 0 0.3 0.9 0.6 0.5 2.3 2.9 3.6
UG/2AS134T 0 0.3 0.5 0.6 0.1 1.3 2.6 3.5
LL (472/537 CG) 0 0.2 0.4 0.75 0.4 0.2 0.4 1.0
TABLE 5.1 List of titre drop with temperature of LL472/537 UG and its derivatives 
measured as the ratio of pfu at 35°C to that at 38°C, 38.5°C, 39°C and 
39.5°C for the BGM assay and at 37.5°C, 38°C, 38.5°C and 39°C for the 
L20B assay.
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FIGURE 5.1 Graphs to show the drop in titre with temperature for LL472/537UG and its 
derivatives in both BGM and L20B cell lines.
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The results displayed above show that both BGM cells and L20B cells can be used to 
measure ts phenotypes as LL472/537 UG is ts and the Leon/Lansing (472/537 CG) virus is 
relatively non ts. But it should also be noted that ts is manifested at a lower temperature in 
L20B cells and that plaques in L20B cells are smaller (see figs 5.2 and 5.3). The graphs 
depicting log drop of titre with temperature (see fig 5.1) evidently show that the 2A 
changes in a LL472/537 UG background had little or no enhancing effect in L20B cells. 
Clearly all the viruses with 2A changes have similar profiles to the non ts Leon/Lansing in 
BGM cells and they all have similar profiles to that of the ts LL472/537 UG virus in L20B 
cells.
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35°C
BGM L20B
FIGURE 5.2 Plates from a ts assay, on the left in BGM cells, on the right in L20B cells.
Inoculated cells were incubated at 35°C with 10 fold dilutions from 10'^ to 
10'^. The viruses assayed were all Leon/Lansing constructs with a UG 
mismatch at 472/537. Three viruses also had amino acid substitutions in 
2A: 1 = LL472/537 UG; 2 = LL472/537 UG E25G; 3 = LL472/537 UG 
S134T; 4 = LL472/537 UG P106S.
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39°C
BGM
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L20B
FIGURE 5.3 Plates from a ts assay, on the left in BGM cells, on the right in L20B cells.
Cells were inoculated with 10 fold dilutions from 10*^  to 10'^ and incubated 
at the relatively higher temperatures of 39°C in BGM cells and at 38°C in 
L20B cells. The viruses assayed were all Leon/Lansing constructs with a 
UG mismatch at 472/537. Three viruses also had amino acid substitutions 
in 2A as indicated: 1 = LL472/537 UG; 2 = LL472/537 UG E25G;
3 = LL472/537 UG S134T; 4 = LL472/537 UG P106S.
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A further observation from the graph using data from the L20B cells is that although at the 
higher temperatures of 38.5°C and 39°C all the non ts revertants have equivalent reductions 
in titre, at 38.2°C the values are more spread out. This is in contrast to the data from BGM 
cells where throughout the temperature range all the viruses are more similar to each other. 
This could mean that although overall the mutations in 2A have little effect on the ts 
phenotype in L20B cells there could be a limited effect at lower temperatures.
5.2.2 SABIN 2
Similarly, non ts revertants of Sabin 2 were assayed in L20B cells. For comparison, Sabin 
2 and the Sabin 2 virus with a G at 481 were included as ts and non ts controls respectively. 
Again the mutations in 2A appeared to have no enhancing effect as can be seen in table 5.2 
and the graphs of fig 5.4. Although the Sabin 2 with a G at 481 is non ts, all the viruses 
carrying 2A mutations have similar profiles to that of the parent ts virus in L20B cells 
where as profiles were similar to the non ts Sabin 2/481G in BGM cells. In contrast to the 
data obtained from LL472/537 UG non ts revertants, those derived from Sabin 2 have 
much more similar values of drop in titre to each other in both BGM and L20B cells.
VIRUS LogioCpfu at 35°C/pfu at T°C) for 
BGM cells
Logio(pfu at 35°C/pfu at T°C) for 
L20B cells
38°C 38.5°C 39°C 39.5°C 37°C 37.5°C 38°C 38.5°C
Sabin 2 0.5 1.25 3.0 4.0 0.75 1.0 1.8 3J^
Sabin 2/481 G 0 0 0.25 1.5 0 0 0.3 0.75
Sabin 2/2A Y19H 0 0 0.25 1.25 0.75 1.0 1.8 2.9
Sabin 2/2A H96Y 0 0 0.25 1.75 0.75 1.0 1.8 3.75
Sabin 2/2A 1122V 0 0 0.25 0.75 0.75 1.0 1.8 2.9
TABLE 5.2 List of titre drop with temperature of Sabin 2 and its derivatives measured as 
the ratio of pfu at 35°C to that at 38°C, 38.5°C, 39°C and 39.5°C for the 
BGM assay and at 37°C, 37.5°C, 38°C and 38.5°C for the L20B assay.
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FIGURE 5.4 Graphs to show the drop in titre with temperature for Sabin 2 and its 
derivatives.
5.2.3 OTHER VIRUSES
Other viruses discussed in chapter three were similarly assayed in L20B cells and the 
results are displayed in table 5.3. In BGM cells all the viruses with 2A mutations are non 
ts in comparison with the parent viruses. In contrast the 2A mutations appear to have no 
suppressive effect on the ts phenotypes in L20B cells. All viruses with 2A mutations were 
as ts as the parental virus from which they were derived. The results for the LLA483
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viruses indicate the 2A mutation may have some significance but no consistent and 
dramatic reduction in ts in obtained in L20B cells like that seen in BGM cells.
VIRUS Log 10 (pfu at 35°C/pfu at 
39°C) for BGM cells
Logio(pfu at 35°C/pfu at 
38°C) for L20B cells
LEON/LANSING 0.1 0.1
L L 471/538 AA 1.7 2.1
L L 471/538 AA/2A E65K 0.5 2
LL471/538 G A /2A I122V 0.7 1.7
LLA472 4.0 >3.4*
LLA472/2A F80L 0.5 4.3
LLA472/2A C17Y 0.7 4.6
LL473/536 UG 2.0 0 .5 t
LL473/536 UG/2A K45E 0.5 0 .6 t
LL473/536 UG/2A T79A 0.4 0 .5 t
LLA483 4.0 5.3
LLA483/2A T23I 0.9 3.6
LLA483/528 2.5 1.2
LLA483/528/2A G48D 0.2 1.7
LL514A 3.0 2.7
LL514A/2A YIOC 0.4 2.8
LL514A/2A Y19C 1.5 2.6
LL514C 1.5 0.5
LL514C/2A E65V 0.2 0.5
TABLE 5.3 Comparison of log drop in pfu in BGM cells and L20B cells for a number of 
non ts viruses carrying mutations in 2A. For BGM cells it is measured as a 
ratio of pfu at 39°C and 35°C where as for L20B cells the ratio is pfu at 
38°C and 35°C.
* The figure for LLA472 is not a definite number as the titre of the virus 
used was so low that plaques were only obtained at 37°C. 
t  The figures quoted are from a higher temperature of 39°C as the ts 
phenotype for LL473/532 UC was not expressed at 38°C.
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By comparison with the results for Leon/Lansing the original domain V disruptions 
resulted in ts viruses in both cell lines whereas the effect of the 2A mutations was restricted 
to BGM cells. This indicated therefore that the phenomenon was cell specific involving 
previously unknown interactions with cellular factors. Suppression of ts by 2A is therefore 
not a simple interaction with domain V.
5.3 NON TS REVERTANTS PICKED IN L20B CELLS
From the results shown above all non ts revertants with 2A mutations plaque picked from 
BGM monolayers were found to still be ts on assaying in L20B cells. However it was not 
known whether any other 2A mutations could be selected in L20B cells and function as 
suppressors of the ts phenotype. It was thus decided to try to select revertant non ts viruses 
in L20B cells. All structures presented here were predicted using the ‘foldRNA’ 
programme of GCG (GCG Program Manual 1994) as described in M acadam et al., (1992).
5.3.1 SABIN 2 REVERTANTS
Cells were infected with Sabin 2 virus in serial log dilutions using a six well plate and 
incubated at 35°C, 37°C and 38.4°C. After three days plaques were visualised using 
neutral red stain and five relatively large plaques were picked from cells grown at 38.4°C. 
Viruses were then grown on HEp-2C monolayers in 25cm^ flasks and virus was assayed in 
L20B cells with Sabin 2 and a Sabin 2 virus with a G at 481 for comparison. All plaque 
derived viruses were found to be similar to Sabin 2 in ts (see table 5.4). Sequencing of the 
5 ’NCR domain V from PCR amplified fragments made using primer PCR F and PCR 9 
(see chapter two) and cycle sequencing using a labelled 13/n prim er (see chapter two) 
indicated that all had an A at 481 like Sabin 2.
131
VIRUS Log 10 (pfu at 35°C/pfu at 
31.T C )  for L20B cells
Logio(pfu at 35°C/pfu at 
38.2°C) for L20B cells
Sabin 2/481G 0.4 0.5
Sabin 2 0.2 1.2
Sabin 2/384.1 0.2 1
Sabin 2/384.2 0.4 1.1
Sabin 2/384.3 0.3 0.8
Sabin 2/384.4 0.3 0.9
Sabin 2/384.5 0.5 1
TABLE 5.4 A comparison of log drop in titre at 37.7°C and 38.2°C as compared to that 
at 35°C for Sabin 2/484 G, Sabin 2 and the variants plaque picked from it, 
five were picked at 38.4°C.
These five viruses were further plaque purified at 35°C in L20B cells and two plaques were 
picked from each. After assaying in L20B cells and sequencing through 481 in domain V it 
was found that seven viruses were non ts and had a G at 481 and that two viruses were ts 
and had an A at 481 (see table 5.5). As these viruses had the expected phenotypes from 
sequence analysis they were not characterised further.
132
VIRUS SEQUENCE 
AT 481
Log 10 (pfu at 35°C/pfu 
at 31.T C )  for L20B
Logio(pfu at 35°C/pfu at 
38.5°C) for L20B cells
Sabin 2/481 G G 0.9 1.6
Sabin 2 A 3.1 4.4
Sabin 2/384.1.1 A 2.0 3.1
Sabin 2/384.1.2 G 0.9 1.6
Sabin 2/384.2.1 G 1.0 2.0
Sabin 2/384.2.2 G 0.5 2.3
Sabin 2/384.3.1 A 3.6 4.6
Sabin 2/384.3.2 A 4.0 4.0
Sabin 2/384.4.1 G 1.7 2.8
Sabin 2/384.4.2 G 1.6 2.9
Sabin 2/384.5.1 G 0.5 2.5
Sabin 2/384.5.2 A 3.4 4.5
TABLE 5.5 A comparison of log drop in titre at 37.7°C and 38.5°C as compared to that at 
35°C for Sabin 2/484 G, Sabin 2 and the second round of variants plaque 
picked, two at 35°C from each original plaque derived virus.
No other second site mutation was found in these revertants and this probably reflects the 
importance of a G at 481. The structural basis of this was further investigated and results 
are presented in chapter seven. These assays also highlight the inter-assay variation 
obtained with these cells and the need for control viruses in each assay for comparison of 
relative effects.
As non ts revertants of Sabin 2 plaque picked in L20B cells were all found to have reverted 
at 481 in domain V of the 5 ’NCR it appears that these cells exert little or no selection 
pressure on the virus to mutate in the protease 2A. This observation is consistent with the 
observation that the 2A mutations found in revertants selected in BGM cells have no 
suppressive effect in L20B cells. This suggested that L20B cells would be useful in 
obtaining further information on the secondary and tertiary structure of the 5 ’NCR which 
was the original aim of selecting revertants in BGM cells. If viruses were unable to
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compensate for 5 ’NCR disruptions with changes in the protease 2A they would be forced 
to compensate for them by changing in the 5 ’NCR itself or elsewhere. M utations selected 
may indicate how other regions interact at these points in domain V or potentially other 
areas of the 5 ’NCR. This method would be ideal to select revertants of viruses that cannot 
directly back mutate. W hen such viruses were grown in BGM cells non ts revertants all 
had 2A changes. Of particular interest would be viruses with deletions e.g. LLA472 or 
LLA483/528.
5.4 NON TS REVERTANTS OF VIRUSES WITH DELETIONS IN THE 5’NCR 
Of the many viruses with 5 ’NCR disruptions, three had base deletions which not only 
made the virus very ts (see table 3.3) but made direct back mutations extremely unlikely. 
The viruses of interest were LLA472, LLA483 and LLA483/528 and their predicted domain 
V secondary structures are depicted below. Non ts revertants of these viruses carrying 2A 
mutations had already been selected in BGM cells and this procedure was repeated using 
L20B cells. All structures displayed in this section were constructed from examination of 
sequences and calculations of folding energies using ‘foldRN A’ which were displayed 
using ‘squiggles’ programmes on GCG. As for structures analysed in chapter four, the 
large 14 base loop was forced to be unpaired following the structure published in Skinner 
et al., (1989) and Filipenko et at., (1989) and the base at 484 (in type 3 numbering) was 
also forced to be unpaired. Assays were also all carried out in L20B cells to completely 
remove the possibility of changes in 2A arising during the assay.
5.4.1 REVERTANTS OF LLA472
On plating the LLA472 virus on L20B cells in a six well plate, nine plaques were selected, 
five at 35°C and four at 37°C. Viruses from these were assayed and although they were
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found to be ts relative to Leon/Lansing, they were not quite as ts as the parent LLA472 
virus. This can be seen in table 5.6 where the log reduction in titre at the lower 
temperature of 37.5°C is smaller for the plaque-purified viruses than for the parent virus 
but all have a similar phenotype at the higher temperature of 38.5°C. On sequencing, all 
the viruses were found to have a change of G to A at position 534 in domain V in addition 
to the deletion at 472. No difference was found between the viruses selected at 35°C and 
those selected at 37°C.
VIRUS Logio (pfu at 35°C/pfu 
at 37.5°C) in L20B cells
Logio (pfu at 35°C/pfu 
at 38.5°C) in L20B cells
Leon/Lansing 0.3 0.6
LLA472 2.8 5.0
LLA472/35.1 1.4 4.6
LLA472/35.2 1.5 4.9
LLA472/35.3 1.8 4.8
LLA472/35.4 1.4 >3*
LLA472/35.5 0.7 >3*
LLA472/37.1 1.1 4.5
LLA472/37.2 1.7 4.7
LLA472/37.3 1.3 >3*
LLA472/37.4 1.0 4.1
TABLE 5.6 A comparison of log drop in titre at 37.5°C and 38.4°C as compared to that at 
35°C for Leon/Lansing, LLA472 and the variants plaque picked from it, five 
were picked at 35°C and four were picked at 37°C.
* A finite number could not be measured from the dilutions used as the virus 
titre was so low that plaques were not formed at the higher temperature.
The probable structures of the domain V regions of the parent LLA472 virus and the
variant virus are shown in fig 5.5. This parent virus has the potential to form two slightly
different structures and these are both shown in fig 5.5. The first structure is shown on the
left with the three base UAA loop between stems (a) and (b) intact but stem (a) is slightly
rearranged. The U at 471 is paired with the G at 537 which originally paired with the C at
135
472. This results in the now unpaired A at 538 forming a larger loop, leaving stem (a) 
reduced to two base pairs. The free energy of this structure calculated as -23.2 kcal/mol 
which is 3.7 kcal/mol higher than that for domain V of Leon. The second version is shown 
on the right of fig 5.5. The loop between stems (a) and (b) is reduced to A A whilst stem
(a) undergoes an alternative rearrangement. The U at 474, previously part of the three base 
loop, pairs with the G at 530, allowing base pairs 471/537 UG and 473/537 CG to form and 
reconstruct stem (a) as three base pairs. The free energy of this structure is slightly less at 
-26.5 kcal/mol, which is only 1.0 kcal/mol higher than that for Leon and the more likely to 
form thermodynamically. However, the phenotype for LLA472 is very ts, indicating that 
although the domain V structure is stable it is functionally impaired.
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FIGURE 5.5 Possible domain V structures of a LLA472 virus and a variant selected
from it. Structures of LLA472 were calculated in Macadam et al., (1992). 
Previous type 3 numbering is retained to limit confusion of bases. All
structures were analysed using the ‘foldRNA’ and ‘squiggles’ programmes
ofG C G .
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The change at 543 in the variant virus disrupts the 477/534 base pair, shortening stem (b) 
to six base pairs but places extra bases in the loop between stems (a) and (b) (see fig 5.5). 
Although the loss of a base pair may seem surprising the sequence remaining is such that 
the loop is able to re-form with three bases as A AC. Stem (a) is also able to re-form as 
three base pairs whilst the other strand of the loop between stems (a) and (b) is increased. 
Free energy is calculated as -22.8 kcal/mol (c.f. -27.5 kcal/mol for Leon).
The structure predicted here for the LLA472 variant would therefore indicate that length or 
flexibility of the loop between stems (a) and (b) is important to the functional structure of 
domain V. W hilst the variant is less ts than the parent, it is still ts and has a relatively high 
free energy value. The change at 534 should therefore be thought of as improving the 
domain V of LLA472 by preventing a dysfunctional two base loop forming rather than 
improving the stability of the structure. This interpretation also re-forms the 3 base pair 
stem (a). As a three base stem is probably formed in the very ts parent LLA472 virus it 
would appear that the length of stem (a) is less important to the functional domain V 
structure than the adjacent three base loop. The length of stem (b) would also appear to be 
less important as the change at 534 disrupted the 474/534 pair, leaving only six bases in the 
stem.
5.4.2 REVERT ANTS OF LLA483
Plaques were also selected from the LLA483 virus when grown in L20B cells. Deletion of 
483 shortens stem (b) from seven to six base pairs, leaving the U at 528 unpaired (see 
figure 5.6). The potential weak base pairing of the G at 484 with the U at 528 or the U at 
514 would remove the ‘hinge’ base and reduce flexibility. A total of four plaques were 
picked at 37°C and one at 38°C. On assaying in L20B cells all the viruses were found to 
be less ts than the parent virus but more ts than Leon/Lansing (see table 5.7).
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VIRUS Log 10 (pfu at 35°C/pfu 
at 37°C) in L20B cells
Logic (pfu at 35°C/pfu 
at 38°C) in L20B cells
Leon/Lansing 0 0
LLA483 2.8 3.7
LLA483/37.1 0.4 1.1
LLA483/37.2 0.1 0.9
LLA483/37.3 0.2 1.1
LLA483/37.4 0.6 1.3
LLA483/38.1 0.5 1.1
TABLE 5.7 A comparison of log drop in titre at 37°C and 38°C as compared to that at 
35°C for Leon/Lansing, LLA483 and the variants plaque picked from it, 
four were picked at 37°C and one was picked at 38°C.
Sequence data obtained from PCR products of all of these viruses showed that two
mutations had arisen: a change of G to A at 482 and a change of G to A at 531. The
domain V structure of the parent LLA483 virus and the theoretical structure of the variant
are displayed in fig 5.6. The change at 531 can be interpreted as strengthening the 480/531
base pair from UG to UA which would strengthen stem (b) previously shortened by the
deletion at 483. The change at 482 would destroy the base pair with 529, shorten the stem
even more and enlarge the loop, originally made by bases 514-527, on both strands.
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FIGURE 5.6 Probable structures of domain V in the virus LLA483 with a free energy of - 
25.0 kcal/mol and a variant of this with changes of G to A at 482 and a G 
to A at 531 and a free energy value of 24.5 kcal/mol {c.f. -27.5 kcal/mol for 
Leon domain V). Previous type 3 numbering is retained. Both structures 
were analysed using the ‘foldRNA ’ and ‘squiggles’ programmes of GCG.
This suggests that the flexibility that the ‘hinge’ base and the loop between stems (b) and 
(c) allow is functionally more important than definite stem lengths. Placing an extra A at 
base 482 into the ‘hinge’ would allow the original G at 483 to pair with the U at 514, 
increasing the length of stem (c). In addition the original 1 base ‘hinge’ would re-form 
(see figure 5.6) and the potential for the G at 484 to base pair with the U at 528 is removed. 
The loop is already extended from the deletion at 483 and the slight rearrangement could 
alter the three dimensional folding or stacking of the bases in the loop.
The variants were still more ts than a Leon/Lansing virus, probably due to the shorter stem
(b) and it would appear that this is a compromise. Obviously an insertion of a base at 483 
would be the ultimate reversion to re-form the original domain V shape but this is very 
rarely seen as the result of replication errors, if at all. The structure formed therefore is not 
as efficient in its role as the Leon structure. Both the variant and parent domain V 
structures have higher free energy values than the Leon domain V at -27.5 kcal/mol, 
making them slightly more unstable thermodynamically. The variant however has a higher
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free energy value than the parent by 0.5 kcal/mol indicating that the shape and formation of 
domain V is more important to the functional structure than the free energy. It should also 
be noted that the discovery of two mutations from one round of plating and selection of 
plaques is unusual but not totally impossible, particularly as each mutation would 
individually be advantageous.
5.4.3 REVERT ANTS OF LLA483/528
The third virus containing a deletion in domain V had the base pair 483/528 removed and 
the resulting probable structure is displayed in fig 5.7. As can be seen, removal of this base 
pair resulted in a shortened stem (b) but the loop remained unchanged. Unlike LLA483 the 
removal of both 483 and 528 creates no new potential base pairing for the ‘hinge’ base at 
484. Free energy of this is calculated as -24.2 kcal/mol (c.f. -27.5 kcal/mol for Leon).
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FIGURE 5.7 Probable structure of domain V in the virus LLA483/528. Previous type 3 
numbering is retained. This structure was analysed using the ‘foldRN A’ and 
‘squiggles’ programmes of GCG.
As above, LLA483/528 was grown in L20B cells under agar and plaques were picked after 
three days, four at 37°C and two at 38°C. Viruses grown from these plaques were assayed 
and all had similar phenotypes to the parent LLA483/528 virus (see table 5.8). In a second 
round of plaque selection from LLA483/528/37.1, three were picked from 37.5°C and two
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from 38°C and on assaying they were found to be as ts as the parent virus (see table 5.8). 
This correlated with sequencing information which showed that viruses from the plaques 
contained no changes in domain V.
VIRUS
PLAQUES PICKED IN FIRST 
ROUND
Log 10 (pfu at 35°C/pfu 
at 38°C) in L20B cells
Logic (pfu at 35°C/pfu 
at 38.5°C) in L20B cells
Leon/Lansing 0 0
LLA483/528 1.1 5.3
LLA483/528/37.1 1.2 3.2
LLA483/528/37.2 1.3 >5.3*
LLA483/528/37.3 1.2 >6*
LLA483/528/37.4 1 >5*
LLA483/528/38.1 1.4 >5.3*
LLA483/528/38.2 2 >5.6*
B
VIRUS
PLAQUES PICKED IN SECOND 
ROUND
Logic (pfu at 35°C/pfu 
at 37.5°C) in L20B cells
Logic (pfu at 35°C/pfu 
at 38.5°C) in L20B cells
Leon/Lansing 0 0
LLA483/528 1.6 4.4
LLA483/528/375.1 1 >5
LLA483/528/375.2 1 5
LLA483/528/375.3 1 4.1
LLA483/528/38.1 0.8 5
LLA483/528/38.2 0.5 5
TABLE 5.8 A  comparison of log drop in titre at various temperatures as compared to that 
at 35°C for Leon/Lansing, LLA483/528 and the plaques picked from it. Table 
A lists the data for the first round of plaque selection and table B lists 
the data for the second round of plaque selection.
* A finite number could not be measured from the dilutions used as the titre 
of the viruses used was too low to produce plaques at the higher temperatures.
These results suggest that although the LLA483/528 virus is ts and probably attenuated, 
domain V is genetically stable such that any improvement would entail more than one 
mutation and unstable or non functioning intermediate structures with only one mutation
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are unlikely to form. This virus is also less ts than the LLA483 virus but as ts as the 
variants of LLA483 selected in L20B cells despite all three domain V structures having 
very similar values of free energy. This suggests that the extra base pairing potential of the 
‘hinge’ base found in LLA483 but not LLA483/528 is detrimental to the function of domain 
V secondary structure. The selection pressure for any particular mutation in LLA483/528 
could therefore be thought of as relatively small with any changes arising in the sequence 
giving the virus no advantage. This is in direct contrast to the LLA472 and LLA483 viruses 
from which variants arose after one round of plaque selection.
5.5 NON TS REVERTANTS OF A VIRUS WITH W EAKENED BASE PAIR 
MUTATIONS IN THE 5 ’NCR
In stem structures formed from double stranded RNA a CG base pair forms a slightly 
stronger bond than a AU base pair which is stronger than a UG base pair. In an aim to 
produce a more genetically stable vaccine strain it has been suggested that the 5 ’NCR 
domain V be engineered so as to weaken the structure in a way that the virus cannot easily 
revert whilst still rendering the virus attenuated (Macadam et aL, 1992). Therefore viruses 
with GC base pairs replaced by UA base pairs were made by mutagenesis to test this 
(personal communication, J. W. Almond & A. J. Macadam). The only way these viruses 
could revert is by mutating on both sides of the stem simultaneously which is unlikely as 
each single mutation would make a weaker or disrupted base pair.
5.5.1 LL472/537UA/478/533U A/480/53 lU A
A number of combinations to genetically stabilise domain V have been proposed for a 
possible future vaccine strain. One virus was used for selection of non ts revertants in 
L20B cells as described above. The virus investigated here was the result of site directed 
mutagenesis of a Leon/Lansing construction, LL472/537UA/478/533UA/480/531UA
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(LL/UA/UA/UA) and had changes to three base pairs. The probable structure of this virus 
is displayed in fig 5.8 and this shows that one CG base pair in stem (a) and two base pairs 
in stem (b), one CG and UG, were mutated to UA.
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FIGURE 5.8 Probable structure of domain V in the virus
LL472/537UA/478/533UA/480/531UA. The free energy value for the 
domain V of this virus was -24.1 kcal/mol (c.f. -27.5 kcal/mol for Leon).
The structure was analysed using ‘foldRNA’ and ‘squiggles’ programmes of 
GCG.
Virus was grown in six well plates and initially four plaques were selected at 38.5°C. 
Results in table 5.9 show that the parent virus is very ts with a large drop in titre in L20B 
cells at 38.8°C compared to that at 35°C. Therefore changing base pairs from CG to UA 
appears to destabilise the domain V secondary structure to quite an extent. In addition, all 
of the viruses derived from the selected plaques showed no change in the ts phenotype and 
from sequencing data there were no mutations in domain V. Two of these plaque selected 
viruses, LL/UA/UA/UA/385.1 and LL/UA/UA/UA/385.2, underwent further plaque 
selection at 38.5°C and again information from both sequencing and assay in L20B cells 
showed that no changes had occurred (see table 5.9).
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VIRUS
PLAQUES PICKED IN FIRST ROUND
Logio(pfu at 35°C/pfu at 
38.3°C) in L20B cells
LoglO(pfu at 35°C/pfu at 
38.8°C) in BGM cells
Leon/Lansing 0.7 1.1
LL/UA/UA/UA 1.5 4.2
LL/UA/UA/U A/385.1 1.7 4.6
LL/UA/UA/UA/385.2 1.7 5
LL/UA/UA/U A/385.3 1.7 4.7
LL/UA/UA/U A/385.4 1.4 4
B
VIRUS
PLAQUES PICKED IN SECOND 
ROUND
Logio(pfu at 35°C/pfu at 
37.2°C) in L20B cells
LoglO(pfu at 35°C/pfu at 
37.8°C) in BGM cells
Leon/Lansing 0 0
LL/UA/UA/UA 0.4 0.7
LL/UA/UA/U A /385.1.1 0.6 0.9
LL/UA/UA/U A /385.1.1 0.3 0.7
TABLE 5.9 A comparison of log drop in titre at various temperatures as compared to
that at 35°C for Leon/Lansing, LL/UA/UA/UA and the plaques picked from 
it. Table A lists the data for the first round of plaque selection and table B 
lists the data for the second round of plaque selection.
This evidence indicates that the LL/UA/UA/UA virus is unable to revert easily in L20B 
cells. Much more work would need to be carried out with LL/UA/UA/UA before it was 
deemed unable to revert completely. The virus studied here is also of a Leon/Lansing 
construction. Any suitable changes would need to be introduced into Sabin vaccine strains 
and results from preliminary studies with a type 3 version are optimistic (personal 
communication, A. J. Macadam).
5.6 DISCUSSION
The results presented in this chapter follow on from results of chapter three. Previously the 
changes in 2A were found to be able to compensate for mutations in domain V that
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disrupted secondary structure and render a virus non ts in BGM cells. However in a 
monkey neurovirulence test such non ts viruses remained attenuated. This suggested that 
the phenomenon was cell specific and involved interactions with cell specific factors, an 
observation that was substantiated when viruses were assayed in L20B cells as the changes 
in 2A had no compensating effect in these cells. Viruses were all found to be as ts as the 
parental viruses with only domain V mutations. Consistent with this all non ts revertant 
viruses selected in L20B cells were found to have mutated to re-form domain V secondary 
structure. None were found to have changes in 2A.
All the non ts revertants of Sabin 2 were found to have directly back mutated at 481. This 
meant that L20B cells did not exert any selection pressure on polioviruses to mutate in 2A 
and that these cells did not express the cellular factor necessary for this activity of 2A. 
Following on from this observation, it was decided that L20B cells could therefore be used 
as a tool in the study of domain V structure. Although it is possible to select non ts 
revertants in BGM cells which have reverted in domain V, the majority were found to have 
mutated in 2A instead. In addition, viruses with no obvious method of domain V 
reversion, e.g. a virus with a deletion at 472, could now be investigated. Such viruses were 
all constructed in the laboratory and were not naturally occurring but their reversion could 
give insight about important secondary or tertiary structures.
Viruses selected from LLA472 and LLA483 were less ts variants of the parent rather that 
non ts revertants. This illustrates to what extent base deletions disable the secondary 
structure of a virus. Two of the viruses were not found to alter on growth at elevated 
temperatures. Any changes that the virus is able to achieve would probably be even more 
detrimental to the virus. Therefore LLA483/528 and LL/UA/UA/UA appeared to be 
genetically stable in L20B cells. If LL/UA/UA/UA was confirmed to be attenuated then
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either of these sequences could be incorporated into useful vaccine candidates unless such 
viruses were found to be over-attenuated.
Variants of LLA472 were found to have a mutation that favoured the formation of a three 
base loop between stems (a) and (b) at bases 474-476. Since this loop in the more stable 
parental structure was reduced to two bases in the parent virus the length of loop must 
therefore be an important factor in the secondary structure of domain V, possibly allowing 
correct folding of the overall structure. The re-formed loop in the variant also has a 
different sequence to that found in all polioviruses. This, along with the shorter stem (b), 
could contribute to the reason why the virus remains ts but it would appear that sequence is 
not as important as length. Both the length and sequence requirements of the loop could be 
further studied by the construction of site directed mutants.
Variants of LLA483 illustrated the importance of unpairing the ‘hinge’ base at position 484 
to the functional structure of domain V. In the parent, the G at 484 could potentially base 
pair with the U at 514 or the U at 528, albeit weakly. The mutations found in the variant 
viruses were rationalised as forcing an unpaired A into the ‘hinge’ position whilst 
shortening stem (b) by one base pair. This allowed the original ‘hinge’ base to form a 
potential GU pair and indicated that the flexibility at the ‘hinge’ was more important than 
the specific length of stem (b). The slight rearrangement of the fourteen base loop and the 
stems either side of it could partly explain why the variant is still ts.
These results are consistent with the reversion of the Sabin 2 attenuating mutation at 481 
where potential base pairing of the ‘hinge’ base, 481 A to 511 U is always weakened by 
mutation of 481 A to G. In all other polioviruses the ‘hinge’ base is a G already and has 
the potential to form a base pair with the U at 514, e.g. in Leon, but it is a relatively weak
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pair. The requirements of the unpaired ‘hinge’ base could be investigated further by the 
construction of site directed mutants with different base pairing at this region.
In summary the results presented indicate a number of features about the compensatory 
role of 2A. Cell specificity means that direct interaction of 2A with the 5’NCR is ruled 
out. A cellular factor is instead required for this role. The large number of changes in 2A 
that are able to bring about the effect suggest that they disrupt a binding function, releasing 
the factor to itself interact with the 5’NCR. The factor would appear to absent or 
sufficiently different in L20B cells and the CNS such that the interaction with 2A is not 
disrupted or absent. This would mean the factor acts to enhance translation rather than as a 
canonical factor.
Further investigations into cell specificity of the changes in 2A could prove useful. Brief 
attempts at using the human diploid MRC-5 cell line, derived from foetal lung tissue 
(Jacobs et al., 1970), showed that assay conditions needed to be refined and no results were 
obtained. The 2A mutations may have no effect in the cell lines used for vaccine 
manufacture as no significant mutations have been found in the past. The results presented 
in this chapter however do present L20B cells as a valuable tool in future experiments to 
identify significant cellular factors.
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CHAPTER SIX
MUTATIONAL ANALYSIS OF BASES 474-476 
IN DOMAIN V OF THE 5’NCR
148
6.1 INTRODUCTION
Selection of revertants of ts Leon/Lansing derived viruses in L20B cells was described in 
chapter five. The aim of this was to study secondary and tertiary structure within the 
5’NCR of polioviruses. The viruses carried mutations in domain V which conferred a ts 
phenotype as well as affecting virulence of the virus. Previously the BGM cell line was 
used to select non ts revertants but due to selection pressures enforced by these cells most 
non ts revertant viruses were found to have compensating amino acid changes in the 
protease 2A. Although this highlighted a previously unknown role of this protein it 
provided no information on requirements of the 5’NCR.
Chapter five also outlined that the viruses with compensating mutations in 2A were still ts 
when assayed in L20B cells so that the ability of 2A to counteract the effect of domain V 
mutations appeared to be cell specific. This led to the use of L20B cells to select non ts 
revertants with 5’NCR mutations as it was presumed there would be no selection pressure 
on the virus to mutate in 2A.
The viruses used in this part of the study were unable to directly back mutate. One such 
virus was LLA472, a site directed mutant of Leon/Lansing with a deletion at 472 
(Macadam et al., 1992; Macadam et al., 1994). This virus has the potential to form two 
slightly different structures as discussed in chapter five and these are shown in fig 6.1. The 
first structure is shown with the UAA loop between stems (a) and (b) and stem (a) reduced 
to two base pairs. The free energy of this is calculated as -23.2 kcal/mol (c.f. -27 kcal/mol 
for Leon). The second is shown with the loop reduced to AA whilst the U at 474 base 
pairs with the G at 536 allowing stem (a) to retain three base pairs. The free energy of this 
structure is -26.5 kcal/mol, making this the more likely structure to form.
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FIGURE 6.1 Two possible domain V structures of the parent LLA472 virus and the
L20B derived LLA472/534A virus with the calculated free energy values. 
Structures and values were determined using ‘foldRNA’ and ‘squiggles’ 
GCG programs.
Less ts variants of LLA472 were found to have a change of G to A at 534. This was 
rationalised as reforming the three base loop between stems (a) and (b) and resulted in the 
reduction of stem (b) from seven base pairs to six (see fig 6.1). The sequence of the loop 
would become AAC. In addition stem (a) would be able to also reform as a three base 
stem. From this it could be concluded that the length or flexibility of this 474-476 loop is 
more important to the virus in terms of functional structure formed than the actual 
sequence of it or the length of stem (b). The change at 534 can be thought of as preventing 
the formation of a thermodynamically stable two base loop. The free energy value of the
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variant, -22.8 kcal/mol, is higher than the free energy values for either form of the LLA472 
domain V but the variant is less ts.
Data presented in fig 4.10 in chapter four showed that in all polioviruses the sequence 474- 
476 is conserved as UAA except in Mahoney and Sabin 1 where it is CAA. Furthermore 
the sequence here is conserved as NAA across the entire enterovirus group (Jackson et a l, 
1994) although a wild type virus from Brazil was found to have a G at 476 (Minor & Dunn 
1988). Therefore it would seem unlikely that many variations at these positions would 
result in viable viruses. Such high conservation may suggest that this loop interacts either 
with other areas of the .5’NCR, which may be discovered by mutant/revertant analysis, or 
with proteins involved in translation.
It was therefore decided that viruses with site-directed mutations in this 474-476 loop 
would be made to test the hypothesis. This chapter will describe how mutant viruses were 
constructed with changes in loop sequence and length. The effect of the mutations on the 
virus were analysed in terms of viability and growth at higher temperatures.
RESULTS
6.2 MUTATIONS TO BE INTRODUCED
It was decided to introduce three types of mutation into the loop formed by bases 474-476 
in domain V of the 5’NCR in order to determine the requirements of length and sequence 
to the virus. The first type of mutation introduced any base into the three positions 474- 
476, the second deleted 476, and the third deleted bases 475-476.
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6.2.1 STRATEGY FOR MUTAGENESIS
The mutagenesis strategy took advantage of the available unique restriction sites in the 
poliovirus sequence. Changes were introduced into DNA using mutagenic primers in a 
PCR reaction and amplification was kept to a minimum number of cycles to avoid the 
introduction of extra changes by the Taq polymerase. For this, it was necessary therefore 
to make a sub-clone in M13, inserting a portion of the 5’NCR from a clone of 
Leon/Lansing already in existence, pT7SFP (Skinner et a l,  1989). pT7SFP incorporated a 
T7 promoter such that RNA could be transcribed from the Leon/Lansing insert using T7 
RNA polymerase.
Sub-cloning was achieved by cleavage of Ipg of pT7SFP with restriction enzymes Kpnl 
(New England Biolabs) and Sacl (New England Biolabs). Sacl uniquely cleaves 
Leon/Lahsing at position 751 while Kpnl cleaves at 70 and 2267. After electrophoresis of 
the cleavage products a DNA fragment of 681 base pairs was purified from the agarose 
slice using the Prep-a-Gene method. The same procedure was carried out on Ipg of 
double stranded M13 (mpl9 from New England Biolabs), uniquely cleaved at positions 
6273 with Kpnl and 6279 with Sacl in the polylinker. The small fragment of six bases was 
lost by simple direct purification using the Prep-a-Gene method. The 681 base pair 
fragment of Leon DNA was then ligated into the large fragment of M l3 using 0.5 units of 
ligase (Promega), incubating at room temperature.
This ligated M l3 DNA was transfected into chemically competent TGI cells and 
transformed bacteria were plated onto agar plates. White plaques formed from this were 
picked and phage grown in a TGI culture at 37°C for extraction of DNA. Single stranded 
DNA was extracted for sequencing using the M13 1211 primer and then double stranded 
DNA was extracted for mutagenesis. The whole of the insert was sequenced to ensure that 
the sub-clone was correct.
152
After mutagenesis, described below, the M13 sub-clone and the original pT7SFP were then 
cleaved using Mlul (New England Biolabs) and Sacl (New England Biolabs), both of 
which uniquely cleave Leon/Lansing at positions 278 and 751 respectively. M l3 has no 
Mlul sites. The correct fragment from the M13 sub-clone, purified by using the Prep-a- 
Gene method on an excised gel slice, was then ligated into the large fragment purified in 
the same way from the cleaved pT7SFP again using 0.5units of ligase (Promega). Ligated 
pT7SFP derived DNA was then electroporated into competent DH5a cells and resulting 
bacteria spread onto selective agar. Colonies were picked and grown in culture at 37°C, 
DNA extracted and sequencing was carried out using primer (xLL390 to check that the 
correct mutations were obtained. A schematic of the process described above is shown in 
fig 6.2.
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FIGURE 6.2 A schematic to show the strategy for constructing site-directed mutants of 
domain V at positions 474-476 of a Leon/Lansing virus. Initially a sub­
clone was made in M l3, mutated DNA from a PCR reaction was then 
ligated into the sub-clone and finally the mutated Leon/Lansing insert was 
ligated back into the Leon/Lansing full length clone.
RNA was made from correct clones using T7 RNA polymerase and plasmid DNA 
linearised with restriction enzyme Sail (New England Biolabs). This RNA was then 
transfected into HEp-2C and L20B monolayers, both in 25cm  ^ flasks, to produce a liquid 
culture and in overlayed six well plates for selection of plaques.
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6.2.2 MUTAGENESIS
Three mutagenic primers were synthesised (see chapter two). AM39 was made with 
degenerate bases at the positions corresponding to 474-476. AM40 was made with a 
deletion corresponding to base 476 and AM41 (see chapter two) was made with a double 
deletion corresponding to bases 475-476. All three were made complementary to the Leon 
sequence with at least twelve bases either side of the mismatches to enable accurate 
hybridisation to template DNA. In addition they incorporated the Ncol cleavage site at 
477.
Using these antisense primers and PCR F (see chapter two) as sense primer, PCR reactions 
were carried out using a highly processive and accurate polymerase, Amplitaq (Perkin 
Elmer), on 2pg of Leon/Lansing cloned DNA. This enabled a minimum number of cycles 
to be used to limit PCR error. Products from these PCR reactions were purified using the 
Prep-a-Gene method prior to cleavage with restriction enzymes Mlul and Ncol (New 
England Biolabs). These enzymes cleave Leon/Lansing at positions 272 and 477 
respectively and cloning was performed as described above.
Using this approach, both the single and double deletions were successfully introduced into 
the M l3 sub-clone. In addition, in a clone with a double deletion mutation, an extra 
change of C to U at position of 472 had been introduced presumably from a PCR error. It 
was decided that this mutation should be included in this experiment. In the case of 
sequence changes, from forty two plaques that were selected, eleven were found to have 
different sequence at equivalent Leon/Lansing positions 474-476. The M13 sub-clones 
with mutations in the lAon/Tansing insert that were obtained are summarised in table 6 1 
Unfortunately not all of the M13 mutated sub-clones were reconstructed into the pT7SFP 
clone due to limited time factors.
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M13 CLONE MUTATIONS
INTRODUCED
RECONSTRUCTED
VIRUSES
M39.1 474-476 CGG n.d.
M39.2 474-476 ACA n.d.
M39.3 474-476 TTA n.d.
M39.4 474-476 ACC n.d.
M39.5 474-476 GOT n.d.
M39.6 474-476 TTT n.d.
M39.7 474-476 AAC n.d.
M39.8 474-476 ACG n.d.
M39.9 474-476 ATC n.d.
M39.10 474-476 CAC n.d.
M 39.il 474-476 GAA n.d.
M39.12 474-476 ATC LL/AUC
M40.1 A476 LLA476
M41.1 AA475-476 LLAA475-476
M41.2 AA475-476/473 T LLAA475-476/473 U
TABLE 6.1 A list of all the M l3 sub-clones obtained after ligation of mutagenic PCR 
products.
n.d. means not done
6.3 EFFECTS OF A476 ON LEON/LANSING
The Leon/Lansing insert from sub-clone M40.1 was substituted into PT7SFP using 
restriction enzymes Mlul ^ d  Sacl as described above. The following transfection of RNA 
from this clone was carried out in triplicate but results were the same for each. The 
success o f a transfection relies on the quality and quantity of the RNA produced. As RNA 
is unstable, the failure to produce virus may not always be due to its non viability. 
Repeating this in triplicate therefore confirms that the results observed are valid.
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Plasmid DNA was extracted from bacteria, checked by sequencing with primer ocLL390 
and linearised with Sail. Full length RNA was then transcribed from this using T7 RNA 
polymerase. One quarter of the RNA was used to transfect a HEp-2C monolayer in a 
25cm^ flask and one quarter was used to transfect a L20B monolayer in a 25cm  ^ flask. 
These and control mock transfected flasks were then incubated at 35°C and checked daily 
for CPE. This would produce a stock of any virus which grew. The rest of the RNA was 
used to make serial logio fold dilutions in the 1 X HBSS/glucose/DEAE-dextran mix for 
transfection of L20B and HEp-2C monolayers in a six well plate. These were overlayed 
and incubated at 35°C for three days before visualising plaques with neutral red for plaque 
selection.
All three duplicate experiments for this plasmid gave the same results. While LLA476 was 
viable in HEp-2C cells, no virus grew in L20B cells in flasks or under overlay. This was 
probably due to the fact that these cells are less permissive than HEp-2C cells to growth of 
viruses with detrimental mutations in domain V of the 5’NCR (Macadam et a l, 1992). 
The HEp-2C infected flasks showed CPE after three to four days whilst the control flask 
transfected with RNA from the pT7SFP clone showed CPE after only twenty four hours. 
The three or four days taken for signs of CPE is relatively slow and would either indicate 
poor quality RNA from the T7 RNA polymerase reaction or that the growth of the virus 
was severely retarded. Plaques were visualised in the HEp-2C infected six well plates only 
in the wells inoculated at a 2 logio dilution of the original RNA whereas the plates 
transfected with RNA from pT7SFP had plaques in the wells inoculated at a 4 log dilution. 
This probably indicated again that the RNA was of poor quality or quantity or that the 
virus was retarded in growth. Tliree plaques were picked from the HEp-2C plates; 
LLA476/35.1; LLA476/35.2 and LLA476/35.3. Stocks were subsequently grown in HEp- 
2C monolayers in 25cm^ flasks. RNA extracted from these viruses was made into cDNA 
and amplified in a PCR reaction using primers PCR F and PCR 9. Sequencing using
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primer aLL 390 (see chapter two) in a T7 reaction confirmed that these viruses had the 
deletion at 476 (see fig 6.3).
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FIGURE 6.3 Photograph of sequencing radiograph showing the base deletion at position 
476 for LLA476. Sequencing was carried out on a PCR product made from 
primers PCR F and PCR 9 and primer ocLL390 was used in a T7 sequencing 
reaction. Lanes are marked AGCT and the position of the deletion is 
indicated.
Viruses derived from the selected plaques were assayed in both BGM and L20B cells. The 
results from this are listed in table 6.2. Viruses appear to be viable although all display a 
severe ts phenotype in both BGM and L20B cells compared to Leon/Lansing. The ts 
phenotype of the LLA476 viruses was more severe in L20B cells than in BGM cells. This 
confirms previous observations that viruses will grow at higher temperatures in BGM cells 
than in L20B cells (Macadam et aL, 1992). In L20B cells, plaques were relatively small at 
35°C and titres were reduced by at least three logs at 37.5°C. It is less surprising therefore 
that transfection of the RNA into L20B cells produced no virus. The HEp-2C flask derived
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stocks of the original transfections were also assayed in BGM cells. However these stocks 
had such low titres at 35°C that it was impossible to measure the log drop in titre at 38°C 
and 39°C. These viruses and the plaque derived viruses should have been assayed at lower 
temperatures so that a direct comparison could be made if time had permitted.
VIRUS Logio(pfu at 35°C/pfu at T°C) 
for BGM cells
Logio(pfu at 35°C/pfu at T°C) 
for L20B cells
38°C 39°C 37.5°C 38.5°C
Leon/Lansing 0.4 1.7 0.2 0.4
LLA476/35.1 2.8 4.0 3.0 4.9
LLA476/35.2 2.2 3.5 3.2 3.7
LLA476/35.3 2.7 4.2 3.1 >4.0
TABLE 6.2 List of titre drop with temperature of LLA476 viruses derived from plaques 
measured as the ratio of pfu at 35°C to that at 38°C and 39°C for the BGM 
assay and at 37°C and 38°C for the L20B assay.
As for previous chapters the structures and free energies discussed here were calculated 
using the GCG (GCG Program Manual 1994) programs ‘foldRN A ’ and ‘squiggles’. The 
probable structure of domain V of the LLA476 virus is displayed in fig 6.4. As before, the 
loop formed by bases 514 to 527 and base 484 (type 3 numbering) was forced to be 
unpaired following the structure of Skinner et al., (1989) and Filipenko et al., (1989).
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FIGURE 6.4 Probable structure of the domain V of virus LLA476 with the free energy 
values of -27.9 kcal/mol {c.f. -27.5 kcal/mol for Leon). The structures and 
energies were calculated using GCG programs ‘foldRN A’ and ‘squiggles’. 
Numbering is of the original type 3.
Figure 6.4 shows that the deletion at 476 shortened the loop from 3 to 2 bases. The virus 
could restore this by unpairing bases 477/534 and shortening the stem (b) which was 
thought to have occurred in the L20B derived revertant of LLA472 in chapter five. In the 
same way, unpairing base pair 473/536 would also restore the loop by shortening stem (a). 
However these changes would unpair a strong GC pair and either unpairing would increase 
the free energy by 1.7 kcal/mol. Alternatively, the virus could unpair bases 473/536 and 
force the C at 473 to become part of the loop. This would cause a rearrangement and 
shortening of the stem (a), pairing 471 with 537 and 472 with 536. This second structure 
however has a higher free energy than the first by 3.3 kcal/mol. Therefore the virus 
probably forms the structure with the shorter loop, having the lowest free energy value and 
it is this disruption to the secondary structure which presumably causes the ts phenotype. 
Further analysis of structure and function can be addressed from changes that might occur 
from selection of non ts revertants.
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6.4 LLAA475-476 AND LLAA475-476/473 U
The inserts of M l3 sub-clones M41.1 and M41.2 were cloned into PT7SFP in the same 
way as the insert of M 40.1 described above. The resulting plasmids were sequenced 
before the production of full length RNA using T7 RNA polymerase (see fig 6.5). 
Transfection was carried out in the same way as for LLA476, in flasks and six well plates 
of HEp-2C cells and L20B cells, except that for these, transcription and transfection were 
done in duplicate.
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FIGURE 6.5 Photographs of sequencing autoradiographs showing the base deletions at 
475 and 476 for LLA475-476 on the left and the additional change at 473 
for LLAA475-476/473 U on the right. T7 sequencing was carried out on 
plasmid DNA. Primer 13/11 was used LLA475-476 and ocLL390 was used 
for LLAA475-476/473 U. Lanes are marked AGCT and the position of the 
deletions and changed are indicated.
For both LLA475-476 and LLAA475-476/473 U no plaques were formed in plates and no 
CPE was observed in either HEp-2C or L20B cells in flasks. Positive control flasks showed 
CPE after 24-48 hours. To test for the presence of virus flasks showing no CPE were 
frozen after seven days and tissue culture fluid from these flasks was plaqued in both BGM
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and L20B cells. No plaques were observed at 35°C. In addition, RNA extraction followed 
by cDNA synthesis and PCR amplification was carried out and no PCR product was 
obtained. It appeared therefore that these mutations in domain V resulted in non viable 
viruses.
The probable structure of LLAA475-476 is displayed in fig 6.6. The loop is clearly 
reduced and would inevitably disrupt the overall folding of domain V and the rest of the 
5’NCR. If the base at 473 is forced to become part of the loop and the stem forced to pair 
as 471/537, the energy of the structure is increased by 4.8 kcal/mol. This severe disruption 
to domain V could explain why the virus was non viable although the structure has a 
relatively low free energy value.
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FIGURE 6.6 Probable structures of 5 ’NCR domain V regions of viruses LLAA475-476 
and LLAA475-476/473 U with free energy values {c.f. -27.5 kcal/mol for 
Leon). Structures and energies were calculated using GCG programs 
‘foldRNA ’ and ‘squiggles’. Numbering is of the original type 3.
The probable structure of LLAA475-476/473 U is also displayed in fig 6.6. Again the 
structure is severely disrupted due to the reduction in loop length, despite the U at 473. In 
addition, forcing this base into the loop and rearranging stem (a) increases the energy of the 
structure by 3.4 kcal/mol. This may explain why the virus was non viable.
6.5 M UTATIONS OF 474-476 LOOP SEQUENCE
6.5.1 LL/AUC
The insert of M 39.12 was cloned into PT7SFP as described above. Transfection from 
RNA made from the plasmid using T7 RNA polymerase was carried out as above,
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transfecting into HEp-2C cells and L20B cells, in both flasks and six well plates. This was 
also only performed once.
This virus was found to be viable. CPE was observed in flasks after twenty four hours in 
both cell lines and plaques were found to form in the wells inoculated with RNA diluted to 
4 logs of the original concentration. RNA was extracted from the supernatant of the 
HEp-2C flask stock for synthesis of cDNA. PCR amplification of this was carried out 
using primers PCR F and PCR 9 and purified fragments were sequenced using aLL390 as 
primer in a T7 reaction to confirm the correct sequence (see fig 6.7).
A G C T
c
= 0 LOOP SEQUENCE AUC 474-476
FIGURE 6.7 Photograph of the sequencing autoradiograph showing the base substitutions 
at 474-476 for LL/AUC. Sequencing was carried out on a PCR product 
made from primers PCR F and PCR 9 and primer aLL 390 was used in T7 a 
sequencing reaction. Lanes are marked AGCT and the position of the base 
changes are indicated.
Virus from the HEp-2C stock was assayed in both BGM and L20B cells and the results can 
be seen below in table 6.3. Data shows that although LL/AUC is viable it displays a slight 
ts phenotype in both cell lines. As expected, the ts phenotype is more pronounced in L20B
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cells in comparison with Leon/Lansing for each assay. But in comparison with LLA476 
viruses in table 6.2, the LL/AUC virus is much less ts.
VIRUS LogioCpfu at 35°C/pfu at T°C) 
for BGM cells
LogioCpfu at 35°C/pfu at T°C) 
for L20B cells
38°C 39°C 37.5°C 38.5°C
Leon/Lansing 0.4 1.7 0.2 0.4
LL/AUC 0.7 2.4 0.2 1.1
TABLE 6.3 List of titre drop with temperature of LL/AUC measured as the ratio of pfu 
at 35°C to that at 38°C and 39°C for the BGM assay and at 37°C and 38°C 
for the L20B assay.
Mutations that changes the loop sequence from UAA to AUC are therefore less detrimental 
to the domain V than a mutation that shortens the loop structure in terms of ts. Selection of 
the LLA472 variant that had a loop sequence of AAC also suggested that the sequence was 
not of fundamental importance to viability of virus. In addition transfection of RNA into 
L20B cells produced virus. These cells are much less permissive to viruses with 
detrimental growth mutations so this also confirms that a change of loop sequence to AUC 
has little effect on the virus. The results presented here further support that the length of 
loop is the main consideration. As the free energy of domain V of this virus is the same as 
that for Leon, the fact that LL/AUC shows a slight ts phenotype could be due to stacking 
effects exerted by these bases and interaction with adjacent bases. Again further analysis 
of structure and function would be obtained from changes occurring from selection of non 
ts revertants. The probable structure of domain V of LL/AUC is shown in fig 6.8.
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FIGURE 6.8 The probable structure of LL/AUC as calculated using ‘foldRN A’ and 
‘squiggles’ programs of GCG. The free energy is calculated as -27.5 
kcaFmol (c.f. -27.5 kcal/mol for Leon). Numbering is of the original type 3.
6.5.2 OTHER LOOP MUTANTS
Due to limitations on time none of the other inserts from the mutated M l3 sub-clones were 
re-introduced into the Leon/Lansing clone. Consequently the full effects of changing the 
sequence of the loop 474 to 476 were not studied. Examples of sequencing gels showing 
mutations are displayed in fig 6.9.
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FIGURE 6.9 Photographs of sequencing autoradiographs of some of the M l3 clones 
made with changes in the equivalent loop sequence at 474-476. Single 
stranded T7 sequencing was carried out using M13 1211 primer. Lanes are 
marked AGCT.
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Tertiary RNA or protein interactions with this loop sequence are unlikely since LL/AUC 
and the variant of LLA472 were both viable. However some sequences of the loop may 
not be accommodated by the virus if they favoured alternative folding that changed the 
loop length. For example, any virus with a G in positions 474 or 476 would have the 
potential to reduce the loop to two bases. By pairing with the C at 535, the three base stem 
or the seven base stem would be lengthened. Such rearrangements may have implications 
on the whole folding of domain V and render a virus ts or non viable. Such considerations 
may explain the high conservation of the loop sequence. Alternatively the decrease in 
length of loop may be compensated by a decrease in a stem, possibly even in some kind of 
resonance of base pairing, e.g. a base pair of 474/535 could unpair 477/534. A wild type 
virus was found with a G at 475 (Minor & Dunn 1988) although as it was in the middle of 
the loop it is unlikely to have undergone the rearrangement described above.
Reconstruction of the inserts from M39.1, M39.5, M39.8 and M3 9 . i l  sub-clones all have 
at least one G in the equivalent 474-476 positions and these would be of particular interest. 
The predicted domain V structures of M39.1 and M39.5 are shown in figure 6.10. Both 
structures, M39.1 increasing stem (a) and M39.5 increasing stem 7(b), have free energy 
values of -29.4 kcal/mol {c.f. -27.5 kcal/mol for Leon) making them energetically very 
stable.
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FIGURE 6.10 Predicted domain V structures that would result from the mutations
introduced into the sub-clones M39.1 and M39.5. Free energy values are 
also shown {c.f. -27.5 kcal/mol for Leon). Structures and energies were 
calculated using ‘foldRNA’ and ‘squiggles’ GCG programs.
The insert of sub-clone M39.7 has the same sequence at 474-476 as that found in type 1
Mahoney and Sabin 1 viruses. It would be surprising if inserting this sequence into a Leon
type domain V was detrimental to the virus. However there are some differences in
domain V sequences between Leon and the type 1 viruses (fig 4.10 in chapter four). If the
474-476 loop did interact within the 5’NCR, a sequence of CAA at these positions in a
Leon type background may disrupt the virus. Alternatively interaction may only involve
the AA at 475-476 in which case any base could be tolerated at 474. Reconstruction of a
virus from the insert of M39.7 would therefore be of interest.
6.6 DISCUSSION
Results from selection of variants from LLA472 in chapter five suggested that the length of 
the loop comprising bases 474 to 476 (type 3 numbering) was significant whilst the actual 
sequence was not. Loops would therefore appear to be as important to the functional 
structure of domain V as stems. The sequence of this loop is particularly highly conserved 
in enteroviruses which would suggest a vital role in the lifecycle of the virus rather than
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simply acting as a spacer. Indeed many of the loop sequences in the secondary structure of 
the 5 ’NCR have highly conserved sequences.
The results presented in this chapter give further support to the importance of the length of 
the three base loop. Quite clearly the deletion of a single base is detrimental to the virus 
making it ts. From analysis of the domain V secondary structure the virus cannot easily re­
form a three base stem from the disruption of bases in either stem (a) or (b) without 
significantly raising the free energy. In addition to this, the viruses made with two 
deletions in the loop were non viable. It is possible that the viruses may have been able to 
grow if incubated at a lower temperature. A three base loop in this position may therefore 
allow the correct folding of the domain to occur. A change in loop length could affect the 
overall shape of the domain to a greater extent than a change in stem length. Domain V is 
always depicted as being flat but in reality it is likely to have a three dimensional shape. 
This shape is thought to interact with other domains to form the 1RES required for 
initiation of protein synthesis. There would be some limit as to length of stem but changes 
in lengths of loop could alter the folding and reduce the efficiency of initiation of protein 
synthesis.
The selection of revertants of LLA476 may provide more information of the sequence 
requirements of domain V. Non ts revertant viruses selected in BGM cells would be 
expected to have changes in 2A and previous experience is such that a deletion is very 
difficult to revert by base substitution. From the results above, if revertants were selected 
in L20B cells they would have a three base loop formed from the unpairing of the adjacent 
base pair in either stem (a) or (b).
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The results presented here also suggest that changes in the sequence of the loop can be 
accommodated by the virus. A virus with an AUC loop is slightly more ts than a virus 
with a UAA loop which suggests that folding may have been affected by the introduction 
of steric hindrance. This was a little surprising as the high sequence conservation 
indicated a specific role for the sequence in tertiary structure or in protein interactions. 
The reconstruction of the other loop sequences, currently available as inserts into an M l3 
sub- clone, could confirm these observations. The behaviour of the sequence constructed 
in sub clones M39.1 and M39.5 would be especially interesting as the G bases allow 
rearrangements to occur which shorten the loop and probably result in ts viruses. In a 
further investigation of the requirements of loop length, revertants selected from these 
would be predicted to have mutations that allow the three base loop to be re-formed.
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CHAPTER SEVEN
REQUIREMENTS OF BASE PAIRS 483/528 AND 
484/514 TO DOMAIN V OF THE 5’NCR
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7.1 INTRODUCTION
Results from previous chapters have highlighted the importance of unpaired bases in loops 
on the flexibility or folding of the domain V secondary structure and chapter six addressed 
the requirements of the loop made up of bases 474-476. Other results have shown the 
significance of the large fourteen base loop made up of bases 514-527 and the ‘hinge’ in 
the opposite strand, formed by base 484 (type 3 numbering, see fig 7.1). A number of 
viruses with changes or deletions around this area have been discussed already and 
revertants selected from them have given some insight into the importance of secondary 
structure formed.
C c — 500 
C A
Cq -c  c
4 9 0 ^ —A A
C -G
G " C — 510 
G -C  (C)
A «U
480 G C ' G ^ / 5 1 4
U ^ ^ C C A U G G A
FIGURE 7.1 Predicted structure of domain V of the 5’NCR of polio viruses. Sequencing 
and numbering is of type 3 Leon virus. The four stems under discussion 
are named (a), (b), (c) and (d) for ease.
As discussed before, the rationale of the attenuating change found in domain V of the
5’NCR of Sabin 2 at 481 (484 in type 3 numbering) is not obvious. The base at position
484 is highly conserved as G (see chapter four, fig 4.10) and can potentially pair with the U
at 514 (see fig 7.1). However this is not likely to occur as allowing 484 to pair with 514 in
the Leon domain V secondary structure (whilst forcing the fourteen base loop between
stems (b) and (c) to unpair) using ‘foldRNA’ on GCG raises the free energy by 5.4
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kcal/mol. The G is therefore always shown as unpaired, able to form a ‘hinge’ at the loop 
between stems (b) and (c).
A change of G to A at 481 (484 in type 3 numbering) found in Sabin 2 is thought to favour 
the formation of a base pair with the U at 514 (Macadam et al., 1991b; Macadam et a l, 
1993). The ‘hinge’ nucleotide is therefore removed, the loop is reduced to thirteen bases 
and stem (d) increases from five to six base pairs. The ts and attenuated phenotypes are 
thought to arise from the 484/514 base pair altering the folding of domain V and raising the 
free energy of the functional structure. In revertant viruses a G at 484 is always selected in 
tissue culture and on passage through the gut, weakening the potential base pair with the U 
at 514. No other bases have been found at this position but this probably reflects the 
requirement for the base at 484 to be totally unpaired as a C or U would allow an 
alternative base pairing with the G at 527.
In chapter five the selection of a less ts variant of the virus LLA483 in L20B cells was 
described. LLA483 was originally produced by site directed mutagenesis of a 
Leon/Lansing clone and had a deletion at 483 (Macadam et a l, 1994). This deletion 
resulted in a domain V structure with a free energy value of -25.0 kcal/mol, a shortened 
stem (b) and an enlarged loop between stems (b) and (c) (see figure 7.2). As discussed in 
chapter five, the G at 484 can potentially make two GU base pairs, with either the U at 514 
or the U at 528. If either of these base pairs form, the predicted free energy value for the 
structure is raised by 3.7 kcal/mol and the ‘hinge’ base is lost. The significance of these 
potential base pairs is illustrated by the less severe ts phenotype of LLA483/528 compared 
to LLA483 (see chapter five). The double deletant has a shortened stem (b) but only one 
potential base pair partner for 484, as in the wild type sequence.
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The variant of LLA483 selected in L20B cells had two mutations, a change of G to A at 
482 and a change of G to A at 531. In figure 7.2, the probable domain V structure of both 
LLA483 and the variant are shown. The change at 482 may appear surprising as it destroys 
the base pair 482/529 and reduces stem (b) even further to five base pairs. However, this is 
compensated to some extent by the change at 531 which strengthens stem (b), changing a 
GU pair to a stronger AU pair. In addition, the A at 482 can then form the ‘hinge’ between 
stems (b) and (c) whilst allowing the original G in the ‘hinge’ to base pair with the U at 
514, increasing stem (c). This meant that the flexibility at the loop was the main 
consideration in this area of domain V rather than the precise lengths of stems (b) or (c).
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FIGURE 7.2 Probable structures of domain V of the 5’NCR in the virus LLA483 and a 
variant of this with changes of G to A at 482 and a G to A at 531. Both 
structures were calculated using ‘foldRNA’ and ‘squiggles’ programs of 
GCG.
In chapter three non ts revertants with changes in 2A selected in BGM cells from the virus 
LL514C were described. The parent virus, made by site directed mutagenesis of a 
Leon/Lansing clone (Skinner et al., 1989), was shown to be ts in BGM cells at 39°C (see 
chapter three, fig 3.3) and a 2A amino acid substitution was found to counteract this. The 
change of U to C at 514 in domain V of the 5’NCR would allow a GC base pair at 484/514 
to form. This could he seen as equivalent to the effect of a G to A change at 484 in Sabin 2
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and result in a similar change of folding in this area. Similarly LL484/514 AU was found 
to be ts (personal communication, A. J. Macadam). The G to A change at 484, as in Sabin 
2 allows a base pair of AU to form between 484 and 514.
Recently other clones of Leon/Lansing have been made by site directed mutagenesis of a 
Leon/Lansing clone by colleagues at Reading University. Changes at 483, 484, 514 and 
528 were introduced into the sequence in a number of combinations. Viruses generated 
from them would have different abilities to form base pairs at 483/528 and 484/514 and 
therefore may give insight as to the importance of base pairing in this region. The clones 
produced are listed below in table 7.1 along with other viruses already partly characterised 
with differences at the same bases. In addition any revertants selected from ts viruses 
would give information on secondary structure of domain V.
A
B
CLONES BASES AT 
483/528
BASES AT 
484/514
LL/GC/CC GC CC
LL/CA/CG CA CG
LL/CC/CC CC CC
LL/CG/CA CG CA
LIVCA/UC CA UC
LL/AG/GC AG GC
LL/CC/UC CC UC
VIRUS BASES AT 
483/528
BASES AT 
484/514
LEON/LANSING, LL/AU/GU AU GU
LL514C, LL/AU/GC AU GC
LL484/514 AU, LL/AU/AU AU AU
TABLE 7.1 Table A lists the clones and potential viruses of Leon/Lansing with
changes at 483,484, 514 and 528. Table B lists the Leon/Lansing viruses 
already in existence with changes at these positions.
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This chapter describes the generation of viruses with various changes at 483, 484, 514 and 
528 from these clones. The initial viability of the virus and the ts phenotype as measured 
in a plaque assay was used to determine the importance of sequence and structure of 
domain V at this ‘hinge’ area. The phenotypes of LL/AU/GC and LL/AU/AU previously 
recorded will also be discussed in terms of potential base pairing at 483/514 and 484/528.
RESULTS
7.2 RECONSTRUCTION OF VIRUSES
Plasmid DNA for each of the eleven clones was linearised using Sail (New England 
Biolabs) and RNA transcribed using T7 RNA polymerase. The RNA, diluted in the 1 X 
HBSS/glucose/DEAE-dextran mix, was used to transfect cell monolayers. A quarter of the 
mix was used to transfect HEp-2C cells in a 25cm^ flask and another quarter was used to 
transfect L20B cells in a 25cm  ^flask. These were incubated in liquid culture at 35°C until 
CPE was observed. The rest of the RNA was used to make serial 10 fold dilutions in the 1 
X HBSS/glucose/DEAE-dextran mix. HEp-2C and L20B cells in six well plates were 
inoculated with serial log dilutions, overlayed and incubated for three days. Plaques were 
picked following visualisation with neutral red before the plates were stained with 
naphthalene black. HEp-2C cells were used because they exert little selection pressure on 
poliovirus so that virus stocks would be representative of the original virus. L20B cells 
were also used to exploit the inability of changes in 2A to compensate for 5’NCR changes 
in these cells. Although poliovirus grows to slightly lower titres in L20B cells (Pipkin et 
a l, 1993) the selection pressure exerted by these cells to change in the 5’NCR could give 
rise to informative variants.
In chapter six, viruses were recovered from clones at least in duplicate to confirm the 
observed results. In contrast, the recovery of viruses described here was carried out once
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from each clone. Controls were also used as for all transfections: one set o f cells was mock 
transfected with the 1 X HBSS/glucose/DEAE-dextran mix and one set of cells was 
transfected with RNA made from a linearised clone of Leon/Lansing. In all cases, the 
mock transfected cells did not show CPE where as the Leon/Lansing transfected cells 
displayed CPE after 24-48 hours. Flasks of transfected cells were checked daily and frozen 
when complete CPE was detected. The supernatant from these flasks formed stocks of the 
resulting viruses. When no CPE was detected flasks were frozen after six days.
All HEp-2C derived virus stocks were checked for sequence at positions 483, 484, 514 and 
528. This was carried out by RNA extraction, cDNA synthesis and PCR amplification 
with primers PCR F and PCR 9 (see chapter two). Purified PCR products were sequenced 
using primer (xLL390 (see chapter two). Virus stocks were also assayed in BGM cells to 
measure the ts phenotype resulting from the mutations.
7.2.1 VIABILITY OF VIRUSES
Of all the combinations of bases at 483, 484, 514 and 528 that were tested, only one 
resulted in a non viable virus. This was LL/AG/GC. On assay in BGM cells at 35 °C, no 
plaques were obtained, even when the supernatant stock was used undiluted, from either 
HEp-2C or L20B cells. No PCR product could be obtained from RNA extracted from the 
supernatant stocks and positive controls were used to test the procedure. All other 
transfections were successful and the HEp-2C grown virus stocks were assayed in BGM 
cells. The viruses, LL/UA/GC, LL/AU/GA and LL/AU/AU were also assayed. Results 
can be seen in table 7.2 below.
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VIRUS Logio(pfu at 35°C/pfu at 
38°C) for BGM cells
LogioCpfu at 35°C/pfu at 
39°C) for BGM cells
Leon/Lansing
AU/GU
0.5 0.8
LL/GC/CC 2.0 >2.0*
LL/CA/CG 2.2 3.1
LL/CC/CC 1.7 2.2
LL/CG/CA 2.5 4.3
LIVCA/UC 2.3 >2.3*
LL/AG/GC - -
LL/CC/UC 0.7 >1*
LL/AU/GC 1.2 2.5
LL/AU/AU 1 4.5
TABLE 7.2 Table to show ts phenotypes in BGM cells of viruses with differences at
483/528 and 484/514. Values shown are the log difference between titre at 
35°C and the higher temperatures of 38°C and 39°C. For some viruses a 
finite value could not be obtained for the higher temperature as the titre of 
the virus was so low.
Observation of the domain V structure shown in fig 7.1 reveals that the potential for base 
pairs 483/528 and 484/514 relies fundamentally of the bases found at these positions. 
Clearly, either there will be a mismatch or a pair formed, leaving four possible 
combinations in each virus. They are: pair/mismatch; mismatch/pair; pair/pair and 
mismatch/mismatch. All naturally occurring viruses have the pair/mismatch version as 
found in the virulent, non ts Leon type virus. However, from the results in table 7.2 above, 
there does not appear to be a finite connection between the bases formed at this point and ts 
phenotype displayed.
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7.3 PAIR/MISMATCH
PAIR/MISMATCH
VIRUS
Logio(pfu at 35°C/pfu 
at 38°C) for BGM cells
Logio(pfu at 35°C/pfu 
at 39°C) for BGM cells
Leon/Lansing AU/GU 0.5 0.8
LL/CG/CA 2.5 4.3
LL/GC/CC 2.0 >2.0
LL/AU/GA 3.3 4.3
TABLE 7.3 Temperature sensitivity of viruses with a pair/mismatch genotype at bases 
483/528 484/514 of domain V.
The viruses LL/CG/CA and LL/GC/CC should perhaps be discussed in the ‘pair/pair’
section below as the C in position 484 can form a base pair with the G at 527 at the end of
the loop adjacent to stem (b) (see fig 7.3). This results in a domain V structure with an
eight base stem (b), a thirteen base loop and no base in the hinge position. Calculated free
energy values of these structures are quite low at -27.6 kcal/mol {c.f. -27.5 kcal/mol for
Leon domain V) making them thermodynamically stable.
Folding of domain V could be disrupted to some extent as a result of different stacking of 
the loop sequence or because stem (b) is too long. Lengthening stem (b) has not been 
previously seen although a less ts variant of LLA483 had a stem (b) that was reduced from 
its parental six base pairs to five. This virus suggested a certain flexibility at this area of 
domain V provided by the ‘hinge’ base between stems (b) and (c) was more important than 
length of stem (b). These viruses without a ‘hinge’ base are ts and support this idea.
A virus with the ability to form a pair at 483/528 but no pair at 484/514 wiU have a domain 
V that has a seven base pair stem (b) and a fourteen base loop with a single base at the 
hinge (see fig 7.3). In the case of Leon/Lansing, this results in a viable, non ts, virulent 
virus, but in the case of LL/AU/GA, it results in a very ts virus. Comparison of these
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viruses shows that the type of base pair at 483/528 has no effect as both have AU at this 
position. They also both have a G at the 484 hinge position. However the G in 
Leon/Lansing is able to form a weak base pair with the U at 514 whereas the G in 
LL/AU/GA has no potential base pairs. This does not support the hypothesis for the 
requirement of an unpaired ‘hinge’ base as LL/AU/GA would be predicted to be non ts. 
The only difference between these viruses is at position 528, the end base in the loop 
adjacent to stem (b). It is possible that a difference at this position interferes with the 
stacking or folding of the loop and causes the virus to be ts. This virus is however very ts 
and it would appear unlikely that a simple perturbation in the folding of the loop would 
bring about such a strong effect.
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FIGURE 7.3 Probable domain V structures of viruses Leon, LL/CG/CA, LL/GC/CC and 
LL/AU/GA. The structures were calculated using ‘foldRNA’ and 
‘squiggles’ GCG programs. Free energies are indicated.
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7.4 MISMATCH/PAIR
MISMATCH/PAIR
VIRUS
Logio(pfu at 35°C/pfu 
at 38°C) for BGM cells
Logio(pfu at 35°C/pfu 
at 39°C) for BGM cells
LL/CA/CG 2.2 3.1
LL/AG/GC NON VIABLE NON VIABLE
TABLE 7.4 Temperature sensitivity of viruses with a mismatch/pair genotype at bases 
483/528 484/514 of domain V.
A mismatch/pair combination at this area of domain V would result in a structure with only 
six base pairs in stem (b), a fourteen base loop with a single base hinge and an increase to 
six base pairs in stem (c) (see fig 7.4). The mismatch/pair combination might be thought of 
as the ‘opposite’ of that found in Leon/Lansing but is such that a single ‘hinge’ base can 
stiU form. Previous results would predict that these viruses would be non ts when in actual 
fact they are very ts or non viable.
The requirement for flexibility at the ‘hinge’ base could feasibly be altered in the case of 
LL/AG/GC. The bases in the loop are such that a strong base pair could form between the 
G at 528 and the C at 514 in the large loop between stems (b) and (c). This would disrupt 
the secondary structure quite considerably and possibly promote the pairing of other bases 
in the loop which is thought to be unpaired according to analysis by strand specific 
reagents. Although there is potential for base pairing in this loop in the Leon domain V 
structure it does not occur so near to the ‘hinge’. This would add further support to the 
idea that flexibility at this region is required.
In previous chapters the reduction of stem (b) does not appear to be very detrimental to the 
vims. The increase in base pairs in stem (c) however has not been addressed until now.
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This could feasibly affect the way that the unpaired bases at the ‘apex’ of this domain V are 
presented to interact with either RNA in tertiary structure or with protein factors. Although 
there is some variation in this loop structure formed by bases 496-501 (see chapter four) 
this does not totally rule out interactions at this point.
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FIGURE 7.4 Probable domain V structures of viruses LL/CA/GC and LL/AG/GC as 
calculated using ‘foldRNA’ and ‘squiggles’ programs on GCG. The free 
energies of the structures are indicated.
7.5 PAIR/PAIR
PAIR/PAIR
VIRUS
Logio(pfu at 35°C/pfu 
at38°C)forBGMceUs
Logio(pfu at 35°C/pfu 
at 39°C) for BGM cells
LL/AU/GC 1.2 2.5
LL/AU/AU 1 4.5
TABLE 7.5 Temperature sensitivity of viruses with a pair/pair genotype at bases 
483/528 484/514 of domain V.
With base pairs at both 483/528 and 484/514 able to form, the domain V structure of these 
viruses could be quite constrained at this area. Stem (b) would have seven base pairs, as 
found in the Leon type virus, stem (c) would be increased to six base pairs and the loop 
would be decreased to thirteen bases (see fig 7.5). This loop also has potential base pairing 
between the G at 527 and the C at 515, equivalent to the potential base pairing discussed
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for LL/AG/GC. This extra base pair, combined with the lack of ‘hinge’ base would again 
alter the folding and flexibility of domain V at this area. The calculated free energy of 
these structures are relatively high. This contrasts with the low free energy values 
calculated for LL/CG/CA and LL/GC/CC which also have no ‘hinge’ base and are 
similarly ts. Again the lack of a ‘hinge’ would appear to be a major determinant of a ts 
phenotype.
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FIGURE 7.5 Probable domain V structures of viruses LL/AU/GC and LL/AU/AU
calculated using ‘foldRNA’ and ‘squiggles’ GCG programs. Free energies 
are indicated.
7.6 MISMATCH/MISMATCH
MISMATCH/MISMATCH
VIRUS
LogioCpfu at 35°C/pfu 
at 38°C) for BGM cells
LogioCpfu at 35°C/pfu 
at 38°C) for BGM cells
LL/CC/UC 0.7 >1
LL/CC/CC 1.7 2.2
LL/CA/UC 2.3 >2.3
TABLE 7.6 Temperature sensitivity of viruses with a mismatch/mismatch genotype at 
bases 483/528 484/514 of domain V.
These viruses have no ability to base pair at the positions being studied here. Therefore 
they have domain V structures that have a reduction to six base pairs in stem (b), two bases
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in the hinge position and fifteen bases in the loop (see fig 7.6). As previously discussed 
extra bases in the loop and hinge could affect the stacking of bases in the loop and the 
folding of the entire structure. This could conceivably contribute to the ts phenotype of a 
virus. However from the results in table 7.6 there is no direct link as the phenotype these 
viruses express varies. However LL/CC/CU may appear to be relatively non ts due to 
revertants arising during the assay.
The viruses UJCCJCC and LL/CC/UC are also capable of forming an alternative structure 
involving stem (b) and these are shown in fig 7.6. Both viruses have a C at 483 and this 
enables base pairs to form between 482/528 and 483/527, reducing the loop to thirteen 
bases, whilst the C at 529 in stem (b) is forced to unpair. A single base is then left in the 
‘hinge’ position. The unpaired base in stem (b) could conceivably alter the folding of the 
stem and the entire domain V structure, contributing to the ts phenotype of the virus. In 
both cases the free energy is decreased by 1 kcal/mol, making this the more energetically 
favourable form but with such a small energy difference it is possible that both structures 
are present in the virus population. Two bases in the ‘hinge’ position would therefore 
appear to be as detrimental to the virus as the absence of a ‘hinge’ base.
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FIGURE 7.6 Probable domain V structures of viruses LL/CC/UC, LL/CC7CC and
LL/CA/UC calculated using ‘foldRNA’ and ‘squiggles’ GCG programs. 
Free energies are indicated.
7.7 DISCUSSION
The results presented in this chapter are somewhat confusing. While on the whole the 
requirement for a finite flexibility from a single base in the ‘hinge’ position at 484 is 
upheld, not all the phenotypes of the viruses generated here can be totally rationalised in 
this way.
A mismatch/mismatch combination would result in two bases forming the ‘hinge’ and a 
pair/pair combination leaves no base at all in this position. All of these viruses are ts and 
would support the requirement for a single ‘hinge’ base except LL/CC/UC. The phenotype
1 8 6
of this virus cannot therefore be explained in terms of ‘hinge’ requirements. As sequencing 
confirmed the bases present it is possible that revertants may have arisen during the assay 
making the virus appear non ts. As the initial growth of the virus in HEp-2C cells did not 
appear to produce revertants so easily this would seem to be unlikely. Analysis of plaques 
from this virus would establish if this was true.
Some of the ts phenotypes could be a result of the potential base pairs in the thirteen base 
loop between stems (b) and (c). Although some potential base pairings exist in the Leon 
domain V loop these are not thought to form (see previous chapters) and therefore would 
appear to be detrimental to the functional structure. However not all of the viruses have 
this potential and remain ts. LL/AG/GC would be expected to have a single ‘hinge’ base 
and therefore be non ts but instead it is non viable. Both LL/AU/GA and LL/CA/CG 
would also be predicted to have a single ‘hinge’ base and little potential base pairing in the 
loop yet are still ts. The phenotypes of these viruses do not support the single ‘hinge’ base 
theory and cannot be rationalised in terms of requirements of functional structure at the 
moment unless the folding of the unpaired bases in the loop is considerably altered by a 
slight change in sequence or length.
The effects that the changes at the four bases around the loop exert are complex and in 
some cases allow alternative structures to form. Ideally other mutations should be 
introduced into the virus to further analyse the requirement of bases at this position. As 
other features of domain V were also altered in these clones it would be useful to singularly 
analyse the effects of these changes on the virus. Future clones to be made would include a 
deletion of only the ‘hinge’ base at 484, deletion or addition of bases to the thirteen base 
loop, substitutions of bases in the loop and adding or deleting base pairs in stem (b) and (c) 
(LLA483/527 already exists). The addition of an extra base into the ‘hinge’ without
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forming extra base pairs would also be informative but unfortunately this appears to be 
virtually impossible to achieve. Reversion of Sabin 2 always leaves a G at 481 because any 
other base in this position would result in the formation of other base pairs. However it is 
possible that inserting a C after the G in position 484 would fulfil this although the free 
energy of this is predicted to be high at -18.7 kcal/mol {c.f. -27.5 kcal/mol for Leon).
The results here show that the simple ‘hinge’ theory does not fully account for the sequence 
requirements of domain V in the region between stems (b) and (c). They also do not 
suggest an obvious alternative model. Analysis of revertants or variants of these viruses 
from plaque selection will undoubtedly give more insight as to the functional structure 
required. It might be expected that a single ‘hinge’ would be formed wherever possible 
and that potential base pairing in the loop would be removed if the discussions above have 
been correct. In addition revertants may also reveal why LL/AU/GA and LL/CA/CG are ts. 
The reconstruction of LL/AG/GC should also be repeated to ensure the virus is truly non 
viable.
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CHAPTER EIGHT
GENERAL DISCUSSION
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8.1 GENERAL DISCUSSION
The positive strand polioviruses have an unusually long 5’NCR with extensive secondary 
structure that is essential for replication and translation of the genomic RNA. Part of the 
secondary structure forms an internal ribosome entry site (1RES) which is able to steer the 
ribosomal initiation complex directly onto the RNA near to the initiating AUG codon. In 
contrast, most cellular RNA molecules have a cap structure at their 5’ ends and initiation of 
translation from them occurs by a scanning, cap-dependent mechanism. Polioviruses are 
able to inhibit cap-dependent translation and force an infected cell to preferentially 
synthesise viral proteins by the alternative cap-independent method. This is achieved, at 
least in part, by the cleavage of the initiation factor eIF4G by the viral protease 2A, which 
effectively removes the cap binding protein, eIF4E, from the initiating complex, eIF4F. 
Efficient initiation of viral translation requires an intact stem-loop secondary structure of 
the 1RES along with canonical cellular factors but is also enhanced by many other protein 
factors.
The 1RES is composed of domains II, IV, V and VI of the 5’NCR. Mutations in domain V 
which alter secondary structure confer a ts phenotype and reduce viral translation 
efficiency. Coding changes in poliovirus protease 2A are able to compensate in vitro for 
such mutations in the 5’NCR. This phenomenon was first reported in Macadam et a l, 
(1994) and consolidated by the results described in chapters three and five of this thesis, 
based on analysis of revertants and site directed mutants. The protease 2A is known to 
have several functions in the lifecycle of the virus, acting mainly as a protease both in 
polyprotein processing and in host cell translation shut off. Involvement of 2A as a 
transactivator of poliovirus 1RES driven translation was first reported by Hambidge & 
Samow (1992). This function was also later found to be a property of the human 
rhinovirus 2A proteinase acting with the cognate 1RES (Liebig et a l, 1993).
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Perhaps surprisingly a large number of different coding changes found along the entire 
length of 2A are able to compensate for a ts phenotype in BGM cells. The protease is fairly 
highly conserved among polioviruses. Limited variation of 2A was confirmed from 
sequence analysis of eight wild type polioviruses which were isolated over a number of 
years from a variety of countries. No X-ray crystallographic information exists for the 
structure of 2A, merely a putative a-carbon chain model of the protease based on sequence 
alignments with serine proteases. On the basis of the model, changes appear to be on the 
external surface of the protein, suggesting they affect interaction with other proteins or 
RNA molecules. However as the protein is relatively small this finding is not necessarily 
significant. As a result the structural consequence of the coding changes is difficult to 
resolve. Comparisons of picomaviral 2A sequences revealed variation specific to a genera 
and to viruses within a genus, in agreement with current published data. This was thought 
to reflect adaptation to different growth conditions.
The discovery that the compensatory mutations were cell specific indicates that this 
property of 2A requires cellular factors and that 2A probably does not interact directly with 
the 5’NCR. Interaction could involve general protein-protein association or factor cleavage 
by the proteolytic activity of 2A. The precise mechanism by which the protein is acting in 
this function is still unknown. It was suggested that the transactivating function of 2A 
existed so as to extend the range of cell types that polioviruses can infect (Hambidge & 
Samow 1992). Indeed changes in 2A, along with changes in VPl, were associated with 
mouse neurovirulence of the adapted mouse strain LS-a (Lu et al., 1994). Interestingly two 
of the three changes observed by Lu et a l, (1994), at residues 25 and 70, were found to be 
at positions where compensating mutations were identified. The change at 70 was the 
same as that found in a Leon/Lansing non ts revertant reported here. It was proposed
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therefore that the protease acts to enhance translation rather than as a fundamentally 
required factor, at least in vitro.
The transactivational activity of 2A was reported to be related to the protease activity 
(Ventoso & Carrasco 1995). Mutant 2A proteins with changes at residue 88 which were 
unable to cleave 3 CD also had a reduced ability to enhance translation from a reporter gene 
under control of a poliovirus 1RES in HeLa cells. Cleavage of eIF4G by the mutant protein 
was however not affected, indicating that the substrate specificity of 2A can be 
differentially altered. Proteolytic activity was also reported to be a requirement for full 
enhancement of rhinovirus translation by rhinovirus 2A (Ziegler et a i,  1995a). Reduced 
translational enhancement activity in rabbit reticulocytes was shown to result from either 
inhibiting 2A proteolysis with elastatinal or mutating the catalytic cysteine to serine.
However there is no evidence of the compensatory 2A mutations described in this thesis as 
having any effect on proteolytic activity. Although it is difficult to position these changes 
on the putative 2A model it is clear that most are not found at or near the catalytic triad. 
Indeed none of the changes were found to alter the highly conserved GDCGG proteolytic 
motif. In addition, protein translation experiments in Macadam et al., (1994) showed no 
effect on the shut off of host cell protein synthesis. In fact 2A mutations were found to act 
at a stage after the inhibition of host cell translation was achieved. This meant that 2A had 
a role in cap-independent translation other than cleavage of the initiation factor.
It is possible however that the changes to 2A alter the equilibrium of the reaction between 
the protease, its substrate and cleavage products, e.g. releasing more cleaved eIF4G for 
initiation of cap-dependent translation. This would provide some link of the changes to the 
proteolytic activity of 2A. Only the C-terminus of cleaved eIF4G is required for the
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translation of uncapped RNA, with or without an 1RES element (Ohlmann et a l, 1995; 
Ohlmann et a l,  1996; Pestova et a l, 1996) and eIF4G was suggested to be a factor 
involved in translation stimulation by Ziegler et a l, (1995a & 1995b). However eIF4G is 
unlikely to be the factor proposed to interact with 2A because there is no evidence of 2A 
being inefficient in its role of inhibiting cap-dependent translation. Indeed, proteolysis of 
eIF4G was observed even when poliovirus replication was severely inhibited so that only a 
low level of viral proteins will be present (Bonneau & Sonenberg 1987a). There is also no 
evidence for a fundamental factor such as eIF4G being absent or sufficiently different in 
either monkey CNS or L20B cells. Finally, the compensatory role of the 2A changes 
discussed here is an in vitro, cell specific observation and it is unlikely that the function 
observed involves a fundamental factor that is present in all cells.
Polioviral 2A proteinase is also reported to be required for replication. A bicistronic virus 
was constructed in which poliovirus 2A was replaced by an EMCV 1RES between PI and 
P2, removing the autocatalytic activity requirement of 2A (Molla et a l, 1993b). This virus 
was found to be non viable and negative results from RT-PCR lead to the conclusion that 
replication had been abolished. Similarly, site-directed mutation in 2A in full length 
clones were found to reduce RNA levels in transfected cells as shown by Northern blots 
(Yu et a l, 1995). However a reduction in RNA could equally be the result of a reduction 
in translation limiting viral proteins essential for replication. Results from protein labelling 
experiments in which infected cell sheets were incubated at the permissive temperature of 
35°C prior to labelling at elevated temperatures provided no evidence that the 
compensatory changes in 2A discussed here affect replication rates (personal 
communication, A. I Macadam). RNA dot blots of cytoplasmic lysates of infected cells 
also show no difference in RNA levels.
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It is possible that the coding changes in 2A act so as to diminish a binding function of the 
protease. A binding efficiency could easily be reduced by any number of amino acid 
changes. The unknown protein factor, once released can then act to enhance initiation of 
translation, either binding to the disrupted RNA or other protein factors and then directing 
the ribosumal machinery onto the 1RES. This binding function o f 2A could possibly be an 
additional function to the transactivating function previously reported as no link with 
proteolytic activity was found. The protease could fundamentally enhance translation in 
vivo as well as compensating for translation inefficiencies. Published work involved 
translation in cell culture, rabbit reticulocyte lysates and nuclease treated cytoplasmic 
extracts. In contrast the cell specific function of 2A described in this thesis was not 
identified using a cell free system, in which 2A may perform differently, and this would 
have given confusing results.
The binding function discussed here could itself be temperature dependent. This would 
mean that for a ts virus, the efficiency of translation would rise again at a higher 
temperature as the factor was released. It is possible that this is never observed because at 
the higher temperature other functions of the virus or host cell are disrupted.
Site directed mutants with different codons for residue 79 of 2A indicate that not all coding 
changes are able to equally compensate a disrupted domain V. Indeed not all domain V 
disruptions can be compensated for by 2A mutations. However, the changes introduced 
into residue 79 also suggest that RNA sequence has some role in the compensatory 
function. From initial evidence a protein rather than RNA function was suggested as all 
non ts revertants were found to have coding changes. The lack of any silent changes still 
suggests that the protein has some compensatory role instead of the RNA but this is an 
issue that needs to be addressed in the future.
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Changes in 2A appear to pose no threat to the monitoring of vaccine strains as they have no 
effect on monkey neurovirulence. Changes in 2A arising during vaccine manufacture are 
unlikely to affect test results and in fact may stabilise attenuating mutations. One of the 
compensatory changes in 2A, a change of serine to threonine at residue 134 is also found in 
Sabin 1. It is possible that this change is able to enhance initiation of translation from the 
Sabin 1 5’NCR which is disrupted by the change at 480 in domain V. This would remove 
some pressure on the virus to revert in domain V and help to explain why reversion of 480 
is slower than that of e.g. 472 U in Sabin 3 (Minor & Dunn 1988).
The discovery of these 2A changes does however demonstrate the unpredictability of a 
virus. Live attenuated vaccines will always need to monitored to ensure they will not cause 
adverse reactions to the vaccinee. A monkey neurovirulence test is currently the only 
means of assaying the vaccine’s potential to cause human disease at the moment. The test 
relies on the assumption that monkey neurovirulence is similar enough to human 
neurovirulence for a significant result. A transgenic mouse neurovirulence test could be 
feasible in the same way. Unfortunately molecular biology assays such as the MAPREC 
(mutant analysis by PCR and restriction enzyme cleavage) test (Chumakov et al., 1991) 
may never be able to replace the use of animals. Although the major determinant of Sabin 
3 attenuation is a mutation in domain V which can easily be detected by MAPREC, such an 
assay only tests the vaccine at a single site and will not detect spontaneous changes 
occurring elsewhere.
The observation that changes to 2A were unable to compensate for domain V disruptions in 
L20B cells provides an opportunity to identify the enhancing factor that is proposed to 
interact with 2A. Expression of BGM cDNA libraries in L20B cells using a modified 
CELICS technique may allow identification if the factor is totally absent from L20B cells
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or in limiting amounts. The CELICS method involves a p-galactosidase antibody 
conjugate which gives a blue colour in the presence of X-Gal and was used to identify the 
receptor for echo virus 7 (Ward et al., 1994).
Models of 5 ’NCR secondary structure were initially based on computer predictions, 
biochemical probing and supported by mutagenesis and revertant analysis. However, little 
is known about the region’s tertiary structure which is probably formed through sequence 
specific interactions of unpaired loops or stacking together of helical stems. The discovery 
that compensatory 2A coding changes were cell specific provided a useful system for the 
study of domain V and 5’NCR structure where reversion of site-directed mutants would 
not be complicated by changes in 2A.
U sing this system  (L20B cells), revertants of Sabin 2 were only found with an A to G 
change at 481 and no second site m utation appears to be able to com pensate for this 
disruption to the secondary structure. A lso using this system , variants o f LLA472 and 
site directed m utants revealed that the three base loop m ade up o f bases 474-476 
(type 3 num bering) could accom m odate sequence variation but not reductions in loop 
length. This suggested that the unpaired bases in the loop did not interact with 
either RNA or proteins but rather provide a spacer of specific length betw een base 
paired stem s. In addition, variants of LLA483 im plied a single ‘h inge’ base at 484 
(type 3 num bering) w ith as little potential base pairing was required  to give a specific 
flexibility  betw een stem s (b) and (c). A nalysis of site d irected  m utants produced 
inconclusive results and the exact requirem ents in this region o f dom ain V are still 
unknow n. Other published work on the requirem ents o f bases in the 474-476 
loop and 484 ‘h inge’ base have relied on crude insertions o f linker sequences into
196
domain V and revertants were only found to have re-formed some base pairings in stems 
(Haller & Semler 1992; Haller et a l, 1996).
Although no evidence for tertiary structure was obtained from reversion of ts viruses in 
L20B cells thus far, future experiments may help to pinpoint RNA/RNA interactions. 
Unpaired bases in loops are ideal candidates for this although sequence variation does 
indicate where this is unlikely. Comparison of sequencing evidence shows that the large 
loop between stems (b) and (c) is highly conserved. M utations that alter the length or 
sequence of this loop were also implicated in the ts phenotypes of site directed mutant 
viruses. However the sequence of the three base loop between stems (a) and (b) is also 
highly conserved yet sequence variation has only a limited effect on the virus. Further 
sequence comparisons of other domains would also identify potentially interacting loops. 
It is also possible that the six domains exist as individual entities until the ribosomal 
complex forms for initiation of translation. However close proximity of the domains 
would suggest that some kind of tertiary structure will form, perhaps altering to some 
extent when interacting with translational proteins.
The W H O ’s initiative to eradicate poliomyelitis and polioviruses is currently under debate 
and programs of when to stop vaccinations are being discussed. It is likely that eradication 
will be successful in the near future and this will mean that research on the virus will 
eventually be stopped. It is possible therefore that all polioviruses will be destroyed before 
some of the questions that have arisen from this thesis are answered. Issues may instead be 
addressed with other viruses in the picomavirus family such as enteroviruses and 
rhinoviruses.
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APPENDIX1 A  comparison of nucleotide sequences of the region coding for the protease 
2A obtained from nine wild type viruses. Alignment was calculated using 
GCG ‘pileup’ and ‘pretty’ programs. Conserved residues are shown as dashes 
(-) and differences to the consensus are in lower case. Gaps in the sequence 
are shown as full stops (.) where the sequence is incomplete. Numbering is 
from type 3 Leon.
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APPENDIX 2 A  comparison of nucleotide sequences of the region coding for the protease 
2A. Complete sequences were taken from the GenBank/EMBL database and 
aligned using GCG ‘pileup’ and ‘pretty’ programs. Conserved residues are 
shown as dashes (-) and differences to the consensus are in lower case. 
Numbering is from type 3 Leon. The virulent revertant of Sabin 3, Leon 119 
is also displayed to confirm the sequence is identical to Leon in this region.
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